Document:

Exhibit 10.33

 

TheStreet, Inc. 

Director Compensation Policy 

 

Effective January 1,
2016, non-employee directors of TheStreet, Inc. (the “Company”) shall be entitled to compensation for their services
as Board members as follows:

 

		·	Annual Cash Retainer for Board Service. Each non-employee director
shall receive an annual cash retainer in the amount of $30,000. The retainer is payable in arrears in equal quarterly installments
(on March 31st, June 30th, September 30th, and December 31st) and prorated as necessary to reflect service commencement
or termination during the quarter.

 

		·	Annual Equity Grants for Board Membership. Each non-employee
director shall receive an annual grant of Restricted Stock Units (“RSUs”) awarded under the Company’s 2007 Performance
Incentive Plan or other equity compensation plan approved by the Company’s shareholders (a “Plan”).  The
RSUs are awarded on the first business day of each year and the amount of RSUs so awarded shall be equal to (i) $60,000 divided
by (ii) the closing price of the Company’s common stock on the Nasdaq Stock Market on the date of grant; the RSUs awarded
to a director pursuant to this sentence vest on the first anniversary of the date of grant; provided that the RSUs shall be forfeited
(in whole or in part, as the Board may determine in its sole discretion) if the director’s service on the Board ceases prior
to the vesting date and the Board determines, in its sole discretion, that the circumstances of the cessation of the director’s
service on the Board warrant a total or partial forfeiture of the RSUs.  If a non-employee is elected as a director after
the first business day of the year (the date of such election, the “Commencement Date”), the director will receive,
effective upon the Commencement Date, an RSU grant and the amount of RSUs so awarded shall be equal to (a) (i) $60,000 divided
by (ii) the closing price of the Company’s common stock on the Nasdaq Stock Market on the date of grant, multiplied by (b)
a fraction, the numerator of which is the number of calendar days remaining in the year from and including the Commencement Date
and the denominator of which is the number of calendar days in the year; RSUs awarded to a director pursuant to this sentence shall
vest on the first business day of the following year; provided that the RSUs shall be forfeited (in whole or in part, as the Board
may determine in its sole discretion) if the director’s service on the Board ceases prior to the vesting date and the Board
determines, in its sole discretion, that the circumstances of the cessation of the director’s service on the Board warrant
a total or partial forfeiture of the RSUs.  Vesting of the RSUs awarded pursuant to this paragraph will automatically accelerate
upon the occurrence of a Change of Control of the Company, as defined in the applicable Plan.

 

     

     

    

  

		·	Annual Equity Grants for Membership of Certain Committees.
Each non-employee director of the Company’s Audit Committee, Compensation Committee and Nominating and Corporate Governance
Committee shall receive, with respect to each such committee membership, a grant of 5,000 stock options on the first business day
of each year, awarded under a Plan. If a director is appointed to any one or more of the Company’s Audit Committee, Compensation
Committee and Nominating and Corporate Governance Committee after the first business day of a year (the date of such appointment,
the “Appointment Date” with respect to such committee), the director shall receive, effective upon the Appointment
Date to each such committee, a grant of the number of stock options obtained by multiplying (a) 5,000 by (b) a fraction, the numerator
of which is the number of calendar days remaining in the year from and including the Appointment Date and the denominator of which
is the number of calendar days in the year. Stock options awarded pursuant to this paragraph with respect to membership on a committee
shall have an exercise price equal to the closing price of the Company’s common stock on the Nasdaq Stock Market on the date
of grant and shall vest on the first business day of the following year (or if earlier, upon the occurrence of a Change in Control
of the Company, as defined in the applicable Plan); provided that the stock options related to a committee shall be forfeited (in
whole or in part, as the Board may determine in its sole discretion) if the director’s service on the committee ceases prior
to the vesting date and the Board determines, in its sole discretion, that the circumstances of the cessation of the director’s
service on the committee warrant a total or partial forfeiture of the stock options. Stock options awarded pursuant to this paragraph
shall expire on the fifth (5th) anniversary of the date of grant to the extent not previously exercised or forfeited.

 

		·	Committee Chair Cash Retainers. In addition to the compensation
set forth above, the chair of each board committee identified below shall receive the following additional annual cash retainer
(paid quarterly in arrears and prorated as necessary to reflect service commencement or termination during the quarter), to compensate
him or her for the additional responsibilities and duties of the position:

 

		o	Audit - $20,000

		o	Compensation - $15,000

		o	Nominating and Corporate Governance - $10,000

 

		·	Annual Cash Retainer for Non-Executive Chairman. If the Board
has appointed a Non-Executive Chairman, the Non-Executive Chairman shall receive, in addition to the fees set forth above for Board
and committee service, an annual cash retainer in the amount of $20,000 (paid quarterly in arrears and prorated as necessary to
reflect service commencement or termination during the quarter) for service as Non-Executive Chairman. 

 

    2 

     

    

  

		·	Annual Equity Grant for Non-Executive Chairman. If the Board
has appointed a Non-Executive Chairman, the Non-Executive Chairman shall receive, in addition to the equity grants set forth above
for Board and committee service, an annual grant of RSUs awarded under a Plan.  The RSUs are awarded on the first business
day of each year and the amount of RSUs so awarded shall be equal to (i) $40,000 divided by (ii) the closing price of the
Company’s common stock on the Nasdaq Stock Market on the date of grant; the RSUs awarded to a Non-Executive Chairman pursuant
to this sentence vest on the first anniversary of the date of grant; provided that the RSUs shall be forfeited (in whole or in
part, as the Board may determine in its sole discretion) if the director’s service as Non-Executive Chairman ceases prior
to the vesting date and the Board determines, in its sole discretion, that the circumstances of the cessation of the director’s
service as Non-Executive Chairman warrant a total or partial forfeiture of the RSUs.  If a Non-Executive Chairman is appointed
after the first business day of the year (the date of such appointment, the “Designation Date”), the Non-Executive
Chairman will receive, effective upon the Designation Date, an RSU grant and the amount of RSUs so awarded shall be equal to (a)
(i) $40,000 divided by (ii) the closing price of the Company’s common stock on the Nasdaq Stock Market on the date of grant,
multiplied by (b) a fraction, the numerator of which is the number of calendar days remaining in the year from and including the
Designation Date and the denominator of which is the number of calendar days in the year; RSUs awarded to a Non-Executive Chairman
pursuant to this sentence shall vest on the first business day of the following year; provided that the RSUs shall be forfeited
(in whole or in part, as the Board may determine in its sole discretion) if the director’s service as Non-Executive Chairman
ceases prior to the vesting date and the Board determines, in its sole discretion, that the circumstances of the cessation of the
director’s service as Non-Executive Chairman warrant a total or partial forfeiture of the RSUs.  Vesting of the RSUs
awarded pursuant to this paragraph will automatically accelerate upon the occurrence of a Change of Control of the Company, as
defined in the applicable Plan. 

 

Last amended
December 16, 2015

 

    3Exhibit 10.1

 

 

STOCK PURCHASE AGREEMENT

 

dated March 2, 2016

 

by and among

 

HCSB FINANCIAL CORPORATION

 

and

 

The
purchasers identified on the signature pages hereto

 

    	 

     

    

Exhibit 10.1

 

STOCK PURCHASE AGREEMENT 

 

This Stock Purchase Agreement (this “Agreement”)
is dated as of March 2, 2016, by and among HCSB Financial Corporation, a South Carolina corporation (the “Company”),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser”
and collectively, the “Purchasers”).

 

RECITALS

 

      A.      The Company and each Purchaser are executing and delivering
this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act
of 1933 (the “Securities Act”) and Rule 506 of Regulation D (“Regulation D”) as promulgated
by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act.

 

      B.      Each Purchaser, severally and not jointly, wishes to purchase,
and the Company wishes to sell, upon the terms and conditions stated in this Agreement, that aggregate number of shares of (i)
voting common stock, par value $0.01 per share, of the Company (the “Common Stock”, set forth below such Purchaser’s
name on the signature page of this Agreement (which shall be collectively referred to herein as the “Common Shares”))
and (ii) a newly-issued series of convertible perpetual preferred stock, series A, par value $0.01 per share, of the Company
(the “Series A Preferred Stock”, set forth below such Purchaser’s name on the signature page of this Agreement
(which shall be collectively referred to herein as the “Series A Preferred Shares”)) which shall be convertible
into shares of the Common Stock subject to the terms and conditions set forth in the Articles of Amendment (as defined below) and,
following the adoption and subject to the terms and conditions of the Articles of Amendment, non-voting common stock of the Company,
par value $0.01 per share (the “Non-Voting Common Stock”). The Common Shares and the Series A Preferred Shares
shall be collectively referred herein to as the “Shares”. The Shares of Common Stock and Non-Voting Common Stock
into which the Series A Preferred Stock is convertible are referred to herein as the “Underlying Shares” and
the Underlying Shares and the Shares are referred to herein, collectively, as the “Securities.” Any Purchaser
that proposes to acquire a number of Common Shares that would exceed 10% of the Company’s total outstanding voting equity
immediately following the closing of this offering shall instead acquire Common Shares representing 9.9% of the total outstanding
voting equity immediately following the offering and any shares acquired in excess of this amount shall be issued as Series A Preferred
Shares. The Company anticipates these shares of Series A Preferred Shares would be converted into shares of a newly created class
of Non-Voting Common Stock at the Company’s next annual shareholders’ meeting.

 

      C.      The Company has engaged Hovde Group, LLC as its placement
agent (the “Placement Agent”) for the offering of the Shares, as well as for the shares of Common Stock offered
to the Other Investors (as defined below).

 

      D.      Contemporaneously with the execution and delivery of this
Agreement, the Company and the Purchasers are executing and delivering a registration rights agreement, substantially in the form
attached hereto as Exhibit A (the “Registration Rights Agreement”), pursuant to which, among other things,
the Company will agree to provide certain registration rights with respect to the Securities under the Securities Act and the rules
and regulations promulgated thereunder and applicable state securities laws.

 

      E.      The Company and the Purchasers acknowledge that the Company
has valuable net operating loss (“NOL”) carry-forwards, the use of which would be limited if the Company were
to experience an “ownership change” under Section 382 of the Code as a result of the transfer of the Securities issuable
hereunder (or upon conversion of the Shares into the Underlying Shares), and accordingly, the Company and the Purchasers further
acknowledge that any prospective transferee of the Securities will be required to provide the Transfer Agent with a representation
letter substantially in the form attached hereto as Exhibit M (the “Transferee Letter”) and that each
of the stock certificates issued in connection with this offering will contain a legend to ensure that a prospective transferee
is aware of this requirement. In addition, contemporaneously with the execution and delivery of this Agreement, the Company and
the Purchasers are executing and delivering a letter agreement, substantially in the form attached hereto as Exhibit N (the
“Prior Notice Letter”), pursuant to which, among other things, the Purchasers will agree to consult with the
Company at least 10 days prior to any proposed purchase or sale of Shares regarding the potential adverse tax impact that the purchase
or sale could have on the NOLs and, if requested by the Company, to provide to the other party to the proposed purchase or sale
any disclosure prepared by the Company describing the potential adverse tax impact.

 

    	 	1	 

     

    

Exhibit 10.1

 

      F.      In addition to the Shares to be purchased by the Purchasers
pursuant to this Agreement, the Company intends to effect one or more private placement transactions with other accredited investors
(the “Other Investors”). On the Closing Date (as defined below), the Company will offer and sell to each Other
Investor, pursuant to subscription agreements with the Other Investors (the “Subscription Agreements”), the
number of shares of Common Stock subscribed by such Other Investor and accepted by the Company at a price per share equal to the
Purchase Price (as defined below). The aggregate number of shares that may be subscribed for pursuant to this Agreement and the
Subscription Agreements is 359,468,443 shares of Common Stock and 905,315.57 shares of Series A Preferred Stock. The Company reserves
the right to increase or decrease the size of the offering by up to 5%, subject solely to the receipt of any necessary approval
or nonobjection from the Federal Reserve Bank of Richmond for such increase or decrease.

 

NOW, THEREFORE, in consideration of the
mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and the Purchasers hereby agree as follows:

 

ARTICLE I 

DEFINITIONS 

 

1.1.       Definitions. In addition to
the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings
indicated in this Section 1.1:

 

“Acquisition Proposal” means
a written offer or proposal involving the Company or any Subsidiary with respect to: (i) any merger, reorganization, consolidation,
share exchange, share issuance, recapitalization, business combination, liquidation, dissolution or other similar transaction involving
any sale, issuance, lease, exchange, mortgage, pledge, transfer or other disposition of, all or a material portion of the assets
or equity securities or deposits of, the Company or any Subsidiary, in a single transaction or series of related transactions;
(ii) any tender offer or exchange offer for all or a material portion of the outstanding shares of capital stock of the Company
or any Subsidiary; or (iii) any public announcement of a proposal, plan or intention to do any of the foregoing or any agreement
to engage in any of the foregoing.

 

“Action” means any action,
suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition), or investigation pending
or, to the Company’s Knowledge, threatened against the Company, any Subsidiary, or any of their respective properties or
any officer, director, or employee of the Company or any Subsidiary acting in his or her capacity as an officer, director, or employee
before or by any Governmental Entity.

 

    	 	2	 

     

    

Exhibit 10.1

 

“Affiliate” means, with respect
to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls, is controlled by, or
is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Agency” has the meaning
set forth in Section 3.1(rr).

 

“Agreement” shall have the
meaning ascribed to such term in the Preamble.

 

“Articles of Amendment” has
the meaning set forth in Section 5.1(w).

 

“Articles of Incorporation”
means the Articles of Incorporation of the Company and all amendments thereto, as the same may be amended from time to time.

 

“Bank” means Horry County
State Bank, a South Carolina state bank.

 

“BHCA Control” has the meaning
set forth in Section 3.1(yy).

 

“BHCA” has the meaning set
forth in Section 3.1(b).

 

“Burdensome Condition” has
the meaning set forth in Section 4.16.

 

“Business Day” means a day,
other than a Saturday or Sunday, on which banks in South Carolina are open for the general transaction of business.

 

“Castle Creek” means Castle
Creek Capital Partners VI, LP. Castle Creek is also a Purchaser as such term is used in this Agreement.

 

“Castle Creek Side Letter”
means the letter agreement in the form attached hereto as Exhibit H, dated as of the Closing Date, between the Company and
Castle Creek.

 

“Change in Control” means,
with respect to the Company, the occurrence of any of the following events:

 

      (1)      any Person
or “group” (other than the Purchasers and their Affiliates) becomes a beneficial owner (as defined in Rules 13d-3 of
the Exchange Act), directly or indirectly, of 50% or more of the aggregate shares of Common Stock;

 

      (2)      any Person
or “group” (other than the Purchasers and their Affiliates) becomes a beneficial owner (as defined in Rules 13d-3 of
the Exchange Act), directly or indirectly, of 24.9% or more of the aggregate shares of Common Stock, and in connection with such
event, individuals who, on the date of this Agreement, constitute the board of directors cease for any reason to constitute at
least a majority of the board of directors;

 

      (3)      the consummation
of a merger, consolidation, statutory share exchange, or similar transaction that requires adoption by the Company’s shareholders
(a “Business Combination”), unless immediately following such Business Combination more than 50% of the total
voting power of the corporation resulting from such Business Combination (the “Surviving Corporation”), or,
if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership (as defined in Rules 13d-3
of the Exchange Act) of 100% of the voting securities eligible to elect directors of the Surviving Corporation, is represented
by Common Stock that was outstanding immediately before such Business Combination;

 

    	 	3	 

     

    

Exhibit 10.1

 

     (4)      the shareholders
of the Company approve a plan of liquidation or dissolution of the Company or a sale of all or substantially all of the Company’s
assets; or

 

     (5)     the Company has entered into a definitive
agreement, the consummation of which would result in the occurrence of any of the events described in clauses (1) through (4) of
this definition above.

 

“CIBC Act” means the Change
in Bank Control Act of 1978.

 

“Closing” means the closing
of the purchase and sale of the Shares pursuant to this Agreement.

 

“Closing Date” means the
Trading Day when all of the Transaction Documents have been executed and delivered by the applicable parties thereto, which shall
be no earlier than the third (3rd) Business Day after all of the conditions set forth in Sections 2.1, 2.2, 5.1 and
5.2 hereof are satisfied or waived, as the case may be, or such other date as the parties may agree.

 

“Code” means the Internal
Revenue Code of 1986, including the regulations and published interpretations thereunder.

 

“Commission” has the meaning
set forth in the Recitals.

 

“Common Shares” has the meaning
set forth in the Recitals.

 

“Common Stock” has the meaning
set forth in the Recitals and also includes any securities into which the Common Stock may hereafter be reclassified or changed.

 

“Company” has the meaning
set forth in the Preamble.

 

“Company Counsel” means Nelson
Mullins Riley & Scarborough LLP.

 

“Company Deliverables” has
the meaning set forth in Section 2.2(a).

 

“Company Reports” has the
meaning set forth in Section 3.1(mm).

 

“Company’s Knowledge”
means with respect to any statement made to the knowledge of the Company, that the statement is based upon the actual knowledge
of the executive officers of the Company having responsibility for the matter or matters that are the subject of the statement.

 

“Consent Order” means the
Consent Order, No. FDIC-10-822b, dated February 10, 2011, issued to the Bank by the FDIC and the SCBFI, as it may be amended, modified,
or supplemented from time to time.

 

“Control” (including the
terms “controlling,” “controlled by” or “under common control with”) means the possession,
direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the
ownership of voting securities, by contract, or otherwise for purposes of the BHCA or the CIBC Act.

 

“Covered Person” has the
meaning set forth in Section 3.1(vv).

 

    	 	4	 

     

    

Exhibit 10.1

 

“CRA” has the meaning set
forth in Section 3.1(pp).

 

“Data Room” means the electronic
data room prepared and maintained by the Company for purposes of this offering.

 

“Debentures” has the meaning
set forth in Section 5.1(i).

 

“Disclosure Materials” has
the meaning set forth in Section 3.1(h).

 

“Disqualification Event”
has the meaning set forth in Section 3.1(vv).

 

“Effective Date” means the
date on which the initial Registration Statement required by Section 2(a) of the Registration Rights Agreement is first declared
effective by the Commission.

“EJF”
means EJF Sidecar Fund, Series LLC – Series E. EJF is also a Purchaser as such term is used in this Agreement.

“EJF Side Letter”
means the letter agreement in the form attached hereto as Exhibit J, dated as of the Closing Date, between the Company and
EJF.

“Environmental Laws” has
the meaning set forth in Section 3.1(l).

 

“ERISA” has the meaning set
forth in Section 3.1(tt).

 

“Escrow Agent”
has the meaning set forth in Section 2.1(c).

 

“Escrow Agreement”
has the meaning set forth in Section 2.1(c).

 

“Exchange Act” means the
Securities Exchange Act of 1934 any successor statute, and the rules and regulations promulgated thereunder.

 

“FDIC” means the Federal
Deposit Insurance Corporation.

 

“Federal Reserve” means the
Board of Governors of the Federal Reserve System.

 

“GAAP” means U.S. generally
accepted accounting principles as applied by the Company.

 

“Governmental Entity” means
any court, administrative agency, arbitrator, or commission or other governmental or regulatory authority or instrumentality, whether
federal, state, local, or foreign, and any applicable industry self-regulatory organization or securities exchange.

 

“Insurer” has the meaning
set forth in Section 3.1(rr).

 

“Intellectual Property” has
the meaning set forth in Section 3.1(r).

 

“Investor Presentation” means
that certain Confidential Presentation for Accredited Investors prepared by the Company, dated December 2015.

 

    	 	5	 

     

    

Exhibit 10.1

 

“Law” means any federal,
state, county, municipal or local ordinance, permit, concession, grant, franchise, law, statute, code, rule or regulation or any
judgment, ruling, order, writ, injunction or decree promulgated by any Governmental Entity.

 

“Legend Removal Date” has
the meaning set forth in Section 4.1(c).

 

“Lien” means any lien, charge,
claim, encumbrance, security interest, right of first refusal, preemptive right, mortgage, deed of trust, pledge, conditional sale
agreement, restriction on transfer or other restrictions of any kind.

 

“Loan Investor” has the meaning
set forth in Section 3.1(rr).

 

“Material Adverse Effect”
means any event, circumstance, change or occurrence that has had or would reasonably be expected to have (i) a material and
adverse effect on the legality, validity, or enforceability of any Transaction Document, (ii) a material and adverse effect
on the results of operations, assets, properties, business, condition (financial or otherwise), or prospects of the Company and
the Subsidiaries, taken as a whole, or (iii) any adverse impairment to the Company’s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document; provided, however, that clause (ii) shall not include
the impact of (A) changes in banking and similar laws of general applicability or interpretations thereof by any applicable
governmental authority, (B) changes in GAAP or regulatory accounting requirements applicable to banks and their holding companies
generally, (C) changes in general economic conditions, including interest rates, affecting banks generally, or (D) the
effects of any action or omission taken by the Company or the Bank with the prior written consent of the Purchasers, except, with
respect to clauses (A), (B) and (C), to the extent that the effect of such changes has a material and disproportionate impact
on the Company and the Subsidiaries, taken as a whole, relative to other similarly situated banks and their holding companies generally.

 

“Material Contract” means
any of the following agreements of the Company or any of its Subsidiaries:

 

(1) any contract containing covenants that limit
in any material respect the ability of the Company or any Company Subsidiary to compete in any line of business or with any person
or which involve any material restriction of the geographical area in which, or method by which or with whom, the Company or any
Company Subsidiary may carry on its business (other than as may be required by law or applicable regulatory authorities), and any
contract that could require the disposition of any material assets or line of business of the Company or any Company Subsidiary;

 

(2) any joint venture, partnership, strategic
alliance, or other similar contract (including any franchising agreement, but in any event excluding introducing broker agreements),
and any contract relating to the acquisition or disposition of any material business or material assets (whether by merger, sale
of stock or assets, or otherwise), which acquisition or disposition is not yet complete or where such contract contains continuing
material obligations or contains continuing indemnity obligations of the Company or any of the Company Subsidiaries;

 

(3) any real property lease and any other lease
with annual rental payments aggregating $100,000 or more;

 

(4) other than with respect to loans, any contract
providing for, or reasonably likely to result in, the receipt or expenditure of more than $250,000 on an annual basis, including
the payment or receipt of royalties or other amounts calculated based upon revenues or income;

 

    	 	6	 

     

    

Exhibit 10.1

 

(5) any contract or arrangement under which
the Company or any of the Company Subsidiaries is licensed or otherwise permitted by a third party to use any Intellectual Property
(as defined in Section 3.1(r)) that is material to its business (except for any “shrinkwrap” or “click through”
license agreements or other agreements for software that is generally available to the public and has not been customized for the
Company or the Company Subsidiaries) or under which a third party is licensed or otherwise permitted to use any Intellectual Property
owned by the Company or any of the Company Subsidiaries;

 

(6) any contract that by its terms limits the
payment of dividends or other distributions by the Company or any Company Subsidiary;

 

(7) any standstill or similar agreement pursuant
to which any party has agreed not to acquire assets or securities of another person;

 

(8) any contract that would reasonably be expected
to prevent, materially delay, or materially impede the Company’s ability to consummate the transactions contemplated by this
Agreement and the other Transaction Documents;

 

(9) any contract providing for indemnification
by the Company or any Company Subsidiary of any person, except for immaterial contracts entered into in the ordinary course of
business consistent with past practice;

 

(10) any contract that contains a put, call,
or similar right pursuant to which the Company or any Company Subsidiary could be required to purchase or sell, as applicable,
any equity interests or assets that have a fair market value or purchase price of more than $100,000; and

 

(11) any other contract or agreement which is
a “material contract” within the meaning of Item 601(b)(10) of Regulation S-K.

 

“Material Permits”
has the meaning set forth in Section 3.1(q).

“Mendon” means Mendon Capital
Master Fund Ltd., Mendon Capital QP LP, and Iron Road Multi-Strategy Fund LP, collectively. Mendon is also a Purchaser as such
term is used in this Agreement.

 

“Mendon Side Letter” means
the letter agreement in the form attached hereto as Exhibit I, dated as of the Closing Date, between the Company and Mendon.

 

“Money Laundering Laws” has
the meaning set forth in Section 3.1(kk).

 

“Non-Control Determination”
has the meaning set forth in Section 5.1(q).

 

“Non-Voting Common Stock”
has the meaning set forth in the Recitals.

 

“OFAC” has the meaning set
forth in Section 3.1(jj).

 

“OTC Pink” means the marketplace
for trading over-the-counter stocks provided and operated by the OTC Market Group, Inc.

 

“Other Investor” has the
meaning set forth in the Recitals.

 

“Outside Date” means 120 days
following the date of this Agreement; provided that if such day is not a Business Day, the first day following such day that is
a Business Day.

 

    	 	7	 

     

    

Exhibit 10.1

 

“Person” means an individual,
corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint venture, sole
proprietorship, unincorporated organization, governmental authority, or any other form of entity not specifically listed herein.

 

“Prior Notice Letter” has
the meaning set forth in the Recitals.

 

“Placement Agent” has the
meaning set forth in the Recitals.

 

“Principal Trading Market”
means the Trading Market on which the Common Stock is primarily quoted for trading, which, as of the date of this Agreement and
the Closing Date, shall be the OTC Pink.

 

“Private Placement Memorandum”
means the Company’s Private Placement Memorandum dated on or about March 2, 2016.

 

“Proceeding” means an action,
claim, suit, investigation, or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.

 

“Purchase Price” means $0.10
per Common Share or $10.00 per Series A Preferred Share.

 

“Purchaser Deliverables”
has the meaning set forth in Section 2.2(b).

 

“Purchaser” has the meaning
set forth in the Preamble.

 

“Purchaser Party” has the
meaning set forth in Section 4.8(a).

 

“Registration Rights Agreement”
has the meaning set forth in the Recitals.

 

“Registration Statement”
means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale
by the Purchasers, which are Registrable Securities (as defined in the Registration Rights Agreement).

 

“Regulation D” has the meaning
set forth in the Recitals.

 

“Regulatory Agreement” has
the meaning set forth in Section 3.1(oo).

 

“Required Approvals” has
the meaning set forth in Section 3.1(e).

 

“Rule 144” means Rule 144
promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule
or regulation hereafter adopted by the Commission having substantially the same effect as such Rule 144.

 

“SCBFI”
means the South Carolina Board of Financial Institutions.

“SEC Reports” has the meaning
set forth in Section 3.1(h).

 

“Secretary’s Certificate”
has the meaning set forth in Section 2.2(a)(vi).

 

“Securities” has the meaning
set forth in the Recitals.

 

    	 	8	 

     

    

Exhibit 10.1

 

“Securities Act” has the
meaning set forth in the Recitals.

 

“Series A Preferred Shares”
has the meaning set forth in the Recitals.

 

“Series A Preferred Stock”
has the meaning set forth in the Recitals.

 

“Series T Preferred Stock”
has the meaning set forth in Section 5.1(h).

 

“Shares” has the meaning
set forth in the Recitals.

 

“Solicitor” has the meaning
set forth in Section 3.1(vv).

 

“South Carolina
Courts” means the state and federal courts sitting in the State of South Carolina.

“Stock Certificates” has
the meaning set forth in Section 2.2(a)(ii).

 

“Subscription Amount” means
with respect to each Purchaser, the aggregate amount to be paid for the Shares purchased hereunder as indicated on such Purchaser’s
signature page to this Agreement next to the heading “Aggregate Purchase Price (Subscription Amount).”

 

“Subsidiary” means any entity
in which the Company, directly or indirectly, owns 50% or more of the outstanding capital stock or otherwise has Control over such
entity. For the avoidance of doubt, the Company Subsidiaries include the Bank and HCSB Financial Trust I, a special purpose subsidiary
organized for the sole purpose of issuing trust preferred securities.

 

“SVI” means Strategic Value
Investors, LP. SVI is also a Purchaser as such term is used in this Agreement.

 

“SVI Side Letter” means the
letter agreement in the form attached hereto as Exhibit K, dated as of the Closing Date, between the Company and SVI.

 

“Tax” or “Taxes”
mean (i) any federal, state, local or foreign income, gross receipts, property, sales, use, license, excise, franchise, employment,
payroll, withholding, alternative or add on minimum, ad valorem, transfer or excise tax, or any other tax, custom, duty, governmental
fee or other like assessment or charge of any kind whatsoever, together with any interest or penalty, imposed by any Governmental
Entity and (ii) any liability in respect of any items described in clause (i) above payable by reason of contract, assumption,
transferee or successor liability, operation of law, Treasury Regulations Section 1.1502-6(a) (or any predecessor or successor
thereof or analogous or similar provisions of Law) or otherwise.

 

“Tax Opinion” has the meaning
set forth in Section 5.1(p).

 

“Tax Return” means any return,
declaration, report or similar statement filed or required to be filed with respect to any Tax (including any attached schedules),
including, without limitation, any information return, claim for refund, amended return or declaration of estimated Tax.

 

“Trading Day” means (i) a
day on which the Common Stock is listed or quoted and traded on its Principal Trading Market, or (ii) if the Common Stock
is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by OTC
Markets Group, Inc. (including the OTC Pink); provided, that in the event that the Common Stock is not listed or quoted
as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day.

 

    	 	9	 

     

    

Exhibit 10.1

 

“Trading Market” means whichever
of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market,
or the OTC Pink on which the Common Stock is listed or quoted for trading on the date in question.

 

“Transaction Documents” means
this Agreement, the Schedules and Exhibits attached hereto, including the VCOC Letter Agreement, the Castle Creek Side Letter,
the Mendon Side Letter, the EJF Side Letter, and the SVI Side Letter, the Prior Notice Letter, the Registration Rights Agreement,
the Articles of Amendment, and any other documents or agreements executed by the Company or the Purchasers in connection with the
transactions contemplated hereunder.

 

“Transfer Agent” means Broadridge
Financial Solutions, Inc. or any successor transfer agent for the Company.

 

“Transferee Letter” has the
meaning set forth in the Recitals.

 

“Treasury” has the meaning
set forth in Section 5.1(h).

 

“U.S. Sanctions Laws” has
the meaning set forth in Section 3.2(q).

 

“Underlying Shares” has the
meaning set forth in the Recitals.

 

“VCOC Letter Agreement” means
the letter agreement in the form attached hereto as Exhibit G, dated as of the Closing Date, between the Company and Castle
Creek.

 

“Warrant” has the meaning
set forth in Section 5.1(h).

 

“Written Agreement”
means the Written Agreement, Docket No. 11-034-WA/RB-HC, dated May 9, 2011, by and between the Company and the Federal
Reserve Bank of Richmond, as it may be amended, modified, or supplemented from time to time.

 

ARTICLE II 

PURCHASE AND SALE 

 

2.1.       Closing.

 

(a)       Purchase of Shares. Subject
to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and sell to each Purchaser, and
each Purchaser shall, severally and not jointly, purchase from the Company, the number of Shares set forth below such Purchaser’s
name on the signature page of this Agreement or any Subscription Agreement, as applicable, at a per share price equal to the Purchase
Price.

 

(b)       Closing. The Closing of the
purchase and sale of the Shares pursuant to this Agreement shall take place at the offices of Nelson Mullins Riley & Scarborough
LLP, Poinsett Plaza, Suite 900, 104 South Main Street, Greenville, SC 29601, on the Closing Date or at such other locations or
remotely by facsimile transmission or other electronic means as the parties may mutually agree.

 

(c)       Escrow. Subject to a satisfactory
pre-closing in form and substance satisfactory to each Purchaser, each Purchaser who does not require physical certificates to
be held immediately prior to the Closing shall deliver to a third party escrow agent (the “Escrow Agent”), pursuant
to a written escrow agreement between the Escrow Agent and the Company satisfactory to such Purchaser (the “Escrow Agreement”),
its Subscription Amount, in U.S. dollars and in immediately available funds, in the amount indicated below such Purchaser’s
name on the applicable signature page hereto under the heading “Aggregate Purchase Price (Subscription Amount)” by
wire transfer at least one Business Day prior to the Closing Date to the account provided by the Company.

 

    	 	10	 

     

    

Exhibit 10.1

 

(d)       Form of Payment. Unless otherwise
agreed to by the Company and a Purchaser or Other Investor (in each case as to itself only), on the Closing Date, (1) the
Company shall deliver to each Purchaser one or more stock certificates (if physical certificates are required by the Purchaser
to be held immediately prior to Closing; if not, then facsimile or “.pdf” copies of such certificates shall suffice
for purposes of Closing with the original stock certificates to be delivered within two Business Days of the Closing Date), evidencing
the number of Shares set forth on such Purchaser’s signature page to this Agreement, and (2) upon receipt thereof, each
Purchaser and Other Investor shall wire its Subscription Amount to the Company, in United States dollars and in immediately available
funds. For purposes of clarity, a Purchaser shall not be required to wire its Subscription Amount until it (or its designated custodian
per its delivery instructions) confirms receipt of its Shares.

 

2.2.       Closing Deliveries.

 

(a)      On or prior to the Closing, the Company
shall issue, deliver, or cause to be delivered to each Purchaser and Other Investor (unless otherwise indicated) the following
(the “Company Deliverables”):

 

(i) this Agreement, duly executed by the Company;

 

(ii) one or more stock certificates (if physical
certificates are required by the Purchaser to be held immediately prior to Closing; if not, then facsimile or “.pdf”
copies of such certificates shall suffice for purposes of Closing with the original stock certificates to be delivered within two
Business Days of the Closing Date), evidencing the Shares subscribed for by Purchaser hereunder, registered in the name of such
Purchaser or its nominee (the “Stock Certificates”);

 

(iii) a legal opinion of Company Counsel, dated
as of the Closing Date and in the form attached hereto as Exhibit C, executed by such counsel and addressed to the
Purchasers;

 

(iv) a copy of the Tax Opinion;

 

(v) the Registration Rights Agreement duly
executed by the Company;

 

(vi) a certificate of the Secretary of the
Company, in the form attached hereto as Exhibit E (the “Secretary’s Certificate”), dated as of
the Closing Date, (a) certifying the resolutions adopted by the board of directors of the Company or a duly authorized committee
thereof approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Shares
pursuant to this Agreement and the other Transaction Documents and Common Stock pursuant to the Subscription Agreements, (b) certifying
the current versions of the Articles of Incorporation and Bylaws of the Company, and (c) certifying as to the signatures and
authority of persons signing the Transaction Documents and related documents on behalf of the Company;

 

(vii) a certificate, dated as of the Closing
Date and signed by its President and Chief Executive Officer or its Chief Financial Officer, substantially in the form attached
hereto as Exhibit F;

 

(viii) a Certificate of Existence for each
of the Company and the Bank from the South Carolina Secretary of State as of a recent date;

 

    	 	11	 

     

    

Exhibit 10.1

 

(ix) the Articles of Amendment to the Articles
of Incorporation filed with the South Carolina Secretary of State in the form attached hereto as Exhibit L;

 

(x) with respect to Castle Creek, the VCOC
Letter Agreement and the Castle Creek Side Letter;

 

(xi)      with respect to Mendon, the Mendon
Side Letter;

 

(xii) with respect to EJF, the EJF Side Letter;

 

(xiii) with respect to SVI, the SVI Side Letter;
and

 

(xiv) the Prior Notice Letters duly executed
by the Company.

 

(b)       On or prior to the Closing, each Purchaser
shall deliver or cause to be delivered to the Company the following (the “Purchaser Deliverables”):

 

(i) this Agreement, duly executed by such Purchaser;

 

(ii) subject to a satisfactory pre-closing
in form and substance satisfactory to each Purchaser, each Purchaser that does not require physical possession of a stock certificate
prior to funding shall deliver to the Escrow Agent, pursuant to the Escrow Agreement, its Subscription Amount, in U.S. dollars
and in immediately available funds, in the amount indicated below such Purchaser’s name on the applicable signature page
hereto under the heading “Aggregate Purchase Price (Subscription Amount)” by wire transfer at least one Business Day
prior to the Closing Date to the account provided by the Company;

 

(iii) the Registration Rights Agreement duly
executed by such Purchaser;

 

(iv) a fully completed and duly executed Accredited
Investor Questionnaire, reasonably satisfactory to the Company, in the form attached hereto as Exhibit B, respectively;

 

(v) with respect to Castle Creek, the VCOC
Letter Agreement and the Castle Creek Side Letter;

 

(vi) with respect to Mendon, the Mendon Side
Letter;

 

(vii) with respect to EJF, the EJF Side Letter;

 

(viii) with respect to SVI, the SVI Side Letter;
and

 

(ix) the Prior Notice Letter duly executed
by such Purchaser.

 

 

ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

 

3.1.       Representations and Warranties of
the Company. The Company hereby represents and warrants as of the date hereof and as of the Closing Date, except for the representations
and warranties that speak as of a specific date, which shall be made as of such date and qualified as set forth on the Disclosure
Schedules attached to this Agreement, to each of the Purchasers that:

 

    	 	12	 

     

    

Exhibit 10.1

 

(a)       Subsidiaries. The Company has
no direct or indirect Subsidiaries except as set forth in Exhibit 21 to the Company’s Annual Report on Form 10-K for the
year ended December 31, 2014, as filed with the Commission on March 30, 2015. The Company owns, directly or indirectly,
all of the capital stock (except for any preferred securities issued by Subsidiaries that are trusts) or comparable equity interests
of each Subsidiary free and clear of any and all Liens, and all the issued and outstanding shares of capital stock or comparable
equity interest of each Subsidiary are validly issued and are fully paid, non-assessable, and free of preemptive and similar rights
to subscribe for or purchase securities.

 

(b)       Organization and Qualification.
The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized, validly existing, and in good standing
under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority
to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor
any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation, bylaws, or
other organizational or charter documents. The Company and each of its Subsidiaries is duly qualified to conduct business and is
in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the
case may be, would not in the reasonable judgment of the Company be expected to have a Material Adverse Effect. The Company is
duly registered as a bank holding company under the Bank Holding Company Act of 1956 (the “BHCA”). The Bank
is the Company’s only Subsidiary banking institution. The Bank’s deposit accounts are insured up to applicable limits
by the FDIC, and all premiums and assessments required to be paid in connection therewith have been paid when due. The Company
has conducted its business in compliance with all applicable federal, state and foreign laws, orders, judgments, decrees, rules,
regulations, and applicable stock exchange requirements, including all laws and regulations restricting activities of bank holding
companies and banking organizations, in all material respects except as disclosed in Schedule 3.1(b).

 

(c)       Authorization; Enforcement; Validity.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and the Subscription Agreements and otherwise to carry out its obligations hereunder and thereunder,
including, without limitation, to issue the Securities in accordance with the terms hereof and to issue the shares of Common Stock
in accordance with the terms of the Subscription Agreements. The Company’s execution and delivery of each of the Transaction
Documents and the Subscription Agreements and the consummation by it of the transactions contemplated hereby and thereby (including,
but not limited to, the sale and delivery of the Securities pursuant to this Agreement and the other Transaction Documents and
the Common Stock issued pursuant to the Subscription Agreements) have been duly authorized by all necessary corporate action on
the part of the Company, and no further corporate action is required by the Company, its board of directors, or its shareholders
in connection therewith other than in connection with the Required Approvals. Each of the Transaction Documents and the Subscription
Agreements has been (or upon delivery will have been) duly executed by the Company and is, or when delivered in accordance with
the terms hereof or thereof, will constitute the legal, valid, and binding obligation of the Company enforceable against the Company
in accordance with its terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies
or by other equitable principles of general application, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law. There are no shareholder agreements, voting agreements, or other similar arrangements with respect
to the Company’s capital stock to which the Company is a party or, to the Company’s Knowledge, between or among any
of the Company’s shareholders.

 

    	 	13	 

     

    

Exhibit 10.1

 

(d)       No Conflicts. The execution,
delivery, and performance by the Company of the Transaction Documents and the Subscription Agreements and the consummation by the
Company of the transactions contemplated hereby or thereby (including, without limitation, the issuance of the Securities pursuant
to this Agreement and the other Transaction Documents and the Common Stock issued pursuant to the Subscription Agreements) do not
and will not, subject to receipt of the Required Approvals, (i) conflict with or violate any provisions of the Company’s
or any Subsidiary’s certificate or articles of incorporation, bylaws, or otherwise result in a violation of the organizational
documents of the Company or any Subsidiary, (ii) conflict with, or constitute a default (or an event that with notice or lapse
of time or both would result in a default) under, result in the creation of any Lien upon any of the properties or assets of the
Company or any Subsidiary or give to others any rights of termination, amendment, acceleration, or cancellation (with or without
notice, lapse of time or both) of, any agreement, indenture or instrument to which the Company or any Subsidiary is a party, or
(iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment,
injunction, decree, or other restriction of any court or governmental authority to which the Company is subject (including federal
and state securities laws and regulations and the rules and regulations thereunder, assuming, without investigation, the correctness
of the representations and warranties made by the Purchasers herein and by the Other Investors in the Subscription Agreements,
of any self-regulatory organization to which the Company or its securities are subject, including all applicable Trading Markets),
or by which any property or asset of the Company is bound or affected, except in the case of clauses (ii) and (iii) such
as would not have or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(e)      Filings, Consents and Approvals.
Neither the Company nor any of its Subsidiaries is required to obtain any consent, waiver, authorization, or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local, or other governmental authority,
self-regulatory organization, or other Person in connection with the execution, delivery, and performance by the Company of the
Transaction Documents and the Subscription Agreements (including, without limitation, the issuance of the Securities pursuant to
this Agreement and the other Transaction Documents and the Common Stock issued pursuant to the Subscription Agreements), other
than (i) the filing with the Commission of one or more Registration Statements in accordance with the requirements of the
Registration Rights Agreement, if applicable, (ii) filings required by any applicable state securities laws, (iii) the
filing of a Notice of Exempt Offering of Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) the
filing of any requisite notices and/or application(s) to the Principal Trading Market, if applicable, for the issuance, sale, and
listing or quotation of the Common Shares for trading or quotation, as the case may be, thereon in the time and manner required
thereby, (v) the filings required in accordance with Section 4.5 of this Agreement, (vi) the filing of any applicable
notices and/or applications to or the receipt of any applicable consents or non-objections from the state or federal bank regulatory
authorities that govern the Company or the Bank, (vii) the approval by the Company’s shareholders of the shareholder proposal
regarding the authorization of the shares of Non-Voting Common Stock to be issued on conversion of the Series A Preferred
Stock, (viii) the filing of the Articles of Amendment to create the Non-Voting Common Stock, and (viii) those that have been
made or obtained prior to the date of this Agreement (collectively, the “Required Approvals”). The Company is unaware
of any facts or circumstances relating to the Company or its Subsidiaries which would be likely to prevent the Company from obtaining
or effecting any of the foregoing.

 

(f)      Issuance of the Shares. The issuance
of the Shares has been duly authorized and the Shares, when issued and paid for in accordance with the terms of the Transaction
Documents, will be duly and validly issued, fully paid, and non-assessable and free and clear of all Liens, other than restrictions
on transfer imposed by applicable securities laws, restrictions contemplated by this Agreement and Liens, if any, created by a
Purchaser, and shall not be subject to preemptive or similar rights. The issuance of the Underlying Shares has been duly authorized
and the Underlying Shares, if and when issued in accordance with the terms of the Articles of Incorporation, will be duly and validly
issued, fully paid and non-assessable and free and clear of all Liens, other than restrictions on transfer imposed by applicable
securities Laws, restrictions contemplated by this Agreement and Liens, if any, created by a Purchaser, and shall not be subject
to preemptive or similar rights. Assuming the accuracy of the representations and warranties of the Purchasers in this Agreement
and the Other Investors in the Subscription Agreements, the Shares will be issued in compliance with all applicable federal and
state securities laws.

 

    	 	14	 

     

    

Exhibit 10.1

 

(g)     Capitalization.

 

(i)      The number
of shares and type of all authorized, issued, and outstanding capital stock and other securities of the Company (whether or not
presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) has been set forth in the
SEC Reports and has not changed since the date of such SEC Reports. All of the outstanding shares of capital stock of the Company
are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material respects with
all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase any capital stock of the Company. The shares of Series A Preferred Stock
(upon filing of the related Certificate of Designations with the Secretary of State of the State of South Carolina) will be duly
authorized by all necessary corporate action, and when issued and sold against receipt of the consideration therefor as provided
in this Agreement, such shares of Series A Preferred Stock will be validly issued, fully paid and non-assessable and free of preemptive
rights except for those stated herein. The shares of
Non-Voting Common Stock issuable upon the conversion of the Series A Preferred Stock will, upon receipt of the approval by the
Company’s shareholders of the shareholder proposal and filing of the related amendment to the Articles of Incorporation
with the Secretary of State of the State of South Carolina, have been duly authorized by all necessary corporate action and when
so issued upon such conversion or exercise will be validly issued, fully paid and non-assessable, and free of preemptive rights
except for those stated herein. The Company will reserve, free of any preemptive or similar rights of shareholders of the Company,
a number of unissued shares of Common Stock, sufficient to issue and deliver the Underlying Shares into which the Series A Preferred
Stock or Non-Voting Common Stock is convertible. No shares of the Company’s outstanding capital stock are subject to preemptive
rights or any other similar rights. There are no outstanding options, warrants, scrip, rights to subscribe to, calls, or commitments
of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares
of capital stock of the Company, or contracts, commitments, understandings or arrangements by which the Company is or may become
bound to issue additional shares of capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls, or
commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable
for, any shares of capital stock of the Company, other than the Warrant. There are no material outstanding debt securities, notes,
credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company or by
which the Company is bound, other than the Subordinated Notes and the Debentures. Except for the Registration Rights Agreement,
if applicable, there are no agreements or arrangements under which the Company is obligated to register the sale of any of its
securities under the Securities Act. There are no outstanding securities or instruments of the Company that contain any redemption
or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is or may
become bound to redeem a security of the Company or any of its Subsidiaries. The Company does not have any stock appreciation
rights or “phantom stock” plans or agreements or any similar plan or agreement. Neither the Company nor any of its
Subsidiaries has any liabilities or obligations required to be disclosed in the SEC Reports but not so disclosed in the SEC Reports,
which, individually or in the aggregate, will have or would reasonably be expected to have a Material Adverse Effect. There are
no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that
will be triggered by the issuance of the Shares pursuant to this Agreement and the other Transaction Documents or the Common Stock
issued pursuant to the Subscription Agreements.

 

    	 	15	 

     

    

Exhibit 10.1

 

(ii)     Immediately
following the Closing, (i) 363,314,783 shares of Common Stock, (ii) 905,315.57 shares of Non-Voting Preferred Stock, and (iii)
12,895 shares of Series T Preferred Stock will be issued and outstanding.

 

(h)       SEC Reports; Disclosure Materials.
Except as set forth on Schedule 3.1(h), the Company has filed all reports, schedules, forms, statements, and other documents
required to be filed by it under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 24 months
preceding the date hereof (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Reports” and together with the Private Placement Memorandum,
the Investor Presentation, the information in the Data Room, the third-party loan review reports, this Agreement, including the
Schedules and Exhibits hereto, the Disclosure Schedules, and any certificates furnished pursuant to this Agreement, the “Disclosure
Materials”), on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective filing dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Private Placement Memorandum does not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading.

 

(i)       Financial Statements. The financial
statements (including the notes thereto) of the Company and its Subsidiaries included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect
at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a consistent basis during
the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, complied, in all material respects, with applicable accounting
requirements and with the published rules and regulations of the SEC with respect thereto, and fairly present in all material respects
the balance sheet of the Company and its Subsidiaries taken as a whole as of and for the dates thereof and the results of operations,
shareholders’ equity, and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
year-end audit adjustments, which would not be material, either individually or in the aggregate.

 

(j)       Tax Matters.
The Company and each of its Subsidiaries has (i) timely filed all material foreign, U.S. federal, state and local Tax Returns that
are or were required to be filed, and all such Tax Returns are true, correct and complete in all material respects, (ii) paid all
material Taxes required to be paid by it and any other material assessment, fine or penalty levied against it, whether or not shown
or determined to be due on such Tax Returns, other than any such amounts (x) currently payable without penalty or interest, or
(y) being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance
with GAAP; (iii) timely withheld, collected or deposited as the case may be all material Taxes (determined both individually and
in the aggregate) required to be withheld, collected or deposited by it, and to the extent required, have been paid to the relevant
taxing authority in accordance with applicable Law; and (iv) complied with all applicable information reporting requirements in
all material respects. Neither the Company nor any Subsidiary (i) is subject to any outstanding audit, assessment, dispute or claim
concerning any material Tax liability of the Company or any of its Subsidiaries either within the Company’s Knowledge or
claimed, pending or raised by an authority in writing; (ii) is a party to, bound by or otherwise subject to any obligation under
any Tax sharing or Tax indemnity agreement or similar contract or arrangement (other than an agreement, similar contract or arrangement
to which only the Company and its Subsidiaries are parties); (iii) has participated in a “listed transaction” within
the meaning of Treasury Regulation Section 1.6011- 4(b)(2); or (iv) has any liability for Taxes of any Person arising from the
application of Treasury Regulation Section 1.1502-6 or any analogous provision of state, local or foreign Law, or as a transferee
or successor, by contract, or otherwise. No claim has been made by a tax authority in a jurisdiction where the Company or any Subsidiary
does not pay Taxes or file Tax Returns asserting that the Company or any Subsidiary is or may be subject to Taxes assessed by such
jurisdiction. Neither the Company nor any Subsidiary will be required to include any item of income in, or exclude any item of
deduction from, taxable income for any period (or any portion thereof) ending after the Closing as a result of any: (1) installment
sale or other open transaction disposition made on or prior to the Closing; (2) prepaid amount received on or prior to the Closing;
(3) written and legally binding agreement with a governmental authority relating to taxes for any taxable period ending on or before
the Closing; (4) change in method of accounting in any taxable period ending on or before the Closing; or (5) election under Section
108(i) of the Code.

    	 	16	 

     

    

Exhibit 10.1

 

(k)       Material Changes. Since the
date of the latest audited financial statements included within the SEC Reports, except as disclosed in subsequent SEC Reports
filed prior to the date hereof, (i) there have been no events, occurrences, or developments that have had or would reasonably
be expected to have, either individually or in the aggregate, a Material Adverse Effect, (ii) the Company has not incurred
any material liabilities (contingent or otherwise) other than (A) trade payables, accrued expenses, and other liabilities
incurred in the ordinary course of business consistent with past practice, and (B) liabilities not required to be reflected
in the Company’s financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the
Company has not altered materially its method of accounting or the manner in which it keeps its accounting books and records, (iv) the
Company has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed,
or made any agreements to purchase or redeem any shares of its capital stock, (v) the Company has not issued any equity securities
to any officer, director, or Affiliate, (vi) there has not been any material change or amendment to, or any waiver of any
material right by the Company under, any Material Contract under which the Company or any of its Subsidiaries is bound or subject,
and (vii) to the Company’s Knowledge, there has not been a material increase in the aggregate dollar amount of (A) the
Bank’s nonperforming loans (including nonaccrual loans and loans 90 days or more past due and still accruing interest) or
(B) the reserves or allowances established on the Company’s or the Bank’s financial statements with respect thereto.
Except for the transactions contemplated by this Agreement and the Subscription Agreements, no event, liability, or development
has occurred or exists with respect to the Company or its Subsidiaries or their respective business, properties, operations, or
financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation
is made that has not been publicly disclosed at least one Trading Day prior to the date that this representation is made. Moreover,
since the date(s) the Company afforded Purchaser (i) the opportunity to ask such questions as it has deemed necessary of,
and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Shares and
the merits and risks of investing in the Shares, and (ii) access to information about the Company and the Subsidiaries and
their respective financial condition, results of operations, business, properties, management, prospects, and any potential transactions
sufficient to enable it to evaluate its investment, there have been no events, occurrences, or developments that have materially
affected or would reasonably be expected to materially affect, either individually or in the aggregate, the information as presented
to the Purchasers in connection with the offering of the Shares.

 

(l)       Environmental Matters. Neither
the Company nor any of its Subsidiaries (i) is in violation of any Law of any Governmental Entity relating to the use, disposal
or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to
hazardous or toxic substances (collectively, “Environmental Laws”), (ii) is liable for any off-site disposal
or contamination pursuant to any Environmental Laws, (iii) owns or operates any real property contaminated with any substance that
is in violation of any Environmental Laws or (iv) is subject to any claim relating to any Environmental Laws; in each case, which
violation, contamination, liability or claim has had or would reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect; and there is no pending or, to the Company’s Knowledge, threatened investigation that might lead
to such a claim. Except as would not result in a Material Adverse Effect, there are no circumstances or conditions (including the
presence of asbestos, underground storage tanks, lead products, polychlorinated biphenyls, prior manufacturing operations, dry-cleaning
or automotive services) involving the Company or any of its Subsidiaries, or any currently or formerly owned or operated property
of the Company or any of its Subsidiaries, that could reasonably be expected to result in any claim, liability, investigation,
cost or restriction against the Company or any of its Subsidiaries, or result in any restriction on the ownership, use, or transfer
of any property pursuant to any Environmental Law, or adversely affect the value of any currently owned property of the Company
or any of its Subsidiaries.

 

    	 	17	 

     

    

Exhibit 10.1

 

(m)       Litigation. There is no Action
pending or, to the Company’s Knowledge, threatened, which (i) adversely affects or challenges the legality, validity,
or enforceability of any of the Transaction Documents, the issuance of Shares pursuant to this Agreement and the other Transaction
Documents or the Common Stock pursuant to the Subscription Agreements, or the conversion of the Shares of Series A Preferred Stock
into the applicable Underlying Shares, or (ii) except as disclosed in Schedule 3.1(m), is reasonably likely to be material to the
Company or any Subsidiary, individually or in the aggregate, if there were an unfavorable decision. Except as disclosed in the
SEC Reports or otherwise disclosed in Schedule 3.1(m), neither the Company nor any Subsidiary, nor any director or officer thereof,
is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty nor is any Action, to the Company’s Knowledge, currently threatened. There is no Action
by the Company or any Subsidiary pending or which the Company or any Subsidiary intends to initiate (other than collection or similar
claims in the ordinary course of business). Except as disclosed in the SEC Reports or otherwise disclosed in Schedule 3.1(m), there
has not been, and to the Company’s Knowledge there is not pending or contemplated, any investigation by the Commission involving
the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the Company or any of its Subsidiaries under the Exchange
Act or the Securities Act. With the exception of the Consent Order and the Written Agreement, there are no outstanding orders,
judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any
executive officers or directors of the Company in their capacities as such, which individually or in the aggregate, would reasonably
be expected to be material to the Company or any Subsidiary.

 

(n)       Employment Matters. No labor
dispute exists or, to the Company’s Knowledge, is imminent with respect to any of the employees of the Company or any Company
Subsidiary which would have or reasonably be expected to have a Material Adverse Effect. None of the employees of the Company or
any Company Subsidiary is a member of a union that relates to such employee’s relationship with the Company or any Company
Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company
and each Subsidiary believes that its relationship with its employees is good. To the Company’s Knowledge, there is no activity
involving any of the employees of the Company or any Company Subsidiary seeking to certify a collective bargaining unit or similar
organization. To the Company’s Knowledge, no executive officer is, or is now expected to be, in violation of any material
term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement,
or any other contract or agreement or any restrictive covenant in favor of a third party, and to the Company’s Knowledge,
the continued employment of each such executive officer does not subject the Company or any Company Subsidiary to any liability
with respect to any of the foregoing matters. The Company and each of its Subsidiaries are in compliance with all Laws and regulations
relating to employment and employment practices, immigration, terms and conditions of employment and wages and hours, except where
the failure to be in compliance would not have or reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect. As of the date of this Agreement, except as otherwise disclosed to the Purchasers, no material employee has given
notice to the Company or any of its Subsidiaries of his or her intent to terminate his or her employment or service relationship
with the Company or any of its Subsidiaries. The Company and its Subsidiaries are in material compliance with all Laws concerning
the classification of employees and independent contractors and have properly classified all such individuals for purposes of participation
in employee benefit plans.

 

    	 	18	 

     

    

Exhibit 10.1

 

(o)       Compliance. Neither the Company
nor any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any of its Subsidiaries under), nor has
the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it is in violation
of, any Material Contract (whether or not such default or violation has been waived), (ii) is in violation of any order (other
than the Consent Order and the Written Agreement) of which the Company has been made aware in writing of any court, arbitrator,
or governmental body having jurisdiction over the Company or its Subsidiaries or their respective properties or assets, (iii) is
in violation of, or in receipt of written notice that it is in violation of, any statute, rule, regulation, policy, guideline,
or order (other than the Consent Order and the Written Agreement) of any governmental authority or self-regulatory organization
(including the Principal Trading Market) applicable to the Company or any of its Subsidiaries, or which would have the effect of
revoking or limiting FDIC deposit insurance, except in each case as would not have or reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect.

 

(q)       Regulatory Permits. The Company
and each of its Subsidiaries possess or have applied for all certificates, authorizations, consents, and permits issued by the
appropriate federal, state, local, or foreign regulatory authorities necessary to conduct their respective businesses as currently
conducted and as described in the SEC Reports, except where the failure to possess such certificates, authorizations, consents,
or permits, individually or in the aggregate, has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect (“Material Permits”), and (i) neither the Company nor any of its Subsidiaries
has received any notice in writing of proceedings relating to the revocation or material adverse modification of any such Material
Permits, and (ii) the Company is unaware of any facts or circumstances that would give rise to the revocation or material
adverse modification of any Material Permits.

 

(q)       Title to Assets. The Company
and its Subsidiaries have good and marketable title to all real property and tangible personal property owned by them which is
material to the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear of all Liens, except
such as do not materially affect the value of such property or do not interfere with the use made and proposed to be made of such
property by the Company and any of its Subsidiaries. Any real property and facilities held under lease by the Company and any of
its Subsidiaries are held by them under valid, subsisting, and enforceable leases with such exceptions as are not material and
do not interfere with the use made and proposed to be made of such property and facilities by the Company and its Subsidiaries.
No notice of a claim of default by any party to any lease entered into by the Company or any of its Subsidiaries has been delivered
to either the Company or any of its Subsidiaries or is now pending, and there does not exist any event or circumstance that with
notice or passing of time, or both, would constitute a default or excuse performance by any party thereto. None of the owned or
leased premises or properties of the Company or any of its Subsidiaries is subject to any current or potential interests of third
parties or other restrictions or limitations that would impair or be inconsistent in any material respect with the current use
of such property by the Company or any of its Subsidiaries, as the case may be.

 

    	 	19	 

     

    

Exhibit 10.1

 

(r)       Patents and Trademarks. The
Company and its Subsidiaries own, possess, license, or have other rights to use all foreign and domestic patents, patent applications,
trade and service marks, trade and service mark registrations, trade names, copyrights, inventions, trade secrets, technology,
Internet domain names, know-how, and other intellectual property (collectively, the “Intellectual Property”)
necessary for the conduct of their respective businesses as now conducted or as proposed to be conducted as disclosed in the SEC
Reports except where the failure to own, possess, license, or have such rights would not have or reasonably be expected to have
a Material Adverse Effect. Except where such violations or infringements would not have or reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect, (a) there are no rights of third parties to any such Intellectual
Property, (b) there is no infringement by third parties of any such Intellectual Property, (c) there is no pending or
threatened action, suit, proceeding, or claim by others challenging the Company’s and its Subsidiaries’ rights in or
to any such Intellectual Property, (d) there is no pending or threatened action, suit, proceeding, or claim by others challenging
the validity or scope of any such Intellectual Property, and (e) there is no pending or threatened action, suit, proceeding,
or claim by others that the Company and/or any Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade
secret, or other proprietary rights of others.

 

(s)       Insurance. The Company and each
of the Subsidiaries are, and following the Closing Date will remain, insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as the Company reasonably believes to be prudent and customary in the businesses
and locations in which and where the Company and the Subsidiaries are engaged. The Company and the Company Subsidiaries have not
been refused any insurance coverage sought or applied for, and the Company and the Company Subsidiaries do not have any reason
to believe that they will not be able to renew their existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue their business at a cost that would not have a Material
Adverse Effect. All premiums due and payable under all such policies and bonds have been timely paid, and the Company and its Subsidiaries
are in material compliance with the terms of such policies and bonds. Neither the Company nor any of its Subsidiaries has received
any notice of cancellation of any such insurance, nor, to the Company’s Knowledge, will it or any Subsidiary be unable to
renew their respective existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that would be materially higher than their existing insurance coverage.
The Company (i) maintains directors’ and officers’ liability insurance and fiduciary liability insurance with
financially sound and reputable insurance companies with benefits and levels of coverage as disclosed in Schedule 3.1(s),
(ii) has timely paid all premiums on such policies, and (iii) there has been no lapse in coverage during the term of
such policies.

 

(t)       Transactions with Affiliates and
Employees. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and,
to the Company’s Knowledge, none of the employees of the Company or any Subsidiary, is presently a party to any transaction
with the Company or any Subsidiary or to a presently contemplated transaction (other than for services as employees, officers,
and directors) that would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Securities
Act.

 

(u)      Internal Control over Financial Reporting.
Except as set forth in the SEC Reports, the Company and its Subsidiaries maintain internal control over financial reporting (as
such term is defined in Rule 13a-15(f) under the Exchange Act) designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and has disclosed,
based on its most recent evaluation prior to the date of this Agreement, to the Company’s outside auditors and the audit
committee of the board of directors (A) any significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting that are reasonably likely to adversely affect the Company’s ability to record, process,
summarize, and report financial information, and (B) any fraud, whether or not material, that involves management or other employees
who have a significant role in the Company’s internal control over financial reporting. The Company has no knowledge of any
reason that its outside auditors and its principal executive officer and principal financial officer will not be able to give the
certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley
Act of 2002, without qualification, when next due. Since December 31, 2012 , (i) neither the Company nor any Company Subsidiary
nor, to the Company’s Knowledge, any director, officer, employee, auditor, accountant or representative of the Company or
any Company Subsidiary has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or
claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company
or any Company Subsidiary or their respective internal accounting controls, including any material complaint, allegation, assertion
or claim that the Company or any Company Subsidiary has engaged in questionable accounting or auditing practices, and (ii) no attorney
representing the Company or any Company Subsidiary, whether or not employed by the Company or any Company Subsidiary, has reported
evidence of a violation of securities laws, breach of fiduciary duty or similar violation by the Company, its Subsidiaries or any
of its officers, directors, employees or agents to the board of directors or any committee thereof or to any director or officer
of the Company or any of its Subsidiaries.

 

    	 	20	 

     

    

Exhibit 10.1

 

(v)       Sarbanes-Oxley; Disclosure Controls.
The Company is in compliance in all material respects with all of the provisions of the Sarbanes-Oxley Act of 2002 which are applicable
to it. Except as disclosed in the SEC Reports, the Company maintains disclosure controls and procedures (as such term is defined
in Rule 13a-15(e) and 15d-15(e) under the Exchange Act), and such disclosure controls and proceedings are effective.

 

(w)       Certain Fees. No person or entity
will have, as a result of the transactions contemplated by this Agreement, any valid right, interest, or claim against or upon
the Company, any Subsidiary or any Purchaser for any commission, fee, or other compensation pursuant to any agreement, arrangement,
or understanding entered into by or on behalf of the Company or any Subsidiary, other than the Placement Agent with respect to
the offer and sale of the Shares pursuant to this Agreement and the Other Transaction Documents and the Common Stock issued pursuant
to the Subscription Agreements (which placement agent fees are being paid by the Company and are set forth in the Disclosure Materials).

 

(x)       Private Placement. Assuming
the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2 of this Agreement, the accuracy
of the information disclosed in the Accredited Investor Questionnaires, and the accuracy of the Other Investors representations
and warranties set forth in the Subscription Agreements, no registration under the Securities Act is required for the offer and
sale of the Shares by the Company to the Purchasers under the Transaction Documents or the Common Stock to the Other Investors
pursuant to the Subscription Agreements. The issuance and sale of the Shares hereunder and the Common Stock pursuant to the Subscription
Agreements does not contravene the rules and regulations of the Principal Trading Market.

 

(y)       Registration Rights. Other than
each of the Purchasers and the Other Investors, no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary other than those securities which are currently registered
on an effective registration statement on file with the Commission.

 

    	 	21	 

     

    

Exhibit 10.1

 

(z)       No Integrated Offering. Assuming
the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2 and the accuracy of the Other
Investors’ representations and warranties set forth in the Subscription Agreements, none of the Company, its Subsidiaries
nor, to the Company’s Knowledge, any of its Affiliates or any Person acting on its behalf has, directly or indirectly, at
any time within the past six months, made any offers or sales of any Company security or solicited any offers to buy any security
under circumstances that would eliminate the availability of the exemption from registration under Regulation D under the Securities
Act in connection with the offer and sale by the Company of the Shares as contemplated hereby.

 

(aa)       Listing and Maintenance Requirements.
The Company’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and the Company has taken no
action designed to terminate the registration of the Common Stock under the Exchange Act nor has the Company received any written
notification that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding
the date hereof, received written notice from any Trading Market on which the Common Stock is listed or quoted to the effect that
the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance in all material respects with the listing
and maintenance requirements for continued trading of the Common Stock on the Principal Trading Market.

 

(bb)       Investment Company. Neither
the Company nor any of its Subsidiaries is required to be registered as, and is not an Affiliate of, and immediately following
the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company
Act of 1940.

 

(cc)       Unlawful Payments. Neither
the Company nor any of its Subsidiaries, nor to the Company’s Knowledge, any directors, officers, employees, agents, or other
Persons acting at the direction of or on behalf of the Company or any of its Subsidiaries has, in the course of its actions for,
or on behalf of, the Company or any of its Subsidiaries (a) directly or indirectly, used any corporate funds for unlawful
contributions, gifts, entertainment, or other unlawful expenses relating to foreign or domestic political activity, (b) made
any direct or indirect unlawful payments to any foreign or domestic governmental officials or employees or to any foreign or domestic
political parties or campaigns from corporate funds, (c) violated any provision of the Foreign Corrupt Practices Act of 1977,
or (d) made any other unlawful bribe, rebate, payoff, influence payment, kickback, or other material unlawful payment to any
foreign or domestic government official or employee.

 

(dd)       Application of Takeover Protections;
Rights Agreements. The Company has not adopted any shareholder rights plan or similar arrangement relating to accumulations
of beneficial ownership of its Common Stock or a Change in Control of the Company. The Company and its board of directors have
taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement), or other similar anti-takeover provision under the Company’s
Articles of Incorporation or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which
is or could become applicable to any Purchaser solely as a result of the transactions contemplated by this Agreement or to any
of the Other Investors solely as a result of the transactions contemplated by the Subscription Agreements, including, without limitation,
the Company’s issuance of the Shares, any Purchaser’s ownership of the Shares, the Company’s issuance of Common
Stock to any of the Other Investors, and any of the Other Investors’ ownership of shares of the Common Stock.

 

(ee)       No Undisclosed Liabilities.
There are no material liabilities or obligations of the Company or any of the Subsidiaries of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable, or otherwise, except for (i) liabilities appropriately reflected or reserved
against in accordance with GAAP in the Company’s audited balance sheet or that are otherwise disclosed in the footnotes to
the financial statements for the year ended December 31, 2014, and (ii) liabilities that have arisen in the ordinary
and usual course of business and consistent with past practice since December 31, 2014.

 

    	 	22	 

     

    

Exhibit 10.1

 

(ff)       Disclosure. The Company confirms
that neither it nor any of its officers or directors nor any other Person acting on its or their behalf has provided, and it has
not authorized the Placement Agent to provide, any Purchaser or its respective agents or counsel with any information that it believes
constitutes or could reasonably be expected to constitute material, non-public information except insofar as the existence, provisions,
and terms of the Transaction Documents and the proposed transactions hereunder may constitute such information, all of which will
be disclosed by the Company in the Initial Press Release or the Closing Press Release as contemplated by Section 4.7 hereof.
The Company understands and confirms that each of the Purchasers will rely on the foregoing representations in effecting transactions
in securities of the Company. No event or circumstance has occurred or information exists with respect to the Company or any of
its Subsidiaries or its or their business, properties, operations, or financial conditions, which, under applicable law, rule,
or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed,
except for the announcement of this Agreement and related transactions.

 

(gg)       Off Balance Sheet Arrangements.
There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other
off- balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed.

 

(hh)       Acknowledgment Regarding Purchasers’
Purchase of Shares. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an
arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The
Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser
or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated
thereby is merely incidental to the Purchasers’ purchase of the Shares.

 

(ii)       Absence of Manipulation. The
Company has not, and to the Company’s Knowledge no one acting on its behalf has, taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the
sale or resale of any of the Shares.

 

(jj)       OFAC. Neither the Company nor
any Subsidiary nor, to the Company’s Knowledge, any director, officer, agent, employee, Affiliate, or Person acting on behalf
of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (“OFAC”); and the Company will not knowingly use the proceeds of the sale of
the Shares towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar, or any other country sanctioned by OFAC or for
the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered by OFAC.

 

(kk)       Money Laundering Laws. The
operations of each of the Company and any Subsidiary are, and have been conducted at all times, in compliance in all material respects
with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder, and any related or similar
rules, regulations, or guidelines, issued, administered, or enforced by any applicable governmental agency (collectively, the “Money
Laundering Laws”), and to the Company’s Knowledge, no action, suit, or proceeding by or before any court or governmental
agency, authority, or body or any arbitrator involving the Company and/or any Subsidiary with respect to the Money Laundering Laws
is pending or threatened.

 

    	 	23	 

     

    

Exhibit 10.1

 

(ll)       No
Additional Agreements. The Company has no agreements or understandings (including, without limitation, side letters) with any
Purchaser or other Person to purchase shares of Common Stock or Series A Preferred Stock on terms more favorable to such Person
than as set forth herein, except that the Company may enter into one or more side letters,
including the Castle Creek Side Letter, the Mendon Side Letter, the EJF Side Letter, and the SVI Side Letter, to provide certain
Purchasers with the right to either appoint a representative to the Company’s board of directors or appoint a non-voting
observer to attend Company board meetings or certain other rights. Except for the Castle Creek Side Letter, the Mendon Side Letter,
the EJF Side Letter, the SVI Side Letter, and any such other side letters, the Company does not have any agreement or understanding
with any Purchaser with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction
Documents and in the Subscription Agreements. 

 

(mm)       Reports, Registrations and Statements.
Since January 1, 2013, the Company and each Subsidiary have filed all material reports, registrations, and statements, together
with any required amendments thereto, that it was required to file with the Federal Reserve, the FDIC, the SCBFI, and any other
applicable federal or state securities or banking authorities. All such reports and statements filed with any such regulatory body
or authority are collectively referred to herein as the “Company Reports.” As of their respective dates, the
Company Reports complied in all material respects with all the rules and regulations promulgated by the Federal Reserve, the FDIC,
the SCBFI, and any other applicable foreign, federal, or state securities or banking authorities, as the case may be.

 

(nn)       Bank Regulatory Capitalization.
As of December 31, 2015, the Bank was considered “significantly undercapitalized” under the FDIC’s regulatory
framework for prompt corrective action.

 

(oo)       Agreements with Regulatory Agencies.
Except for the Consent Order and the Written Agreement or otherwise disclosed in the SEC Reports, neither the Company nor any Subsidiary
is subject to any cease-and-desist or other similar order or enforcement action issued by, or is a party to any written agreement,
consent agreement, or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or is
subject to any capital directive by, or since December 31, 2013, has adopted any board resolutions at the request of, any
Governmental Entity that currently restricts in any material respect the conduct of its business or that in any material manner
relates to its capital adequacy, its liquidity and funding policies and practices, its ability to pay dividends, its credit, risk
management or compliance policies, its internal controls, its management, or its operations or business (each item in this sentence,
a “Regulatory Agreement”), nor has the Company or any Subsidiary been advised in writing since December 31,
2013 by any Governmental Entity that it intends to issue, initiate, order, or request any such Regulatory Agreement. Except as
set forth in Schedule 3.1(oo), the Company is in compliance in all material respects with the Regulatory Agreements.

 

(pp)       Compliance with Certain Banking
Regulations. To the Company’s Knowledge, there are no facts or circumstances, and the Company has no reason to believe
that any facts or circumstances exist, that would cause the Bank (i) to be deemed not to be in satisfactory compliance with
the Community Reinvestment Act (“CRA”) and the regulations promulgated thereunder or to be assigned a CRA rating by
federal or state banking regulators of lower than “satisfactory,” (ii) to be deemed to be operating in violation,
in any material respect, of the Bank Secrecy Act, the Uniting and Strengthening America by Providing Appropriate Tools Required
to Intercept and Obstruct Terrorism (USA PATRIOT) Act of 2001, any order issued with respect to anti-money laundering by OFAC,
or any other anti-money laundering statute, rule, or regulation, (iii) to be deemed not to be in satisfactory compliance,
in any material respect, with the Home Mortgage Disclosure Act, the Fair Housing Act, the Community Reinvestment Act, the Equal
Credit Opportunity Act, or (iv) to be deemed not to be in satisfactory compliance, in any material respect, with all applicable
privacy of customer information requirements contained in any applicable federal and state privacy laws and regulations as well
as the provisions of all information security programs adopted by the Bank.

 

    	 	24	 

     

    

Exhibit 10.1

 

(qq)       No General Solicitation or General
Advertising. Neither the Company nor, to the Company’s Knowledge, any person acting on its behalf has engaged or will
engage in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act)
in connection with any offer or sale of the Shares pursuant to this Agreement and the other Transaction Documents or the Common
Stock offered and sold pursuant to the Subscription Agreements.

 

(rr)       Mortgage Banking Business.
Except as has not had and would not reasonably be expected to have a Material Adverse Effect:

 

(i) The Company and each of its Subsidiaries
has complied with, and all documentation in connection with the origination, processing, underwriting, and credit approval of any
mortgage loan originated, purchased, or serviced by the Company or any of its Subsidiaries satisfied, (A) all applicable federal,
state, and local laws, rules, and regulations with respect to the origination, insuring, purchase, sale, pooling, servicing, subservicing,
or filing of claims in connection with mortgage loans, including all laws relating to real estate settlement procedures, consumer
credit protection, truth in lending laws, usury limitations, fair housing, transfers of servicing, collection practices, equal
credit opportunity, and adjustable rate mortgages, (B) the responsibilities and obligations relating to mortgage loans set
forth in any agreement between the Company or any of its Subsidiaries and any Agency, Loan Investor, or Insurer, (C) the applicable
rules, regulations, guidelines, handbooks, and other requirements of any Agency, Loan Investor, or Insurer, and (D) the terms
and provisions of any mortgage or other collateral documents and other loan documents with respect to each mortgage loan; and

 

(ii) No Agency, Loan Investor, or Insurer has
(A) claimed in writing that the Company or any of its Subsidiaries has violated or has not complied with the applicable underwriting
standards with respect to mortgage loans sold by the Company or any of its Subsidiaries to a Loan Investor or Agency, or with respect
to any sale of mortgage servicing rights to a Loan Investor, (B) imposed in writing restrictions on the activities (including
commitment authority) of the Company or any of its Subsidiaries, or (C) indicated in writing to the Company or any of its
Subsidiaries that it has terminated or intends to terminate its relationship with the Company or any of its Subsidiaries for poor
performance, poor loan quality, or concern with respect to the Company’s or any of its Subsidiaries’ compliance with
laws.

 

For purposes of this Section 3.1(rr),
(A) “Agency” means the Federal Housing Administration, the Federal Home Loan Mortgage Corporation, the
Farmers Home Administration (now known as Rural Housing and Community Development Services), the Federal National Mortgage Association,
the United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture, or any
other federal or state agency with authority to (i) determine any investment, origination, lending, or servicing requirements
with regard to mortgage loans originated, purchased, or serviced by the Company or any of its Subsidiaries, or (ii) originate,
purchase, or service mortgage loans, or otherwise promote mortgage lending, including state and local housing finance authorities,
(B) “Loan Investor” means any person (including an Agency) having a beneficial interest in any mortgage
loan originated, purchased, or serviced by the Company or any of its Subsidiaries or a security backed by or representing an interest
in any such mortgage loan, and (C) “Insurer” means a person who insures or guarantees for the benefit of
the mortgagee all or any portion of the risk of loss upon borrower default on any of the mortgage loans originated, purchased,
or serviced by the Company or any of its Subsidiaries, including the Federal Housing Administration, the United States Department
of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture, and any private mortgage insurer,
and providers of hazard, title, or other insurance with respect to such mortgage loans or the related collateral.

 

    	 	25	 

     

    

Exhibit 10.1

 

(ss)      Risk Management Instruments.
The Company and the Subsidiaries have in place risk management policies and procedures sufficient in scope and operation to protect
against risks of the type and in amounts reasonably expected to be incurred by companies of similar size and in similar lines of
business as the Company and the Subsidiaries. Except as has not had or would not reasonably be expected to have a Material Adverse
Effect, since January 1, 2014, all derivative instruments, including, swaps, caps, floors, and option agreements, whether
entered into for the Company’s own account, or for the account of one or more of the Subsidiaries, were entered into (1) only
in the ordinary course of business, (2) in accordance with prudent practices and in all respects with all applicable laws,
rules, regulations, and regulatory policies, and (3) with counterparties believed to be financially responsible at the time,
and each of them constitutes the valid and legally binding obligation of the Company or one of the Subsidiaries, enforceable in
accordance with its terms. Neither the Company nor the Subsidiaries, nor, to the Company’s Knowledge, any other party thereto,
is in breach of any of its obligations under any such agreement or arrangement.

 

(tt)       ERISA. The Company and its
Subsidiaries are in compliance in all material respects with all presently applicable provisions of the Employee Retirement Income
Security Act of 1974, including the regulations and published interpretations thereunder (“ERISA”); no “reportable
event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined in ERISA) for which
the Company or any Subsidiary would have any liability; the Company and its Subsidiaries have not incurred and does not expect
to incur liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan,
“ or (ii) Sections 412 or 4971 of the Code; and each “Pension Plan” for which the Company or any Subsidiary
would have liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects
and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification.

 

(uu)       Shell Company Status. The Company
is not, and has never been, an issuer identified in Rule 144(i)(1).

 

(vv)       No “Bad Actor” Disqualification.
The Company has exercised reasonable care, in accordance with Commission rules and guidance, and has conducted a factual inquiry
including the procurement of relevant questionnaires from each Covered Person (as defined below) or other means, the nature and
scope of which reflect reasonable care under the relevant facts and circumstances, to determine whether any Covered Person (as
defined below) is subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act (“Disqualification Events”). To the Company’s Knowledge, after conducting such sufficiently
diligent factual inquiries, no Covered Person is subject to a Disqualification Event, except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3) under the Securities Act. The Company has complied, to the extent applicable, with any disclosure obligations
under Rule 506(e) under the Securities Act. “Covered Persons” are those persons specified in Rule 506(d)(1)
under the Securities Act, including the Company, any predecessor or affiliate of the Company, any director, executive officer,
other officer participating in the offering, general partner or managing member of the Company, any beneficial owner of 20% or
more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, any promoter (as defined
in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of the sale of the Securities, and
any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with
the sale of the Shares (a “Solicitor”), any general partner or managing member of any Solicitor, and any director,
executive officer or other officer participating in the offering of any Solicitor or general partner or managing member of any
Solicitor.

 

    	 	26	 

     

    

Exhibit 10.1

 

(ww)       Nonperforming Assets. To the
Company’s Knowledge, since the date of the latest audited financial statements included within the SEC Reports, except as
disclosed in subsequent SEC Reports filed prior to the date hereof, the Company believes that the Bank will be able to fully and
timely collect substantially all interest, principal, or other payments when due under its loans, leases, and other assets that
are not classified as nonperforming and such belief is reasonable under all the facts and circumstances known to the Company and
Bank, and the Company believes that the amount of reserves and allowances for loan and lease losses and other nonperforming assets
established on the Company’s and Bank’s financial statements is adequate, and such belief is reasonable under all the
facts and circumstances known to the Company and Bank.

 

(xx)       No Change in Control. Neither
the Company nor any of its Subsidiaries is a party to any employment, Change in Control, severance, or other compensatory agreement
or any benefit plan pursuant to which the issuance of the Shares to the Purchasers as contemplated by this Agreement and the issuance
of the Common Stock to the Other Investors as contemplated by the Subscription Agreements would trigger a “change of control”
or other similar provision in any of the agreements, which results in payments to the counterparty or the acceleration of vesting
of benefits.

 

(yy)       Common Control. The Company
is not and, after giving effect to the offering and sale of the Shares, will not be under the control (as defined in the BHCA and
the Federal Reserve’s Regulation Y (12 CFR Part 225) (“BHCA Control”) of any company (as defined in the
BHCA and the Federal Reserve’s Regulation Y). The Company is not in BHCA Control of any federally insured depository institution
other than the Bank. The Bank is not under the BHCA Control of any company (as defined in the BHCA and the Federal Reserve’s
Regulation Y) other than Company. Neither the Company nor the Bank controls, in the aggregate, more than five percent of the outstanding
voting class, directly or indirectly, of any federally insured depository institution. The Bank is not subject to the liability
of any commonly controlled depository institution pursuant to Section 5(e) of the Federal Deposit Insurance Act (12 U.S.C.
§ 1815(e)).

 

(zz)      Material Contracts. The Company
has disclosed in the SEC Reports or otherwise made available to the Purchaser or its representatives, prior to the date hereof,
true, correct, and complete copies of, and listed on Schedule 3.1(zz), each Material Contract to which the Company or any Company
Subsidiary is a party or subject (whether written or oral, express or implied) as of the date of this Agreement. Each Material
Contract is a valid and binding obligation of the Company or any of its Subsidiaries (as applicable) that is a party thereto and,
to the Company’s Knowledge, each other party to such Material Contract, except for such failures to be valid and binding
as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Each such Material Contract
is enforceable against the Company or any of its Subsidiaries (as applicable) that is a party thereto and, to the Company’s
Knowledge, each other party to such Material Contract in accordance with its terms (subject in each case to applicable bankruptcy,
insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors’ rights generally and general
equitable principles, regardless of whether such enforceability is considered in a proceeding of law or at equity), except for
such failures to be enforceable as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Company Subsidiary, nor to the Company’s Knowledge, any other party to a Material Contract,
is in material default or material breach of a Material Contract and there does not exist any event, condition or omission that
would constitute such a default or breach (whether by lapse of time or notice or both), in each case, except as, individually or
in the aggregate, would not reasonably be expected to have a Material Adverse Effect.

 

    	 	27	 

     

    

Exhibit 10.1

 

3.2.       Representations and Warranties of
the Purchasers. Each Purchaser hereby, for itself and for no other Purchaser, represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:

 

(a)       Organization; Authority.

 

(i) If such Purchaser is an entity,
it is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its organization with the requisite
corporate, partnership, limited liability company, or other applicable similar power and authority to enter into and to consummate
the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. If such purchaser is an entity, the execution, delivery, and performance by such Purchaser of the applicable Transaction
Documents to which it is a party and the transactions contemplated by this Agreement have been duly authorized by all necessary
corporate or, if such Purchaser is not a corporation, such partnership, limited liability company, or other applicable like action,
on the part of such Purchaser. If such Purchaser is an entity, each of the applicable Transaction Documents to which it is a party
has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, or similar laws relating
to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general
application.

 

(ii) If
such Purchaser is not an entity, the execution, delivery, and performance by such Purchaser of the applicable Transaction Documents
to which it is a party and the transactions contemplated by this Agreement have been duly authorized. Each of the applicable Transaction
Documents to which such Purchaser is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against
such Purchaser in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation, or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application.

 

(b)       No Conflicts. The execution,
delivery, and performance by such Purchaser of this Agreement and the Registration Rights Agreement, if applicable, and the consummation
by such Purchaser of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational
documents of such Purchaser (if such Purchaser is an entity), (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture, or instrument to which such Purchaser is a party, or (iii) result in a violation
of any law, rule, regulation, order, judgment, or decree (including federal and state securities laws) applicable to such Purchaser,
except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights, or violations which would not,
individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Purchaser to
perform its obligations hereunder.

 

(c)       Investment Intent. Such Purchaser
understands that the Shares are “restricted securities” and have not been registered under the Securities Act or any
applicable state securities law and is acquiring the Shares as principal for its own account and not with a view to, or for distributing
or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities laws, provided,
however, that by making the representations herein, such Purchaser does not agree to hold any of the Shares for any minimum
period of time and reserves the right at all times to sell or otherwise dispose of all or any part of such Shares pursuant to an
effective registration statement under the Securities Act or under an exemption from such registration and in compliance with applicable
federal and state securities laws. Such Purchaser is acquiring the Shares hereunder in the ordinary course of its business. Such
Purchaser does not presently have any agreement, plan, or understanding, directly or indirectly, with any Person to distribute
or effect any distribution of any of the Shares (or any securities which are derivatives thereof) to or through any person or entity.

 

    	 	28	 

     

    

Exhibit 10.1

 

(d)       Purchaser Status. At the time
such Purchaser was offered the Shares, it was, and at the date hereof it is, an “accredited investor” as defined in
Rule 501(a) under the Securities Act. Such Purchaser has provided the information in the Accredited Investor Questionnaire attached
hereto as Exhibit B.

 

(e)       Reliance. The Company will be
entitled to rely upon this Agreement and is irrevocably authorized to produce this Agreement or a copy hereof to (A) any regulatory
authority having jurisdiction over the Company and its Affiliates, and (B) any interested party in any administrative or legal
proceeding or official inquiry with respect to the matters covered hereby, in each case, to the extent required by any court or
governmental authority to which the Company is subject, provided that the Company provides the Purchaser with prior written notice
of such disclosure to the extent practicable and allowed by applicable law.

 

(f)       General Solicitation. Such Purchaser
is not purchasing the Shares as a result of any advertisement, article, notice, or other communication regarding the Shares published
in any newspaper, magazine, or similar media or broadcast over television or radio or presented at any seminar or any other form
of “general solicitation” or “general advertising” (as such terms are used in Regulation D promulgated
under the Securities Act and interpreted by the Commission).

 

(g)       Direct Purchase. Purchaser is
purchasing the Shares directly from the Company and not from the Placement Agent. The Placement Agent did not make any representations
or warranties to Purchaser, express or implied, regarding the Shares, the Company, or the Company’s offering of the Shares.

 

(h)       Experience of Such Purchaser.
Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication, and experience in business
and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares and has
so evaluated the merits and risks of such investment. Such Purchaser is capable of protecting its own interests in connection with
this investment and has experience as an investor in securities of companies like the Company. Such Purchaser is able to hold the
Shares indefinitely if required, is able to bear the economic risk of an investment in the Shares, and, at the present time, is
able to afford a complete loss of such investment. Further, Purchaser understands that no representation is being made as to the
future trading value or trading volume of the Shares.

 

(i)       Access to Information. The Purchaser
is sufficiently aware of the Company’s business affairs and financial condition to reach an informed and knowledgeable decision
to acquire the Shares. Such Purchaser acknowledges that it has had the opportunity to review the Disclosure Materials and has been
afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, management
and representatives of the Company concerning the terms and conditions of the offering of the Shares and the merits and risks of
investing in the Shares and any such questions have been answered to such Purchaser’s reasonable satisfaction; (ii) access
to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business,
properties, management, and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain
such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. The Purchaser has received all information it deems appropriate
for assessing the risk of an investment in the Shares. Neither such inquiries nor any other investigation conducted by or on behalf
of such Purchaser or its representatives or counsel shall modify, amend, or affect such Purchaser’s right to rely on the
truth, accuracy, and completeness of the Disclosure Materials provided to such Purchaser and the Company’s representations
and warranties contained in the Transaction Documents. Such Purchaser has sought such accounting, legal, and tax advice as it has
considered necessary to make an informed decision with respect to its acquisition of the Shares. Purchaser acknowledges that neither
the Company nor the Placement Agent have made any representation, express or implied, with respect to the accuracy, completeness,
or adequacy of any available information except that the Company has made the express representations and warranties contained
in Section 3.1 of this Agreement.

 

    	 	29	 

     

    

Exhibit 10.1

 

(j)       Brokers and Finders. No Person
will have, as a result of the transactions contemplated by this Agreement, any valid right, interest, or claim against or upon
the Company or any Purchaser for any commission, fee, or other compensation pursuant to any agreement, arrangement, or understanding
entered into by or on behalf of such Purchaser.

 

(k)       Independent Investment Decision.
Such Purchaser has independently evaluated the merits of its decision to purchase Shares pursuant to the Transaction Documents,
and such Purchaser confirms that it has not relied on the advice of the Company or the Placement Agent (or any of their respective
agents, counsel, or Affiliates) or any other Purchaser or other Purchaser’s business and/or legal counsel in making such
decision. Such Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company
(including, without limitation, by the Placement Agent) to the Purchaser in connection with the purchase of the Shares constitutes
legal, regulatory, tax, or investment advice. Such Purchaser has consulted such legal, tax, and investment advisors as it, in its
sole discretion, has deemed necessary or appropriate in connection with its purchase of the Shares. Such Purchaser understands
that the Placement Agent has acted solely as the agent of the Company in this placement of the Shares and such Purchaser has not
relied on the business, legal, or regulatory advice of the Placement Agent or any of their agents, counsel, or Affiliates in making
its investment decision hereunder, and confirms that none of such Persons has made any representations or warranties to such Purchaser
in connection with the transactions contemplated by the Transaction Documents.

 

(l)       Reliance on Exemptions. Such
Purchaser understands that the Shares are being offered and sold to it in reliance on specific exemptions from the registration
requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy of,
and such Purchaser’s compliance with, the representations, warranties, agreements, acknowledgements, and understandings of
such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such Purchaser
to acquire the Shares.

 

(m)       No Governmental Review. Such
Purchaser understands that no U.S. federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor have such authorities
passed upon or endorsed the merits of the offering of the Common Shares.

 

(n)       Residency. Such Purchaser’s
residence (if an individual) or office in which its investment decision with respect to the Shares was made (if an entity) is located
at the address immediately below such Purchaser’s name on its signature page hereto.

 

(o)       Antitrust and Other Consents, Filings,
Etc. Assuming the accuracy of the Company’s representations and warranties regarding its capitalization, no approval,
consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Entity or authority or any
other person or entity in respect of any law or regulation, including the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, and the rules and regulations thereunder, is necessary or required to be obtained or made by such Purchaser, and no
lapse of a waiting period under law applicable to such Purchaser is necessary or required, in each case in connection with the
execution, delivery, or performance by such Purchaser of this Agreement or the purchase of the Shares contemplated hereby or the
Common Stock contemplated to be purchased under the Subscription Agreements, other than passivity or anti-association commitments
or other documentation that may be required by the Federal Reserve or other federal or state banking authority.

 

    	 	30	 

     

    

Exhibit 10.1

 

(p)       Trading. Purchaser acknowledges
that there is a very limited trading market for the Common Stock and that there will be no trading market for the Series A Preferred
Stock.

 

(q)       OFAC and Anti-Money Laundering.
The Purchaser understands, acknowledges, represents, and agrees that (i) the Purchaser is not the target of any sanction,
regulation, or law promulgated by the Office of Foreign Assets Control, the Financial Crimes Enforcement Network, or any other
U.S. Governmental Entity (“U.S. Sanctions Laws”), (ii) the Purchaser is not owned by, controlled by, under
common control with, or acting on behalf of any person that is the target of U.S. Sanctions Laws, (iii) the Purchaser is not
a “foreign shell bank” and is not acting on behalf of a “foreign shell bank” under applicable anti-money
laundering laws and regulations, (iv) the Purchaser’s entry into this Agreement or consummation of the transactions
contemplated hereby will not contravene U.S. Sanctions Laws or applicable anti-money laundering laws or regulations, (v) to
the extent permitted under applicable law, the Purchaser will promptly provide to the Company or any regulatory or law enforcement
authority such information or documentation as may be required to comply with U.S. Sanctions Laws or applicable anti-money laundering
laws or regulations, and (vi) the Company may provide to any regulatory or law enforcement authority information or documentation
regarding, or provided by, the Purchaser for the purposes of complying with U.S. Sanctions Laws or applicable anti-money laundering
laws or regulations.

 

(r)       Knowledge as to Conditions.
Purchaser does not know of any reason why any regulatory approvals and, to the extent necessary, any other approvals, authorizations,
filings, registrations, and notices required or otherwise a condition to the consummation by it of the transactions contemplated
by this Agreement will not be obtained, solely with respect to facts or circumstances related to the Purchaser.

 

(s)       Bank Holding Company Status.
Purchaser has not or is not acting in concert with any other Person in connection with the transactions contemplated by this Agreement
or the Subscription Agreements, other than Affiliates of the Purchaser identified by the Purchaser to the Company as Affiliates.
Assuming the accuracy of the representations and warranties of the Company contained herein, the Purchaser, either acting alone
or together with any other Person will not, directly or indirectly, own, control or have the power to vote, immediately after giving
effect to its purchase of Shares pursuant to this Agreement, in excess of 9.9% of the outstanding shares of the Company’s
voting stock of any class or series. Without limiting the foregoing, assuming the accuracy of the representations and warranties
of the Company contained herein, the Purchaser represents and warrants that it does not and will not as a result of its purchase
or holding of the purchased Shares or any other securities of the Company have “control” of the Company or the Bank,
and has no present intention of acquiring “control” of the Company or the Bank, for purposes of the BHCA or the CIBC
Act.

 

3.3       The Company and each of the Purchasers
acknowledge and agree that no party to this Agreement has made or makes any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Article III and the Transaction Documents.

 

    	 	31	 

     

    

Exhibit 10.1

 

ARTICLE IV 

OTHER AGREEMENTS OF THE PARTIES 

 

4.1.       Transfer Restrictions.

 

(a)       Compliance with Laws. Notwithstanding
any other provision of this Article IV, each Purchaser covenants that the Shares may be disposed of only pursuant to an effective
registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption
from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with any applicable
state, federal or foreign securities laws. In connection with any transfer of the Shares other than (i) pursuant to an effective
registration statement, (ii) to the Company, or (iii) pursuant to Rule 144 (provided that the transferor provides the
Company with reasonable assurances (in the form of a seller representation letter and, if applicable, a broker representation letter)
that such securities may be sold pursuant to such rule), the Company may require the transferor thereof to provide to the Company
and the Transfer Agent, at the transferor’s expense, an opinion of counsel selected by the transferor and reasonably acceptable
to the Company and the Transfer Agent, the form and substance of which opinion shall be reasonably satisfactory to the Company
and the Transfer Agent, to the effect that such transfer does not require registration of such transferred securities under the
Securities Act. As a condition of transfer (other than pursuant to clauses (i), (ii) or (iii) of the preceding sentence),
any such transferee shall agree in writing to be bound by the terms of this Agreement and the Prior Notice Letter and be required
to provide the Transfer Agent with the Transferee Letter and shall have the rights of a Purchaser under this Agreement and the
Registration Rights Agreement, if applicable, with respect to such transferred Shares.

 

(b)       Legends. Certificates evidencing
the Securities shall bear any legend as required by the “blue sky” laws of any state and a restrictive legend in substantially
the following form, until such time as they are not required under Section 4.1(c) or applicable law:

 

THE ISSUANCE OF THESE SECURITIES
HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS.
THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS
AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT
TO RULE 144 UNDER THE ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER
REPRESENTATION LETTER AND, IF APPLICABLE, A BROKER REPRESENTATION LETTER) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE).

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN A STOCK PURCHASE AGREEMENT, DATED AS OF MARCH 2,
2016, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE COMPANY AT THE COMPANY’S PRINCIPAL EXECUTIVE OFFICES.

 

    	 	32	 

     

    

Exhibit 10.1

 

(c)       Removal of Legends. Upon the
written request of the holder, the restrictive legend set forth in Section 4.1(b) above shall be removed and the Company shall
issue a certificate without such restrictive legend or any other restrictive legend (other than the legend described below in Section
4.1(d)) to the holder of the applicable Securities upon which it is stamped, if (i) such Securities are registered for resale
under the Securities Act, (ii) such Securities are sold or transferred pursuant to Rule 144, or (iii) such Securities
are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information
required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale restrictions.
Following the earlier of (A) the Effective Date or (B) Rule 144 becoming available for the resale of Securities, without
the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule
144(i)(2), if applicable) as to the Securities and without volume or manner-of-sale restrictions, the Company, upon the written
request of the holder, shall instruct the Transfer Agent to remove the legend from the Securities and shall cause its counsel to
issue any legend removal opinion required by the Transfer Agent. Any fees (with respect to the Transfer Agent, Company counsel,
or otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the Company. If a legend
is no longer required pursuant to the foregoing, the Company will no later than three Trading Days following the delivery by a
Purchaser to the Company or the Transfer Agent (with notice to the Company) of a legended certificate representing such Securities
(endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or
transfer) and a representation letter to the extent required by Section 4.1(a), (such third Trading Day, the “Legend
Removal Date”) deliver or cause to be delivered to such Purchaser a certificate representing such Securities that is
free from all restrictive legends. The Company may not make any notation on its records or give instructions to the Transfer Agent
that enlarge the restrictions on transfer set forth in this Section 4.1(c).

 

(d)       Purchaser’s Acknowledgement
of Transfer Restrictions and Covenant to Obtain Transferee Letter Prior to, and Provide Notice of, Any Proposed Transfer of Shares.
Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and, accordingly, will not sell or
otherwise transfer the Shares or any interest therein without complying with the requirements of the Securities Act. Except as
otherwise provided below, to the extent applicable to the Purchaser’s Shares, while the above-referenced registration statement
remains effective, such Purchaser may sell the Shares in accordance with the plan of distribution contained in the registration
statement, if applicable, and if it does so, it will comply therewith and with the related prospectus delivery requirements, unless
an exemption therefrom is available. Each Purchaser who is a party to the Registration Rights Agreement agrees that if it is notified
by the Company in writing at any time that the registration statement registering the resale of the Shares is not effective or
that the prospectus included in such registration statement no longer complies with the requirements of Section 10 of the
Securities Act, the Purchaser will refrain from selling such Shares until such time as the Purchaser is notified by the Company
that such registration statement is effective or such prospectus is compliant with Section 10 of the Securities Act, unless
such Purchaser is able to, and does, sell such Shares pursuant to an available exemption from the registration requirements of
Section 5 of the Securities Act, such as under Rule 144 of the Securities Act.

 

Each Purchaser acknowledges
that the Company has valuable NOL carry-forwards the use of which would be limited if the Company were to experience an “ownership
change” under Section 382 of the Internal Revenue Code. Accordingly, until the third anniversary of the Closing, each Purchaser
(i) agrees to consult with the Company at least 10 days prior to any proposed purchase or sale of Shares regarding the potential
adverse tax impact that the purchase or sale could have on the NOLs and (ii) acknowledges that any prospective transferee of the
Securities will be required to provide the Transfer Agent with a Transferee Letter. Each Purchaser further acknowledges that the
Company will place a legend similar to the following on each of the stock certificates issued in connection with the offering to
ensure that a prospective transferee is aware of these requirements:

 

    	 	33	 

     

    

Exhibit 10.1

 

UNTIL THE THIRD ANNIVERSARY
OF THE ISSUANCE OF THE SHARES REPRESENTED BY THIS CERTIFICATE, THE HOLDER OF THIS CERTIFICATE MUST COMPLY WITH THE NOTICE REQUIREMENT
SET FORTH IN THE APPLICABLE SUBSCRIPTION AGREEMENT PRIOR TO ANY PURCHASE OR SALE OF SHARES.

UNTIL THE THIRD ANNIVERSARY
OF THE ISSUANCE OF THE SHARES REPRESENTED BY THIS CERTIFICATE, PRIOR TO ANY TRANSFER OF THESE SHARES THE PROPOSED TRANSFEREE MUST
EXECUTE AND DELIVERY TO THE COMPANY’S TRANSFER AGENT A PURCHASER REPRESENTATION LETTER, A COPY OF WHICH IS ON FILE WITH AND
MAY BE OBTAINED FROM THE SECRETARY OF THE COMPANY AT THE COMPANY’S PRINCIPAL EXECUTIVE OFFICES.

4.2.       Acknowledgment of Dilution.
The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock.
The Company further acknowledges that its obligations under this Agreement, including without limitation its obligation to issue
the Securities pursuant to this Agreement, are unconditional (except as otherwise set forth herein) and absolute and not subject
to any right of set off, counterclaim, delay, or reduction, regardless of the effect of any such dilution or any claim the Company
may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other
shareholders of the Company.

 

4.3      Access, Information and Confidentiality.

 

(a)      Castle
Creek shall be provided with access, information, and other rights as provided in the VCOC Letter Agreement.

 

(b)      Each
party to this Agreement will hold, and will cause its respective subsidiaries and their directors, officers, employees, agents,
consultants and advisors to hold, in strict confidence, unless disclosure to a Governmental Entity is necessary or appropriate
in connection with any necessary regulatory approval, or request for information or similar process, or unless compelled to disclose
by judicial or administrative process or, in the written opinion of its counsel, by other requirement of law or the applicable
requirements of any Governmental Entity (in which case, the party permitted to disclose such information shall, to the extent
legally permissible and reasonably practicable, provide the other party with prior written notice of such permitted disclosure),
all nonpublic records, books, contracts, instruments, computer data and other data and information (collectively, “Information”)
concerning the other party hereto furnished to it by such other party or its representatives pursuant to this Agreement (except
to the extent that such information can be shown to have been (1) previously known by such party on a nonconfidential basis, (2)
in the public domain through no fault of such party or (3) later lawfully acquired from other sources by the party to which it
was furnished), and neither party hereto shall release or disclose such Information to any other person, except its auditors,
attorneys, financial advisors, other consultants and advisors with the express understanding that such parties will maintain the
confidentiality of the Information and, to the extent permitted above, to bank and securities regulatory authorities.

 

4.4.       Furnishing of Information. In
order to enable the Purchasers to sell the Securities under Rule 144 of the Securities Act, the Company shall maintain the registration
of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and timely file (or obtain extensions in respect thereof
and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act. If the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Purchasers
and make publicly available the information described in Rule 144(c)(2), if the provision of such information will allow resales
of the Securities pursuant to Rule 144.

 

    	 	34	 

     

    

Exhibit 10.1

 

4.5.       Form D and Blue Sky. The Company
agrees to timely file a Form D with respect to the Shares as required under Regulation D. Purchaser agrees to timely provide Company
with any and all needed information in connection with Company’s preparation and filing of a Form D. The Company, on or before
the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption
for or to qualify the Shares for sale to the Purchasers at the Closing pursuant to this Agreement under applicable securities or
“Blue Sky” laws of the states of the United States (or to obtain an exemption from such qualification). The Company
shall make all filings and reports relating to the offer and sale of the Shares required under applicable securities or blue sky
laws of the states of the United States following the Closing Date.

 

4.6.       No Integration. The Company
shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer for
sale, or solicit offers to buy, or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that will be integrated with the offer or sale of the Shares in a manner that would require the registration under the Securities
Act of the sale of the Shares to the Purchasers.

 

4.7.       Securities
Laws Disclosure; Publicity.

 

(a)      The Company
shall, by 9:00 a.m., New York City time, on the first Trading Day immediately following the date of this Agreement, issue
one or more press releases (collectively, the “Initial Press Release”) reasonably acceptable to the Purchasers
disclosing all material terms of the transactions contemplated hereby and by the other Transaction Documents. On or before 9:00
a.m., Eastern time, on the fourth Trading Day immediately following the execution of this Agreement, the Company will file a Current
Report on Form 8-K with the Commission describing the terms of the Transaction Documents (and including as exhibits to such Current
Report on Form 8-K the material Transaction Documents (including, without limitation, this Agreement and the Registration Rights
Agreement, if applicable)). If, following public disclosure of the transactions contemplated hereby, this Agreement terminates
prior to Closing, the Company shall issue a press release disclosing such termination by 9:00 a.m., New York City time, on the
first Trading Day following the date of such termination. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser or any Affiliate or investment adviser of any Purchaser, or include the name of any Purchaser or any
Affiliate or investment adviser of any Purchaser in any press release or in any filing with the Commission (other than the Registration
Statement) or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (i) as
required by federal securities law in connection with (A) any registration statement contemplated by the Registration Rights
Agreement and (B) the filing of final Transaction Documents with the Commission, and (ii) to the extent such disclosure
is required by law, at the request of the Staff of the Commission or Trading Market regulations, in which case the Company shall
provide the Purchasers with prior written notice of such disclosure permitted under this subclause (ii). Whenever any party determines,
based upon the advice of such party’s counsel, that a public announcement or other disclosure is required by or advisable
with respect to any applicable law or regulation, the parties shall discuss such disclosure with each other in good faith prior
to the making of such public announcement or other disclosure. 

 

    	 	35	 

     

    

Exhibit 10.1

 

(b)      The
Company shall, by 9:00 a.m., New York City time, on the first Trading Day immediately following the Closing Date, issue one
or more press releases (collectively, the “Closing Press Release”) reasonably acceptable to the Purchasers
disclosing any other material, non-public information that the Company may have provided any Purchaser at any time prior to the
filing of the Closing Press Release. On or before 9:00 a.m., Eastern time, on the fourth Trading Day immediately following the
Closing, the Company will file a Current Report on Form 8-K with the Commission attaching the Closing Press Release. Following
the issuance of the Closing Press Release, no Purchaser shall be in possession of any material, non-public information received
from the Company, any Subsidiary or any of their respective officers, directors, or employees or the Placement Agent. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company, such Purchaser will maintain the confidentiality of the existence and terms of the transaction
contemplated herein.

 

4.8.       Indemnification.

 

(a)       Indemnification
of Purchasers. In addition to the indemnity provided in the Registration Rights Agreement, if applicable, the Company will
indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees, agents, and investment
advisors (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act
and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners, employees, agents,
or investment advisors (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling person (each, a “Purchaser Party”) harmless from
any and all losses, liabilities, obligations, claims, contingencies, damages, costs, and expenses, including all judgments, amounts
paid in settlements, court costs, and reasonable attorneys’ fees and costs of investigation (collectively, “Losses”)
that any such Purchaser Party may suffer or incur as a result of (i) any breach of any of the representations, warranties,
covenants, or agreements made by the Company in this Agreement or in the other Transaction Documents or (ii) any action instituted
against a Purchaser Party in any capacity, or any of them or their respective affiliates, by any shareholder of the Company who
is not an affiliate of such Purchaser Party, with respect to any of the transactions contemplated by this Agreement. The Company
will not be liable to any Purchaser Party under this Agreement to the extent, but only to the extent that a loss, claim, damage,
or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants, or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents or attributable to the actions or inactions
of such Purchaser Party. Any indemnification payment made pursuant to this Agreement shall be treated as an adjustment to purchase
price for Tax purposes, except as otherwise required by Law or deemed impermissible under GAAP.

 

(b)       Conduct of Indemnification Proceedings.
Promptly after receipt by any Purchaser Party of notice of any demand, claim, or circumstances which would or might give rise to
a claim or the commencement of any action, proceeding, or investigation in respect of which indemnity may be sought pursuant to
Section 4.8(a), such Purchaser Party shall promptly notify the Company in writing and the Company shall assume the defense
thereof, including the employment of counsel reasonably satisfactory to such Purchaser Party, and shall assume the payment of all
fees and expenses; provided, however, that the failure of any Purchaser Party so to notify the Company shall not relieve
the Company of its obligations hereunder except to the extent that the Company is actually and materially and adversely prejudiced
by such failure to notify. In any such proceeding, any Purchaser Party shall have the right to retain its own counsel, but the
fees and expenses of such counsel shall be at the expense of such Purchaser Party unless (i) the Company and the Purchaser
Party shall have mutually agreed to the retention of such counsel, (ii) the Company shall have failed promptly to assume the
defense of such proceeding and to employ counsel reasonably satisfactory to such Purchaser Party in such proceeding, or (iii) in
the reasonable judgment of counsel to such Purchaser Party, representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interests between them. The Company shall not be liable for any settlement of any proceeding
effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without the prior
written consent of the Purchaser Party, the Company shall not effect any settlement of any pending or threatened proceeding in
respect of which any Purchaser Party is or could have been a party and indemnity could have been sought hereunder by such Purchaser
Party, unless such settlement includes an unconditional release of such Purchaser Party from all liability arising out of such
proceeding.

 

    	 	36	 

     

    

Exhibit 10.1

 

(c)       Limitation on Amount of Company’s
Indemnification Liability.

 

      (i) Deductible. Except as provided
otherwise in 4.8(c)(iii), the Company will not be liable for losses that otherwise are indemnifiable under Section 4.8(a)
until the total of all losses under Section 4.8(a) incurred by all Purchasers exceeds $50,000, at which point the full amount
of all losses shall be recoverable.

 

      (ii) Maximum. Except as provided
otherwise in Section 4.8(c)(iii), the maximum aggregate liability of the Company for all losses under Section 4.8(a)
is the aggregate Subscription Amount by all Purchasers, provided however, that the maximum aggregate liability of the Company for
all losses under Section 4.8(a) as to any individual Purchaser is the aggregate Subscription Amount of such individual Purchaser.

 

      (iii) Exceptions. The provisions of
Section 4.8(c)(i) and (ii) do not apply to (A) claims due to the inaccuracy of any of the representations or breach
of any of the warranties of the Company in Sections 3.1(a), 3.1(b), 3.1(c), 3.1(e), 3.1(f), 3.1(g), 3.1(i), 3.1(j), 3.1(w), or
3.3(dd), or (B) indemnification claims involving fraud or knowing and intentional misconduct by the Company.

 

      (iv) Materiality Scrape. For purposes
of the indemnity contained in Section 4.8(a)(i) and Section 4.8(c), all qualifications and limitations set forth in the parties’
representations and warranties as to “materiality,” “Material Adverse Effect” and words of similar import
shall be disregarded in determining whether there shall have been any inaccuracy in or breach of any representations and warranties
in this Agreement and the Losses arising therefrom.

 

4.9.       Use of Proceeds. The Company
intends to use the net proceeds from the sale of the Shares hereunder and the Common Stock issued under the Subscription Agreements
(i) to redeem the Company’s outstanding Series T preferred stock held by the U.S. Treasury, (ii) to redeem the
Debentures associated with the Company’s outstanding trust preferred securities, and (iii) to redeem the Company’s
subordinated notes held by the Company’s subordinated note holders. In addition, a portion of the proceeds will be invested
in the Bank and a portion will be retained by the Company. The Company will use the funds it retains for general corporate purposes.
The Bank may use the proceeds it receives from the Company to augment its capital position, support its operations, or for general
corporate purposes.

 

4.10.       Limitation on Beneficial Ownership.
No Purchaser (and its Affiliates or any other Persons with which it is acting in concert) will be entitled to purchase a number
of Common Shares that would result in such Purchaser becoming, directly or indirectly, the beneficial owner (as determined under
Rule 13d-3 under the Exchange Act) of more than 9.9% of the number of shares of the Company’s voting securities issued and
outstanding.

 

    	 	37	 

     

    

Exhibit 10.1

 

4.11.       Certain Transactions. The Company
will not merge or consolidate into, or sell, transfer or lease all or substantially all of its property or assets to, any other
party unless the successor, transferee or lessee party, as the case may be (if not the Company), expressly assumes the due and
punctual performance and observance of each and every covenant and condition of this Agreement to be performed and observed by
the Company.

 

4.12.       No Additional Issuances. Between
the date of this Agreement and the Closing Date, except for the Shares being issued pursuant to this Agreement and the Common Stock
issued pursuant to the Subscription Agreements, the Company shall not issue or agree to issue any additional shares of Common Stock
or other securities which provide the holder thereof the right to convert such securities into, or acquire, shares of Common Stock.

 

4.13.       Conduct of Business. From the
date hereof until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, except as
contemplated by this Agreement, the Company will, and will cause its Subsidiaries to: (i) operate their business in the ordinary
course consistent with past practice; (ii) preserve intact the current business organization of the Company; (iii) use commercially
reasonable efforts to retain the services of their employees, consultants, and agents; (iv) preserve the current relationships
of the Company and its Subsidiaries with material customers and other Persons with whom the Company and its Subsidiaries have and
intend to maintain significant relations; (v) maintain all of its operating assets in their current condition (normal wear and
tear excepted); (vi) refrain from taking or omitting to take any action that would constitute a breach of Section 3.1(k);
and (vii) refrain from (1) declaring, setting aside or paying any distributions or dividends on, or making any distributions (whether
in cash, securities, or other property) in respect of, any of its capital stock, (2) splitting, combining or reclassifying any
of its capital stock or issuing or authorizing the issuance of any other securities in respect of, in lieu of or in substitution
for capital stock or any of its other securities, (3) purchasing, redeeming or otherwise acquiring any capital stock, assets or
other securities or any rights, warrants or options to acquire any such capital stock, assets or other securities, other than acquisitions
of investment securities in the ordinary course of business and the redemption or repurchase of the Company’s Series T preferred
stock, trust preferred securities, or subordinated notes in accordance with this Agreement.

 

4.14.       Avoidance of Control.

 

      (a)       Notwithstanding anything to the
contrary in this Agreement, no Purchaser (together with its Affiliates (as such term is used under the BHCA)) shall have the ability
to purchase or exercise any voting rights of any class of securities in excess of 9.9% of the total outstanding voting securities
of the Company. In the event a Purchaser breaches its obligations under this Section 4.14 or believes that it is reasonably
likely to breach such an obligation, it shall promptly notify the other parties hereto and shall cooperate in good faith with such
parties to modify ownership or make other arrangements or take any other action, in each case, as is necessary to cure or avoid
such breach.

 

      (b)       Notwithstanding
anything to the contrary in this Agreement, neither the Company nor any Subsidiary shall take any action (including, without limitation,
any redemption, repurchase, rescission or recapitalization of Common Stock, or securities or rights, options or warrants to purchase
Common Stock, or securities of any type whatsoever that are, or may become, convertible into or exchangeable into or exercisable
for Common Stock in each case, where each Purchaser is not given the right to participate in such redemption, repurchase, rescission
or recapitalization to the extent of such Purchaser’s pro rata proportion), that would reasonably be expected to pose a substantial
risk that (a) such Purchaser’s equity of the Company (together with equity owned by such Purchaser’s affiliates (as
such term is used under the BHCA) to exceed 33.3% of the Company’s total equity (provided that there is no ownership or control
in excess of 9.9% of any class of voting securities of the Company by such Purchaser, together with such Purchaser’s Affiliates)
or (b) such Purchaser’s ownership of any class of voting securities of the Company (together with the ownership by such Purchaser’s
Affiliates (as such term is used under the BHCA) of voting securities of the Company) to exceed 9.9%, in each case without the
prior written consent of such Purchaser, or to increase to an amount that would constitute “control” under the BHCA,
the CIBC Act, any applicable provisions of South Carolina Law, or any rules or regulations promulgated thereunder (or any successor
provisions) or otherwise cause such Purchaser to “control” the Company under and for purposes of the BHCA, the CIBC
Act or any rules or regulations promulgated thereunder (or any successor provisions). Notwithstanding anything to the contrary
in this Agreement, no Purchaser (together with its Affiliates (as such term is used under the BHCA)) shall have the ability to
purchase more than 33.3% of the Company’s total equity or exercise any voting rights of any class of securities in excess
of 9.9% of the total outstanding voting securities of the Company. In the event either the Company or a Purchaser breaches its
obligations under this Section 4.14 or believes that it is reasonably likely to breach such an obligation, it shall promptly notify
the other parties hereto and shall cooperate in good faith with such parties to modify ownership or, to the extent commercially
reasonable, make other arrangements or take any other action, in each case, as is necessary to cure or avoid such breach.

 

    	 	38	 

     

    

Exhibit 10.1

 

4.15.       Most Favored Nation. With the
exception of the Castle Creek Side Letter, the Mendon Side Letter, the EJF Side Letter, the SVI Side Letter, and other side letters
between the Company and Purchasers to be entered into in connection with the execution and delivery of this Agreement which provide
certain Purchasers with reimbursement for legal expenses and the right to either appoint a representative to the Company’s
board of directors or appoint a non-voting observer to attend Company board meetings as set forth on Schedule 4.15, during the
period from the date of this Agreement through the Closing Date, neither the Company nor its Subsidiaries shall enter into any
additional, or modify any existing, agreements with any existing or future investors in the Company or any of its Subsidiaries
that have the effect of establishing rights or otherwise benefiting such Purchaser in a manner more favorable in any material respect
to such Purchaser than the rights and benefits established in favor of the Purchasers by this Agreement, unless, in any such case,
the Purchasers have been provided with such rights and benefits.

 

4.16.       Filings; Other Actions. Each
Purchaser, with respect to itself only, on the one hand, and the Company, on the other hand, will reasonably cooperate and consult
with the other and use commercially reasonable efforts to provide all necessary and customary information and data, to prepare
and file all necessary and customary documentation, to effect all necessary and customary applications, notices, petitions, filings
and other documents, to provide evidence of non-control of the Company and the Bank, as requested by the applicable Governmental
Entity, including executing and delivery to the applicable Governmental Entities customary passivity commitments, disassociation
commitments, and commitments not to act in concert, with respect to the Company or the Bank, and to obtain all necessary and customary
permits, consents, orders, approvals, and authorizations of, or any exemption by, all third parties and Governmental Entities,
in each case, (i) necessary or advisable to consummate the transactions contemplated by this Agreement, and to perform the
covenants contemplated by this Agreement, in each case required by it, and (ii) with respect to the Purchaser, to the extent
typically provided by the Purchaser to such third parties or Governmental Entities, as applicable, under the Purchaser’s
policies consistently applied, to the extent the Purchaser has such policies, and subject to such confidentiality requests as the
Purchaser may reasonably seek. Each of the parties hereto shall execute and deliver both before and after the Closing such further
certificates, agreements, and other documents and take such other actions as the other parties may reasonably request to consummate
or implement such transactions or to evidence such events or matters, subject, in each case, to clauses (i) and (ii) of
the first sentence of this Section 4.16. Each Purchaser, with respect to itself only, and the Company will have the right
to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating
to the exchange of information and confidential information related to such Purchaser, all the information (other than confidential
information) relating to such other parties, and any of their respective Affiliates, which appears in any filing made with, or
written materials submitted to, any third party or any Governmental Entity in connection with the transactions to which it will
be party contemplated by this Agreement; provided that (i) for the avoidance of doubt, no Purchaser shall have the right to
review any such information relating to another Purchaser and (ii) a Purchaser shall not be required to disclose to the Company
or any other Purchaser any information that is confidential and proprietary to such Purchaser, its Affiliates, its investment advisors,
or its or their control persons or equity holders. In exercising the foregoing right, each of the parties hereto agrees to act
reasonably and as promptly as practicable. Each Purchaser, with respect to itself only, on the one hand, and the Company, on the
other hand, agrees to keep the other reasonably apprised of the status of matters referred to in this Section 4.16. Each Purchaser,
with respect to itself only, and the Company shall promptly furnish the other with copies of written communications received by
it or its Affiliates from, or delivered by any of the foregoing to, any Governmental Entity in respect of the transactions contemplated
by this Agreement; provided, that the party delivering any such document may redact any confidential information
contained therein. Notwithstanding anything in this Section 4.16 or elsewhere in this Agreement to the contrary, the Purchaser
shall not be required to provide to any person pursuant to this Agreement any of its, its Affiliates’, its investment advisors’
or its or their control persons’ or equity holders’ nonpublic, proprietary, personal, or otherwise confidential information
including the identities or financial condition of limited partners, shareholders, or non-managing members of the Purchaser or
its Affiliates or their investment advisors. The Company shall file Form Ds timely with the SEC and other jurisdictions’
securities and blue sky officials and, to the extent applicable, shall cause the Placement Agent to timely file with FINRA all
offering materials required by FINRA Rule 5123. Notwithstanding anything to the contrary in this Section 4.16, no Purchaser
shall be required to perform any of the above actions if such performance would constitute or could reasonably result in any restriction
or condition that such Purchaser determines, in its reasonable good faith judgment, (i) is materially and unreasonably burdensome,
or (ii) would reduce the benefits of the transactions contemplated hereby to such Purchaser to such a degree that such Purchaser
would not have entered into this Agreement had such condition or restriction been known to it on the date of this Agreement (any
such condition or restriction, a “Burdensome Condition”); for the avoidance of doubt, any requirement to disclose
the identities or financial condition of limited partners, shareholders, or non-managing members of such Purchaser or its Affiliates
or its investment advisers shall be deemed a Burdensome Condition unless otherwise determined by such Purchaser in its sole discretion.

 

    	 	39	 

     

    

Exhibit 10.1

 

4.17      Gross-Up Rights.

 

(a)      Sale of
New Securities. For so long as a Purchaser, together with its Affiliates and, for purposes of this Section 4.17, persons who
share a common discretionary investment advisor with the Purchaser, owns 4.9% or more of all of the outstanding shares of Common
Stock (provided that, in making such calculation, (i) all shares of Common Stock into or for which shares of any securities owned
by the Purchaser are directly or indirectly convertible or exercisable (which, for the avoidance of doubt, shall include those
shares of Common Stock and Non-Voting Common Stock issuable upon the conversion of shares of Series A Preferred Stock), shall be
included in the numerator, (ii) the shares described in clause (i) and all such shares owned by or attributed to other Purchasers
or Other Investors shall be included in the denominator, and (iii) all securities issued by the Company after the Closing Date
other than in connection with an issuance in which the Purchaser was offered the right to purchase its pro rata portion of such
securities in accordance with this Section 4.17 shall be excluded from the denominator) (before giving effect to any issuances
triggering provisions of this Section 4.17), if at any time after the date hereof the Company makes any public or nonpublic offering
or sale of any equity (including Common Stock, Series A Preferred Stock, Non-Voting Common Stock or restricted stock), or any securities,
options or debt that is convertible or exchangeable into equity or that includes an equity component (such as, an “equity
kicker”) (including any hybrid security) (any such security, a “New Security”) (other than (i) any Common
Stock, Series A Preferred Stock or other securities issuable upon the exercise or conversion of any securities of the Company issued
or agreed or contemplated (and disclosed to the Purchaser in writing) to be issued as of the date hereof; (ii) pursuant to the
granting or exercise of employee stock options, restricted stock or other stock incentives pursuant to the Company’s stock
incentive plans approved by the Board of Directors or the issuance of stock pursuant to the Company’s employee stock purchase
plan approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise,
for the benefit of any employees, officers or directors of the Company, in each case in the ordinary course of providing incentive
compensation; (iii) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture, strategic
alliance, license agreement or other similar nonfinancing transaction; or (iv) following completion of this offering, issuances
of Common Stock pursuant to a proposed registered offering to existing shareholders and certain other persons to sell up to an
aggregate of $3,000,000 in shares of our Common Stock at the same price per share as in this offering. The amount of New Securities
that the Purchaser shall be entitled to purchase in the aggregate shall be determined by multiplying (x) the total number or principal
amount of such offered New Securities by (y) a fraction, the numerator of which is the total number of shares of Common Stock then
held by the Purchaser (counting for such purposes all shares of Common Stock into or for which any securities owned by the Purchaser
are directly or indirectly convertible or exercisable, including the Series A Preferred Stock and the Non-Voting Common Stock),
if any, and the denominator of which is the total number of shares of Common Stock then outstanding (counting for such purposes
all shares of Common Stock into or for which any securities owned by the Purchaser are directly or indirectly convertible or exercisable,
including the Series A Preferred Stock and the Non-Voting Common Stock). Notwithstanding anything herein to the contrary, in no
event shall the Purchaser have the right to purchase New Securities hereunder to the extent such purchase would result in such
Purchaser, together with any other person whose Company securities would be aggregated with the Purchaser’s Company securities
for purposes of any bank regulation or law, to collectively be deemed to own, control or have the power to vote securities which
(assuming, for this purpose only, full conversion and/or exercise of such securities by the Purchaser) would represent more than
9.9% of the Voting Securities or more than 33.3% of the Company’s total equity outstanding.

 

    	 	40	 

     

    

Exhibit 10.1

 

(b)      Limitation
on Voting Securities. Notwithstanding anything in this Section 4.17 to the contrary, upon the request of the Purchaser that
the Purchaser not be issued Voting Securities in whole or in part upon the exercise of its rights to purchase New Securities,
the Company shall cooperate with the Purchaser to modify the proposed issuance of New Securities to the Purchaser to provide for
the issuance of Series A Preferred Stock, Non-Voting Common Stock or other non-voting securities in lieu of Voting Securities;
provided, however, that to the extent, following such reasonable cooperation, such modification would cause any Other Purchaser
to exceed its respective ownership limitation set forth in the applicable other securities purchase agreement, the Company shall,
and shall only be obligated to, issue and sell to the Purchaser such number of Voting Securities and nonvoting securities as will
not cause any other Purchaser or Other Investors to exceed its respective ownership limitation set forth in the applicable other
securities purchase agreement and that the Purchaser has indicated it is willing to hold following consummation of such Offering
(as defined in Section 4.17(c) below), and any remaining securities may be offered, sold or otherwise transferred to any other
person or persons in accordance with Section 4.17(e).

 

(c)       Notice.
In the event the Company proposes to offer or sell New Securities (the “Offering”), it shall give the Purchaser
written notice of its intention, describing the price (or range of prices), anticipated amount of New Securities, timing, and
other terms upon which the Company proposes to offer the same (including, in the case of a registered public offering and to the
extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering), no later
than 15 Business Days, as the case may be, after the initial filing of a registration statement with the SEC with respect to an
underwritten public Offering or after the commencement of marketing with respect to a Rule 144A Offering or an Offering pursuant
to Section 4(2) of the Securities Act or Regulation D promulgated thereunder. If the information contained in the notice constitutes
material non-public information (as defined under the applicable securities laws), the Company shall deliver such notice only
to the individuals identified (with respect to the Purchaser) in Section 6.3 hereof, and shall not communicate the information
to anyone else acting on behalf of the Purchaser without the consent of one of the designated individuals. The Purchaser shall
have 15 Business Days from the date of receipt of such a notice to notify the Company in writing that it intends to exercise its
rights provided in this Section 4.17 and as to the amount of New Securities the Purchaser desires to purchase, up to the maximum
amount calculated pursuant to Section 4.17. Such notice shall constitute a nonbinding indication of interest of the Purchaser
to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s notice to
it. The failure of the Purchaser to respond within such 15 Business Day period shall be deemed to be a waiver of such Purchaser’s
rights under this Section 4.17 only with respect to the Offering described in the applicable notice.

 

    	 	41	 

     

    

Exhibit 10.1

 

(d)      Purchase
Mechanism. If the Purchaser exercises its rights provided in this Section 4.17, the closing of the purchase of the New Securities
in connection with the closing of the Offering with respect to which such right has been exercised shall take place within 30
calendar days after the giving of notice of such exercise, which period of time shall be extended for a maximum of 180 days in
order to comply with applicable laws and regulations (including receipt of any applicable regulatory or shareholder approvals).
Notwithstanding anything to the contrary herein, the closing of the purchase of the New Securities by the Purchasers will occur
no earlier than the closing of the Offering triggering the right being exercised by the Purchaser. Each of the Company and the
Purchaser agrees to use its commercially reasonable efforts to secure any regulatory or shareholder approvals or other consents,
and to comply with any law or regulation necessary in connection with the offer, sale and purchase of, such New Securities.

 

(e)      Failure
of Purchase. In the event the Purchaser fails to exercise its rights provided in this Section 4.17 within this 15 Business
Day period or, if so exercised, the Purchaser is unable to consummate such purchase within the time period specified in Section
4.17(d) above because of its failure to obtain any required regulatory or shareholder consent or approval, the Company shall thereafter
be entitled (during the period of 60 days following the conclusion of the applicable period) to sell or enter into an agreement
(pursuant to which the sale of the New Securities covered thereby shall be consummated, if at all, within 90 days from the date
of such agreement) to sell the New Securities not elected to be purchased pursuant to this Section 4.17 by the Purchaser or which
the Purchaser is unable to purchase because of such failure to obtain any such consent or approval, at a price and upon terms
no more favorable in the aggregate to the purchasers of such New Securities than were specified in the Company’s notice
to the Purchaser. Notwithstanding the foregoing, if such sale is subject to the receipt of any regulatory or shareholder approval
or consent or the expiration of any waiting period, the time period during which such sale may be consummated shall be extended
until the expiration of five Business Days after all such approvals or consents have been obtained or waiting periods expired,
but in no event shall such time period exceed 180 days from the date of the applicable agreement with respect to such sale. In
the event the Company has not sold the New Securities or entered into an agreement to sell the New Securities within such 60-day
period (or sold and issued New Securities in accordance with the foregoing within 90 days from the date of such agreement (as
such period may be extended in the manner described above for a period not to exceed 180 days from the date of such agreement)),
the Company shall not thereafter offer, issue or sell such New Securities without first offering such New Securities to the Purchaser
in the manner provided above.

 

(f)      Expedited
Issuance; Regulatory Directive. Notwithstanding the foregoing provisions of this Section 4.17, if a majority of the directors
of the board of directors determines that the Company must issue equity or debt securities on an expedited basis, then the Company
may consummate the proposed issuance or sale of such securities (“Expedited Issuance”) and then comply with
the provisions of this Section 4.17 provided that (i) the purchasers of such New Securities has consented in writing to the issuance
of additional New Securities in accordance with the provisions of this Section 4.17, and (ii) the sale of any such additional
New Securities under this Section 4.17(f) to the Purchaser, certain other Purchasers, and Other Investors signatory to other securities
purchase agreements pursuant to this Section 4.17 and similar provisions in the other securities purchase agreements shall be
consummated as promptly as is practicable but in any event no later than 90 days subsequent to the date on which the Company consummates
the Expedited Issuance under this Section 4.17(f). Notwithstanding anything to the contrary herein, the provisions of this Section
4.17(f) (other than as provided in subclause (ii) of this Section 4.17(f)) shall not be applicable and the consent of the purchasers
of such New Securities shall not be required in connection with any Expedited Issuance undertaken at the written direction of
the applicable federal regulator of the Company or the Bank. Notwithstanding anything to the contrary in this Agreement, no rights
of the Purchaser under this Agreement will be adversely affected solely as the result of the temporary dilution of its percentage
ownership of Common Stock due to an Expedited Issuance under this Section 4.17(f); provided, however, that such
rights may be adversely affected from and after such time, if any, that the Purchaser declines to purchase Common Stock offered
to the Purchaser under this Section 4.17.

 

    	 	42	 

     

    

Exhibit 10.1

 

(g)       Non-Cash
Consideration. In the case of the offering of securities for a consideration in whole or in part other than cash, including
securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than
cash shall be deemed to be the fair value thereof as determined by the board of directors; provided, however, that
such fair value as determined by the board of directors shall not exceed the aggregate market price of the securities being offered
as of the date the board of directors authorizes the offering of such securities.

 

(h)      Cooperation.
The Company and the Purchaser shall cooperate in good faith to facilitate the exercise of the Purchaser’s rights under this
Section 4.17, including to secure any required approvals or consents.

 

4.18      Notice of Certain
Events. Each party hereto shall promptly notify the other party hereto of (a) any event, condition, fact, circumstance, occurrence,
transaction or other item of which such party becomes aware prior to the Closing that would constitute a violation or breach of
the Transaction Documents (or a breach of any representation or warranty contained herein or therein) or, if the same were to continue
to exist as of the Closing Date, would constitute the non-satisfaction of any of the conditions set forth in Sections 5.1 or 5.2
hereof, and (b) any event, condition, fact, circumstance, occurrence, transaction or other item of which such party becomes aware
that would have been required to have been disclosed pursuant to the terms of this Agreement had such event, condition, fact, circumstance,
occurrence, transaction or other item existed as of the date hereof; provided that delivery of any notice pursuant to this
Section 4.18 shall not modify the representations, warranties, covenants, agreements or obligations of the parties (or remedies
with respect thereto) or the conditions to the obligations of the parties under this Agreement. Notwithstanding the foregoing,
neither party shall be required to take any action that would jeopardize such party’s attorney-client privilege.

 

4.19       Shareholder
Litigation. The Company shall promptly inform the Purchaser of any claim, action, suit, arbitration, mediation, demand, hearing,
investigation or proceeding (“Shareholder Litigation”) against the Company, any Company Subsidiary or any of
the past or present executive officers or directors of the Company or any Company Subsidiary that is threatened in writing or initiated
by or on behalf of any shareholder of the Company in connection with or relating to the transactions contemplated hereby or by
the Transaction Documents. The Company shall consult with the Purchaser and keep the Purchaser informed of all material filings
and developments relating to any such Shareholder Litigation.

 

    	 	43	 

     

    

Exhibit 10.1

 

4.20      Acquisition Proposals.
The Company shall notify Purchasers orally and in writing promptly (but in no event later than one (1) Business Day) after
receipt by the Company of any proposal or offer from any Person to effect an Acquisition Proposal or any request in connection
with a prospective Acquisition Proposal for non-public information relating to the Company or for access to the properties, books
or records of the Company by any Person other than the Purchasers, indicating in such notice the material terms and conditions
of any such proposal or offer and the identity of the Person making the proposal or offer, and thereafter shall keep Purchasers
reasonably informed with respect to the status of such proposal or offer.

 

4.21      Third-Party
Loan Review Report. The Purchasers hereby acknowledge that (i) the third party loan review reports reviewed by the Purchasers
in connection with their due diligence examination of the Company were prepared by the third-party firm named therein, (ii) the
Purchasers relied solely on such reports for the information contained therein, and (iii) the Purchasers did not rely on any other
party, including the Company and the Placement Agent, in evaluating such information.

 

ARTICLE V 

CONDITIONS PRECEDENT TO CLOSING 

 

5.1.       Conditions Precedent to the Obligations
of the Purchasers to Purchase Shares. The obligation of each Purchaser to acquire Shares at the Closing is subject to the fulfillment
to such Purchaser’s satisfaction, on or prior to the Closing Date, of each of the following conditions, any of which may
be waived by such Purchaser (as to itself only):

 

(a)       Representations and Warranties.
The representations and warranties of the Company contained herein shall be true and correct as of the date when made and as of
the Closing Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific
date.

 

(b)       Performance. The Company shall
have performed, satisfied, and complied in all material respects with all covenants, agreements, and conditions required by the
Transaction Documents to be performed, satisfied, or complied with by it at or prior to the Closing.

 

(c)      No Injunction. No statute, rule,
regulation, executive order, decree, ruling, or injunction shall have been enacted, entered, promulgated, or endorsed by any court
or governmental authority of competent jurisdiction, nor has there been any regulatory communication, that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents or restricts any Purchaser or any of a Purchaser’s Affiliates
from owning or voting any securities of the Company in accordance with the terms thereof.

 

(d)       Consents. The Company shall
have obtained in a timely fashion any and all consents, permits, approvals, non-objections, registrations, and waivers necessary
for consummation of the purchase and sale of the Shares (including all Required Approvals), all of which shall be and remain so
long as necessary in full force and effect.

 

(e)       No Suspensions of Quotation of Common
Stock. The Common Stock (i) shall be designated for quotation on the Principal Trading Market and (ii) shall not
have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading
Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, in
writing by the Commission or the Principal Trading Market.

 

    	 	44	 

     

    

Exhibit 10.1

 

(f)       Company Deliverables. The Company
shall have delivered the Company Deliverables in accordance with Section 2.2(a).

 

(g)       Minimum Offering Amount. The
number of shares of the Common Stock or Series A Preferred Stock to be sold under this Agreement to one of more Purchasers and
the Subscription Agreements to one or more Other Investors shall result in gross proceeds to the Company of at least $42.75 million.
The Company shall have received and accepted the subscriptions for such amount and the proceeds due to the Company under such subscriptions
shall be deposited in escrow for the benefit of the Company or shall have been previously received by the Company.

 

(h)       Redemption of TARP Securities.
The Company shall have reached an agreement with the U.S. Department of the Treasury (the “Treasury”) whereby
the Treasury will permit the Company to redeem its outstanding Fixed Rate Cumulative Perpetual Preferred Stock, Series T (the “Series
T Preferred Stock”) and the Treasury’s warrant to purchase the Company’s Common Stock (the “Warrant”)
and will forgive all unpaid dividends in exchange for a payment of $128,950, plus reimbursement of attorneys’ fees and other
expenses incurred by Treasury not to exceed $25,000.

 

(i)       Redemption of Debentures. The
Company shall have reached an agreement and/or received such consents as are necessary to permit to the Company to redeem the debentures
related to the Company’s trust preferred securities (the “Debentures”) and will forgive all accrued but
unpaid interest and any other amounts due in exchange for a payment of $600,000, plus reimbursement
of attorneys’ fees and other expenses incurred by the holders of the trust preferred securities not to exceed $25,000.

 

(j)       Redemption of Subordinated Notes.
The Company shall have (i) received a final order confirming the settlement of the Snyder class action (Case No. 2014-CP-26-0204)
regarding certain outstanding subordinated notes of the Company, which order may not be subject to appeal, and (ii) for those holders
of subordinated notes that opted out of the class, reached one or more agreements with such holders to allow the Company to redeem
all the subordinated notes and forgive all accrued but unpaid interest in exchange for a payment to all holders of subordinated
notes which shall not to exceed $3.3 million, excluding $250,000 reimbursed by third parties and $250,000
of forgiveness of indebtedness to a holder of a subordinate note.

 

(k)       Regulatory Approvals for Redemptions.
The Company shall have obtained all necessary regulatory approvals for the redemptions described in Sections 5.1(h), (i), and (j).

 

(l)       Termination. This Agreement
shall not have been terminated as to such Purchaser in accordance with Section 6.17 herein.

 

(m)       No Burdensome Condition. Since
the date hereof, there shall not be imposed any Burdensome Condition.

 

(n)       Tier 1 Capital. The Shares shall
qualify as “Additional Tier 1 capital” under 12 C.F.R. Section 217.20(c).

 

(o)       Registration Rights Agreement.
The Company and each Purchaser shall have executed and delivered the Registration Rights Agreement.

 

    	 	45	 

     

    

Exhibit 10.1

 

(p)       Tax Opinion. The Company shall
have received, and shall have provided to the Purchasers: (i) a limited scope tax opinion (the “Tax Opinion”)
from KPMG, in substantially the form attached hereto as Exhibit D, documenting the effect of the transactions contemplated
by the Transaction Documents with respect to the absence of an “ownership change” for purposes of Section 382
of the Code, (ii) the numerical analysis identifying the testing dates evaluated in the Tax Opinion during the applicable
analysis period, the ownership interest held by each shareholder and the ownership change percentage associated with each testing
date, (iii) a comprehensive list of all assumptions and Company representations relied upon by KPMG in preparing the Tax Opinion,
and (iv) a copy of all source documentation relied upon by KPMG in preparing the Tax Opinion.

 

(q)       Non-Control Determination. Each
Purchaser who, together with its Affiliates and persons who share a common investment advisor with such Purchaser, has committed
to acquire a beneficial ownership of 5% or more of the outstanding shares of Common Stock (collectively, the “9.9% Purchaser”
and each a “9.9% Purchaser”) has received, in each 9.9% Purchaser’s sole discretion, satisfactory feedback
from the Federal Reserve that such 9.9% Purchaser will not have “control” of the Company or the Bank for purposes of
the BHCA and that no notice is required under the CIBC Act (each, a “Non-Control Determination”).

 

(r)       Ownership Limitation. The purchase
of the Shares by each Purchaser shall not (i) cause such Purchaser or any of its affiliates to violate any banking regulation,
(ii) require such Purchaser or any of its affiliates to file a prior notice under the CIBC Act, or otherwise seek prior approval
of any banking regulator, (iii) require such Purchaser or any of its affiliates to become a bank holding company or otherwise
serve as a source of strength for the Company or any Subsidiary, or (iv) cause such Purchaser, together with any other person
whose Company securities would be aggregated with such Purchaser’s Company securities for purposes of any banking regulation
or law, to collectively be deemed to own, control, or have the power to vote securities which (assuming, for this purpose only,
full conversion and/or exercise of such securities by the Purchaser and such other Persons) would represent more than 9.9% of any
class of voting securities of the Company outstanding at such time.

 

(s)       Material Adverse Effect. No
Material Adverse Effect shall have occurred since the date of this Agreement.

 

(t)      Chief Executive Officer. The
boards of directors of the Company and the Bank shall have taken all actions necessary to appoint Janet H. Hollar as Chief Executive
Officer of the Company and the Bank, subject to the consummation of the transactions contemplated by this Agreement and receipt
of all required regulatory approvals.

 

(u)      VCOC Letter Agreement. The Company
and Castle Creek shall have executed and delivered the VCOC Letter Agreement.

 

(v)       No Change
in Control. The Company shall not have agreed to enter into or entered into (A) any agreement or transaction in order to raise
capital, or (B) any transaction that resulted in, or would result in if consummated, a Change in Control of the Company, in each
case, other than in connection with the transactions contemplated by the Transaction Documents.

 

(w)      Articles of
Amendment. The Company shall have filed with the South Carolina Secretary of State (and the South Carolina Secretary of State)
shall have issued a certificate of amendment evidencing the effectiveness of) articles of amendment to the Company’s Articles
of Incorporation, substantially in the form attached hereto as Exhibit L (the “Articles of Amendment”),
setting forth the terms of the Series A Preferred Stock.

 

    	 	46	 

     

    

Exhibit 10.1

 

(x)      Well-Capitalized
Status. After the Closing and the consummation of the transactions contemplated by this Agreement and the other securities
purchase agreements, (A) the Bank’s capital levels shall exceed the specific quantitative capital requirements necessary
to be deemed “well capitalized” as defined in 12 C.F.R. § 325.103(b)(1), however, for so long as the Bank remains
subject to the Consent Order, the Bank will not qualify as “well capitalized” due to such Consent Order; (B) the
Company’s capital levels shall exceed the specific quantitative capital requirements necessary to be deemed “well capitalized”
as defined in 12 C.F.R. §§ 225.2(r), however, for so long as the Company remains subject to the Written Agreement, the
Company will not qualify as “well capitalized” due to such Written Agreement; (C) the Company and the Bank shall
meet or exceed all specific quantitative capital requirements stated in any written agreement, order, understanding or undertaking
with the Federal Reserve or the SCBFI, as applicable; (D) the Series A Preferred Stock shall qualify as “Additional Tier
1 capital” under 12 C.F.R. Section 217.20(c); and (E) the Company’s capital structure will otherwise comply with the
“predominance” of voting common equity provisions of 12 C.F.R. Part 225, Appendix A.

 

(y)      Non-Performing
Assets. As of the end of the month immediately prior to Closing, total nonperforming assets shall not have increased more than
33% over total nonperforming assets as of January 31, 2016.

 

5.2.       Conditions Precedent to the Obligations
of the Company to sell the Shares. The Company’s obligation to sell and issue the Shares to each Purchaser at the Closing
is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any
of which may be waived by the Company:

 

(a)       Representations
and Warranties. The representations and warranties made by each Purchaser in Section 3.2 hereof shall be true and correct
in all material respects (except to the extent such representations and warranties are qualified by materiality, in which case
they shall be true and correct in all respects) as of the date when made and as of the Closing Date as though made on and as of
such date (except to the extent such representations and warranties are made as of a specified date, in which case such representations
and warranties shall be true and correct in all material respects as of such date), in each case except as would not have a material
adverse effect on the ability of the Purchaser to consummate the transactions contemplated by this Agreement and the other Transaction
Documents;

 

(b)       Performance. Such Purchaser
shall have performed, satisfied, and complied in all material respects with all covenants, agreements, and conditions required
by the Transaction Documents to be performed, satisfied, or complied with by such Purchaser at or prior to the Closing Date.

 

(c)       No Injunction. No statute, rule,
regulation, executive order, decree, ruling, or injunction shall have been enacted, entered, promulgated, or endorsed by any court
or governmental authority of competent jurisdiction, nor has there been any regulatory communication, that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents.

 

(d)       Consents. The Company shall
have obtained in a timely fashion any and all consents, permits, approvals, non-objections, registrations, and waivers necessary
for consummation of the purchase and sale of the Shares, all of which shall be and remain so long as necessary in full force and
effect.

 

(e)       Purchaser Deliverables. Each
Purchaser shall have delivered its Purchaser Deliverables in accordance with Section 2.2(b).

 

    	 	47	 

     

    

Exhibit 10.1

 

(f)       Minimum Offering Amount. The
number of shares of the Common Stock or Series A Preferred Stock to be sold under this Agreement to one of more Purchasers and
the Subscription Agreements to one or more Other Investors shall result in gross proceeds to the Company of at least $42.75 million.
The Company shall have received and accepted the subscriptions for such amount and the proceeds due to the Company under such subscriptions
shall be deposited in escrow for the benefit of the Company or shall have been previously received by the Company.

 

(g)       Redemption of TARP Securities.
The Company shall have reached an agreement with the Treasury whereby the Treasury will permit the Company to redeem its outstanding
Series T Preferred Stock and the Warrant and will forgive all unpaid dividends in exchange for a payment of $128,950, plus reimbursement
of attorneys’ fees and other expenses incurred by Treasury not to exceed $25,000.

 

(h)       Redemption of Debentures. The
Company shall have reached an agreement and/or received such consents as are necessary to permit to the Company to redeem the Debentures
and will forgive all accrued but unpaid interest at a discount in exchange for a payment of $618,600,
plus reimbursement of attorneys’ fees and other expenses incurred by the holders of the trust preferred securities not to
exceed $25,000.

 

(i)       Redemption of Subordinated Notes.
The Company shall have (i) received a final order confirming the settlement of the Snyder class action (Case No. 2014-CP-26-0204)
regarding certain outstanding subordinated notes of the Company, which order may be subject to appeal, and (ii) for those holders
of subordinated notes that opted out of the class, reached one or more agreements with such holders to allow the Company to redeem
all the subordinated notes and forgive all accrued but unpaid interest in exchange for a payment to all holders of subordinated
notes which shall not to exceed $3.3 million, excluding $250,000 reimbursed by third parties and $250,000
of forgiveness of indebtedness to a holder of a subordinate note.

 

(j)       Regulatory Approvals for Redemptions.
The Company shall have obtained all necessary regulatory approvals for the redemptions described in Sections 5.2(g), (h) and
(i).

 

(k)       Termination. This Agreement
shall not have been terminated as to such Purchaser in accordance with Section 6.16 herein.

 

(l)       Tax Opinion. The Company shall
have received, and shall have provided to the Purchasers: (i) the Tax Opinion from KPMG, in substantially the form attached
hereto as Exhibit D, documenting the effect of the transactions contemplated by the Transaction Documents with respect to
the absence of an “ownership change” for purposes of Section 382 of the Code, (ii) the numerical analysis
identifying the testing dates evaluated in the Tax Opinion during the applicable analysis period, the ownership interest held by
each shareholder and the ownership change percentage associated with each testing date, (iii) a comprehensive list of all
assumptions and Company representations relied upon by KPMG in preparing the Tax Opinion, and (iv) a copy of all source documentation
relied upon by KPMG in preparing the Tax Opinion.

 

(m)       Ownership Limitation. The purchase
of Shares by any Purchaser shall not result in such Purchaser, together with any other person whose Company securities would be
aggregated with such Purchaser’s Company securities for purposes of any bank regulation or law, to collectively be deemed
to own, control or have the power to vote more than 9.9% of the outstanding shares of Common Stock as of the Closing Date.

 

    	 	48	 

     

    

Exhibit 10.1

 

ARTICLE VI 

MISCELLANEOUS 

 

6.1.       Fees and Expenses. Other than
as set forth in the Castle Creek Side Letter or elsewhere in the Transaction Documents, the parties hereto shall be responsible
for the payment of all expenses incurred by them in connection with the preparation and negotiation of the Transaction Documents
and the consummation of the transactions contemplated hereby. The Company shall pay all amounts owed to the Placement Agent relating
to or arising out of the transactions contemplated hereby. The Company shall pay all Transfer Agent fees, stamp taxes and other
taxes and duties levied in connection with the sale and issuance of the Shares to the Purchasers.

 

6.2.       Entire Agreement. The Transaction
Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties with respect to the
subject matter hereof and supersede all prior agreements, understandings, discussions, and representations, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits, and schedules. At or after
the Closing, and without further consideration, the Company and the Purchasers will execute and deliver to the other such further
documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction
Documents.

 

6.3.       Notices. Any and all notices
or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given
and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile
or e-mail (provided the sender receives a machine-generated confirmation of successful facsimile transmission or e-mail notification
or confirmation of receipt of an e-mail transmission) at the facsimile number or e-mail address specified in this Section prior
to 5:00 p.m., Eastern time, on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile or e-mail at the facsimile number or e-mail address specified in this Section on a day that is not a
Trading Day or later than 5:00 p.m., Eastern time, on any Trading Day, (c) if sent by U.S. nationally recognized overnight
courier service with next day delivery specified (receipt requested) the Trading Day following delivery to such courier service,
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as follows:

 

	 	 	 
	If to the Company:	 	
        HCSB Financial Corporation

        5009 Broad Street

        Loris, SC 29569

        Attention : Chief Executive Officer

	 	 
	With a copy to:	 	
        Nelson Mullins Riley & Scarborough LLP

        Poinsett Plaza, Suite 900

        104 South Main Street

        Greenville, SC 29601

        Attention: Neil E. Grayson

        Telephone: (864) 250-2235

        Facsimile: (864) 250-2359

        Email: neil.grayson@nelsonmullins.com

	 	 
	If to a Purchaser:	 	To the address set forth under such Purchaser’s name on the signature page hereof; or such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

    	 	49	 

     

    

Exhibit 10.1

 

or such other address as may be designated in writing hereafter,
in the same manner, by such Person.

 

6.4.       Amendments; Waivers; No Additional
Consideration. No amendment or waiver of any provision of this Agreement will be effective with respect to any party unless
made in writing and signed by a duly authorized representative of such party. No waiver of any default with respect to any provision,
condition, or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition, or requirement hereof, nor shall any delay or omission of either party to
exercise any right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to
any Purchaser to amend or consent to a waiver or modification of any provision of any Transaction Document unless the same consideration
is also offered to all Purchasers who then hold Shares.

 

6.5.      Construction. The headings herein
are for convenience only, do not constitute a part of this Agreement, and shall not be deemed to limit or affect any of the provisions
hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent,
and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted jointly
by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provisions of this Agreement or any of the Transaction Documents.

 

6.6.       Successors and Assigns. The
provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their successors and permitted assigns.
This Agreement, or any rights or obligations hereunder, may not be assigned by the Company without the prior written consent of
the Purchasers. Any Purchaser may assign its rights hereunder in whole or in part to any Person to whom such Purchaser assigns
or transfers any Shares in compliance with the Transaction Documents and applicable law, provided such transferee shall agree in
writing to be bound, with respect to the transferred Shares, by the terms and conditions of this Agreement that apply to the “Purchasers.”

 

6.7.       No Third-Party Beneficiaries.
This Agreement is intended for the benefit of the parties hereto, their respective successors and permitted assigns, and the Placement
Agent and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than, solely with respect
to the provisions of Section 4.8, the Purchaser Parties.

 

6.8.       Governing Law. All questions
concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof.
Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated
by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees
or agents) may be commenced on a non-exclusive basis in the South Carolina Courts. Each party hereto hereby irrevocably submits
to the non-exclusive jurisdiction of the South Carolina Courts for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject
to the jurisdiction of any such South Carolina Court, or that such Proceeding has been commenced in an improper or inconvenient
forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such
Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY.

 

    	 	50	 

     

    

Exhibit 10.1

 

      6.9.       Survival. The representations, warranties, agreements,
and covenants contained herein shall survive the Closing and the delivery of the Shares as follows: (i) the representations and
warranties of the Company set forth in Sections 3.1(a), 3.1(b), 3.1(c), 3.1(e), 3.1(f), 3.1(g), 3.1(i), 3.1(w), and 3.1(dd), and
shall survive indefinitely, (ii) the representations and warranties of the Company set forth in Sections 3.1(j), 3.1(l), 3.1(tt)
shall survive for the applicable statute of limitations, (iii) all other representations and warranties of the Company set forth
in Sections 3.1 shall survive for a period of 24 months following the Closing and the delivery of the Shares, and (iv) all representations
and warranties of the Purchasers set forth in Section 3.2 shall survive for a period of 12 months following the Closing and
the delivery of the Shares.

 

6.10.       Execution. This Agreement may
be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party, it being understood that the
parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, or by e-mail
delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original
thereof.

 

6.11.       Severability. If any provision
of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms
and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon
a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute
provision in this Agreement.

 

6.12.       Replacement of Shares. If any
certificate or instrument evidencing any Shares is mutilated, lost, stolen, or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the Company and the Transfer Agent of such loss, theft,
or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact and an agreement
to indemnify and hold harmless the Company and the Transfer Agent for any losses in connection therewith or, if required by the
Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants for a new certificate or instrument
under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Shares.
If a replacement certificate or instrument evidencing any Shares is requested due to a mutilation thereof, the Company may require
delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

6.13.       Remedies. In addition to being
entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the
Company will be entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence
and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action
for a temporary restraining order) the defense that a remedy at law would be adequate.

 

6.14.       Payment Set Aside. To the extent
that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises
its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by, or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver, or any other person under any law (including, without limitation,
any bankruptcy law, state, or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if
such payment had not been made or such enforcement or setoff had not occurred.

 

    	 	51	 

     

    

Exhibit 10.1

 

6.15.       Independent Nature of Purchasers’
Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the
obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of
any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Shares pursuant to the Transaction
Documents has been made by such Purchaser independently of any other Purchaser and independently of any information, materials,
statements, or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition
(financial or otherwise), or prospects of the Company or any Subsidiary which may have been made or given by any other Purchaser
or by any agent or employee of any other Purchaser, and no Purchaser and any of its agents or employees shall have any liability
to any other Purchaser (or any other Person) relating to or arising from any such information, materials, statements, or opinions.
Nothing contained herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed
to constitute the Purchasers as a partnership, an association, a joint venture, or any other kind of entity, or create a presumption
that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated
by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser in connection
with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser in connection with monitoring
its investment in the Shares or enforcing its rights under the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such
purpose. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.

 

6.16.       Termination.

 

(a)       This Agreement may be terminated and
the sale and purchase of the Shares abandoned at any time prior to the Closing:

 

      (i) by the written consent of the Company
and any Purchaser (with respect to itself only);

 

      (ii) by either the Company or any Purchaser
(with respect to itself only) upon written notice to the other, if the Closing has not been consummated on or prior to 5:00 p.m.,
Eastern time, on the Outside Date; provided, however, that the right to terminate this Agreement under this Section 6.16(a)(ii)
shall not be available to any Person whose failure to comply with its obligations under this Agreement has been the cause of or
resulted in the failure of the Closing to occur on or before such time;

 

      (iii) by the Company or Purchaser, upon written
notice to the other parties, in the event that any Governmental Entity shall have issued any order, decree or injunction or taken
any other action restraining, enjoining or prohibiting any of the transactions contemplated by this Agreement, and such order,
decree, injunction or other action shall have become final and nonappealable;

 

    	 	52	 

     

    

Exhibit 10.1

 

      (iv) by Purchaser (with respect to itself
only), upon written notice to the Company, if there has been a breach of any representation, warranty, covenant or agreement made
by the Company in this Agreement, or any such representation or warranty shall have become untrue after the date of this Agreement,
in each case such that a closing condition in Section 5.1(a) or Section 5.1(b) would not be satisfied;

 

      (v) by the Company, upon written notice to
Purchaser, if there has been a breach of any representation, warranty, covenant or agreement made by Purchaser in this Agreement,
or any such representation or warranty shall have become untrue after the date of this Agreement, in each case such that a closing
condition in Section 5.2(a) or Section 5.2(b) would not be satisfied;

 

      (vi) by the Company or Purchaser (with respect
to itself only), upon written notice to the other, if any of the conditions to Closing set forth in Sections 5.1 or 5.2 are not
capable of being satisfied on or before 5:00 p.m., Eastern time, on the Outside Date; provided, however, that the right
to terminate this Agreement under this Section 6.16(a)(vi) shall not be available to any Person whose failure to comply with
its obligations under this Agreement has been the cause of or resulted in the failure of the conditions to Closing set forth in
Sections 5.1 or 5.2 to occur on or before such time; or

 

      (vii) by the Purchaser,
upon written notice to the Company, if the Purchaser or any of its Affiliates receives written notice from or is otherwise advised
by the Federal Reserve or the SCBFI that the Federal Reserve or the SCBFI, as applicable, will not grant (or intends to rescind
if previously granted) any of the confirmations or determinations referred to in Section 5.1(q);

 

      (viii) by any Purchaser,
with respect to such Purchaser, if the Company directly or indirectly effects or causes to be effected any transaction with a third
party (1) with respect to an Acquisition Proposal or that would reasonably be expected to result in a Change in Control and (2)
such transaction has a purchase price per share of Common Stock that is less than the Purchase Price.

 

(b)       Nothing in this Section 6.16 shall
be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or
the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents. In the event of a termination pursuant to this Section, the Company shall
promptly notify all non-terminating Purchasers. Upon a termination in accordance with this Section, the Company and the terminating
Purchaser(s) shall not have any further obligation or liability (including arising from such termination) to the other, and no
Purchaser will have any liability to any other Purchaser under the Transaction Documents as a result therefrom.

 

6.17.       Rescission and Withdrawal Right.
Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents,
whenever any Purchaser exercises a right, election, demand, or option under a Transaction Document and the Company does not timely
perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice
to its future actions and rights.

 

6.18.       Adjustments in Common Stock Numbers
and Prices. In the event of any stock split, subdivision, dividend, or distribution payable in shares of Common Stock (or other
securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares of Common Stock),
combination, or other similar recapitalization or event occurring after the date hereof and prior to the Closing, each reference
in any Transaction Document to a number of shares or a price per share shall be deemed to be amended to appropriately account for
such event.

 

    	 	53	 

     

    

Exhibit 10.1

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	54	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties hereto
have caused this Stock Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.

 

	 	 	 	 
	 	HCSB FINANCIAL CORPORATION
	 	 	 
	 	By:	 	
 

	 	Name:	 	
 

	 	Title:	 	
 

	 	 
	 	NAME OF PURCHASER:
	 	 
	 	
 

	 	 	 
	 	By:	 	
 

	 	Name:	 	
 

	 	Title:	 	
 

	 	 	 	 
	 	 
	 	Aggregate Purchase Price
	 	(Subscription Amount): $                                      
	 	 
	 	
        No. of Common Shares to be Acquired at $0.10 per

        Share:                                         

         

        No. of Series A Preferred Shares to be Acquired at $10.00 per Share:                       

	 	 
	 	Tax ID No.:                                  
	 	 
	 	Address for Notice:
	 	 
	 	
 

	 	
 

	 	
 

	 	
 

	 	 	 
	 	Telephone:	 	
 

	 	Facsimile:	 	
 

	 	Email:	 	
 

	 	 	 
	 	Attention:	 	 

 

 

	 
	Delivery Instructions:
	(if different than above)
	 
	
 

	
 

	
 

	
 

 

[Signature Page to Stock Purchase Agreement]

 

    	 

     

    

Exhibit 10.1

 

EXHIBITS 

 

A      Form of Registration Rights Agreement

 

B      Accredited Investor Questionnaire

 

C      Form of Opinion of Company Counsel

 

D      Form of Tax Opinion

 

E      Form of Secretary’s Certificate

 

F      Form of Officer’s Certificate

 

G      Form of VCOC Letter Agreement

 

H      Form of Castle Creek Side Letter

 

I      Form of Mendon Side Letter

 

J      Form of EJF Side Letter

 

K      Form of SVI Side Letter

 

L      Form of Articles of Amendment

 

M      Form of Transferee Letter

 

N      Form of Prior Notice Letter

 

[Exhibit Index]

 

    	 

     

    

Exhibit 10.1

 

HCSB
Financial Corporation

REGISTRATION RIGHTS AGREEMENT

 

This Registration
Rights Agreement (this “Agreement”) is made and entered into as of February [•], 2016, by and among HCSB
Financial Corporation, a South Carolina corporation (the “Company”), and the purchaser(s) signatory hereto (each
a “Registration Rights Purchaser” and collectively, the “Registration Rights Purchasers”).

This Agreement is
made pursuant to the Stock Purchase Agreement, dated as of February [•], 2016, between the Company and each Registration Rights
Purchaser (the “Purchase Agreement”).

NOW, THEREFORE,
in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each of the Registration Rights Purchasers agree as follows:

1.                 
Definitions. Capitalized terms used and not otherwise defined herein that are defined
in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following
terms shall have the following meanings:

“Advice”
shall have the meaning set forth in Section 8(h).

“Affiliate”
means, with respect to any Person, any other Person which directly or indirectly controls, is controlled by, or is under common
control with, such Person.

“Agreement”
shall have the meaning set forth in the Preamble.

“Allowable
Grace Period” shall have the meaning set forth in Section 5(d).

“Business
Day” means a day other than a Saturday or Sunday or other day on which banks located in New York City are authorized
or required by law to close.

“Capital
Stock” means, with respect to any Person at any time, any and all shares, interests, participations or other equivalents
(however designated, whether voting or non-voting) of capital stock, securities convertible into or exchangeable or exercise able
for any of its shares, interests, participations or other equivalents, partnership interests (whether general or limited), limited
liability company interests, or equivalent ownership interests in or issued by such Person.

“Closing
Date” has the meaning set forth in the Purchase Agreement.

“Commission”
means the United States Securities and Exchange Commission.

“Common
Stock” means the voting common stock of the Company, par value $0.01 per share, and any securities into which such shares
of voting common stock may hereinafter be reclassified.

“Company”
shall have the meaning set forth in the Preamble.

“Effective
Date” means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the
Commission.

“Effectiveness
Deadline” means, with respect to the Initial Registration Statement or the New Registration Statement, the fifth (5th)
Trading Day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration
Statement will not be “reviewed” or will not be subject to further review; provided, that if the Effectiveness Deadline
falls on a Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended
to the next Business Day on which the Commission is open for business.

    	 	A-1	 

     

    

Exhibit 10.1

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(b).

“Event”
shall have the meaning set forth in Section 2(c).

“Event
Date” shall have the meaning set forth in Section 2(c).

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Filing
Deadline” means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the
date that is the first (1st) anniversary of the Closing Date; provided that if the Filing Deadline falls on a Saturday,
Sunday or other day that the Commission is closed for business, the Filing Deadline shall be extended to the next business day
on which the Commission is open for business.

“FINRA”
shall have the meaning set forth in Section 5(n).

“Grace
Period” shall have the meaning set forth in Section 5(d).

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

“Holders
Counsel” shall have the meaning set forth in Section 5(a).

“Indemnified
Party” shall have the meaning set forth in Section 7(c).

“Indemnifying
Party” shall have the meaning set forth in Section 7(c).

“Initial
Registration Statement” means shall have the meaning set forth in Section 2(a).

“Liquidated
Damages” shall have the meaning set forth in Section 2(c).

“Losses”
shall have the meaning set forth in Section 7(a).

“New Registration
Statement” shall have the meaning set forth in Section 2(a).

“Non-Responsive
Holder” shall have the meaning set forth in Section 8(d).

“Non-Voting
Common Stock” means the Company’s non-voting common stock, $0.01 par value per share, into which the Series A Preferred
Stock is convertible following approval by the Company’s shareholders of an amendment to its articles of incorporation authorizing
said stock.

“OTC Pink”
means the marketplace for trading over-the-counter stocks provided and operated by OTC Markets Group, Inc.

“Other
Securities” means shares of Common Stock, Series A Preferred Stock, Non-Voting Common Stock or shares of other Capital
Stock of the Company which are contractually entitled to registration rights or Capital Stock which the Company is registering
pursuant to a Registration Statement.

    	 	A-2	 

     

    

Exhibit 10.1

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Piggyback
Registration” shall have the meaning set forth in Section 3(a).

“Principal
Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which, as of
the Closing Date, shall be OTC Pink.

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.

“Purchase
Agreement” shall have the meaning set forth in the Recitals.

“Registrable
Securities” means all of the Shares, the Underlying Shares and any securities issued or issuable upon any stock split,
dividend or other distribution, recapitalization or similar event with respect to the Shares or the Underlying Shares, provided
that Shares or the Underlying Shares shall cease to be Registrable Securities upon the earliest to occur of the following: (A)
a sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which case, only such security sold shall
cease to be a Registrable Security); (B) becoming eligible for sale without volume or manner of sale restrictions by the Holders
under Rule 144; (C) if such Shares or Underlying Shares have ceased to be outstanding; (D) the date a Registration Statement becomes
effective including such Shares or Underlying Shares; or (E) if such Shares or Underlying Shares have been sold in a private transaction
in which the Holder’s rights under this Agreement have not been assigned to the transferee.

“Registration
Rights Purchaser” or “Registration Rights Purchasers” shall have the meaning set forth in the Preamble.

“Registration
Statements” means any one or more registration statements of the Company filed under the Securities Act that covers the
resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial
Registration Statement, the New Registration Statement and any Remainder Registration Statements), amendments and supplements to
such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed
to be incorporated by reference in such Registration Statements.

“Remainder
Registration Statement” shall have the meaning set forth in Section 2(a).

    	 	A-3	 

     

    

Exhibit 10.1

 

“Requested
Information” shall have the meaning set forth in Section 8(d).

“Required
Registration Statement” means any Initial Registration Statement, New Registration Statement or Remainder Registration
Statement.

“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any successor rule thereto.

“Rule 144A”
means Rule 144A promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any successor rule thereto.

“Rule 415”
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any successor rule thereto.

“Rule 424”
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any successor rule thereto.

“SEC Guidance”
means (i) any publicly-available written guidance, comments, requirements or requests of the Commission staff and (ii) the Securities
Act.

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Series
A Preferred Stock” means the Company’s Series A Convertible Perpetual Preferred Stock, $0.01 par value per share,
and any securities into which such shares of Series A Convertible Perpetual Preferred Stock may hereinafter be reclassified.

“Shares”
means the shares of Common Stock and the shares of Series A Preferred Stock issued or issuable to the Registration Rights Purchasers
pursuant to the Purchase Agreement.

“Shelf
Offering” shall have the meaning set forth in Section 4(a).

“Take-Down
Notice” shall have the meaning set forth in Section 4(a).

“Trading
Day” means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Market (other than the
OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on
which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common
Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported
in the OTC Pink; provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii)
hereof, then Trading Day shall mean a Business Day.

“Trading
Market” means whichever of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global
Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in
question.

“Underlying
Shares” means the shares of Common Stock and Non-Voting Common Stock into which the shares of Series A Preferred Stock
are convertible, and includes the shares of Common Stock into which the shares of Non-Voting Common Stock are convertible.

2.                 
Mandatory Registration.

    	 	A-4	 

     

    

Exhibit 10.1

 

(a)                        
On or prior to the Filing Deadline, the Company shall prepare and file with the Commission
a Registration Statement covering the resale of all of the Registrable Securities not already covered by an existing and effective
Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for
offers and sales of the Registrable Securities, by such other means of distribution of Registrable Securities as the Company may
reasonably determine (the “Initial Registration Statement”). Notwithstanding the registration obligations set
forth in this Section 2, in the event that (i) the Company’s counsel determines that all such Registrable Securities cannot,
as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement
prior to filing the Initial Registration Statement, or (ii) the Commission informs the Company that all such Registrable Securities
cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement,
the Company agrees to promptly (A) inform each of the Holders thereof and, as applicable, file the Initial Registration Statement,
or use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission
and/or (B) withdraw the Initial Registration Statement and file a new registration statement (a “New Registration Statement”),
in each case covering the maximum number of such Registrable Securities permitted to be registered thereon, on such form available
to the Company to register for resale the Registrable Securities as a secondary offering; provided, that in the case of (ii) above,
prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable
efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance,
including without limitation, Securities Act Rules Compliance and Disclosure Interpretation 612.09, or any successor thereto. Notwithstanding
any other provision of this Agreement, if the opinion of the Company’s counsel or any SEC Guidance sets forth a limitation
of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering
(and, in the case of clause (ii) above, notwithstanding that the Company used commercial reasonable efforts to reasonably advocate
with the Commission for the registration of all or a greater number of Registrable Securities), the number of Registrable Securities
to be registered on such Registration Statement will be reduced on a pro rata on the basis of the aggregate number of Registrable
Securities owned by each such person, and under such circumstances, the Company will not be subject to the payment of Liquidated
Damages in Section 2(c). In the event the Company amends the Initial Registration Statement or files a New Registration Statement,
as the case may be, under clauses (A) or (B) above, the Company will use its commercially reasonable efforts to file with the Commission,
as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or
more registration statements on such form available to the Company to register for resale those Registrable Securities that were
not registered for resale on the Initial Registration Statement, as amended, or the New Registration Statement (the “Remainder
Registration Statements”). No Holder shall be named as an “underwriter” in any Registration Statement without
such Holder’s prior written consent, which shall not be unreasonably withheld.

(b)                       
The Company shall use its commercially reasonable efforts to cause each Required Registration
Statement to be declared effective by the Commission as soon as practicable, and, with respect to the Initial Registration Statement
or the New Registration Statement, as applicable, no later than the Effectiveness Deadline, and shall use its commercially reasonable
efforts to keep each Required Registration Statement continuously effective under the Securities Act until the earlier of (i) such
time as all of the Registrable Securities covered by such Required Registration Statement have been publicly sold by the Holders
or (ii) the date that all Registrable Securities covered by such Required Registration Statement may be sold by the Holders without
volume or manner of sale restrictions under Rule 144, as determined by counsel to the Company pursuant to a written opinion letter
to such effect, addressed and reasonably acceptable to the Company’s transfer agent (the “Effectiveness Period”);
provided, however, if the Company does not meet the eligibility requirements for filing on Form S-3 (or any successor registration
statement form) at the time of filing of a Required Registration Statement, the Effectiveness Period shall not exceed 180 days
following the Effective Date. The Company shall request effectiveness of a Required Registration Statement as of 5:00 p.m., New
York City time, on a Trading Day. The Company shall promptly notify the Holders via facsimile or electronic mail of a “.pdf”
format data file of the effectiveness of a Registration Statement within one (1) Business Day of the Effective Date. The Company
shall file a final Prospectus for a Required Registration Statement with the Commission, as required by Rule 424(b) as promptly
as reasonably practicable following the Effective Date.

    	 	A-5	 

     

    

Exhibit 10.1

 

(c)                        
If: (i) the Initial Registration Statement is not filed with the Commission on or prior to
the Filing Deadline, (ii) the Initial Registration Statement or the New Registration Statement, as applicable, is not declared
effective by the Commission (or otherwise does not become effective) for any reason on or prior to the Effectiveness Deadline,
or (iii) after its Effective Date, (A) such Registration Statement ceases to be effective for any reason (including without limitation
by reason of a stop order, or the Company’s failure to update the Registration Statement), to remain continuously effective
as to all Registrable Securities for which it is required to be effective, or (B) the Holders are not permitted to utilize the
Prospectus therein to resell such Registrable Securities (other than during an Allowable Grace Period), (iv) a Grace Period applicable
to a Required Registration Statement exceeds the length of an Allowable Grace Period, or (v) after the Filing Deadline, and only
in the event a Registration Statement is not effective or available to sell all Registrable Securities, the Holders are unable
to sell Registrable Securities without restriction under Rule 144, (any such failure or breach in clauses (i) through (v) above
being referred to as an “Event,” and, for purposes of clauses (i), (ii), (iii) or (v), the date on which such
Event occurs, or for purposes of clause (iv) the date on which such Allowable Grace Period is exceeded, being referred to as an
“Event Date”), then in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured
by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as liquidated damages
and not as a penalty (“Liquidated Damages”), equal to 2.0% of the aggregate purchase price paid by such Holder
pursuant to the Purchase Agreement for any Registrable Securities held by such Holder on the Event Date. The parties agree that
notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages shall be payable (i) if as
of the relevant Event Date, the Registrable Securities may be sold by the Holders without volume or manner of sale restrictions
under Rule 144, as determined by counsel to the Company pursuant to a written opinion letter to such effect, addressed and reasonably
acceptable to the Company’s transfer agent, (ii) to a Holder causing an Event that relates to or is caused by any action
or inaction taken by such Holder, (iii) to a Holder in the event it is unable to lawfully sell any of its Registrable Securities
(including, without limitation, in the event a Grace Period exceeds the length of an Allowable Grace Period) because of possession
of material non-public information or (iv) with respect to any period after the expiration of the Effectiveness Period (it being
understood that this clause shall not relieve the Company of any Liquidated Damages accruing prior to the expiration of the Effectiveness
Period). If the Company fails to pay any Liquidated Damages pursuant to this Section 2(c) in full within ten (10) Business Days
after the date payable, the Company will pay interest on the amount of Liquidated Damages then owing to the Holder at a rate of
1.0% per month on an annualized basis (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder,
accruing daily from the date such Liquidated Damages are due until such amounts, plus all such interest thereon, are paid in full.
The Liquidated Damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the
cure of an Event, except in the case of the first Event Date. With respect to a Holder, the Effectiveness Deadline for a Required
Registration Statement shall be extended without default or Liquidated Damages hereunder in the event that the Company’s
failure to obtain the effectiveness of the Registration Statement on a timely basis results from the failure of such Holder to
timely provide the Company with information requested by the Company and necessary to complete the Registration Statement in accordance
with the requirements of the Securities Act (in which case the Effectiveness Deadline would be extended with respect to Registrable
Securities held by such Registration Rights Purchaser).

    	 	A-6	 

     

    

Exhibit 10.1

 

3.                 
Piggyback Registration. 

(a)                        
If the Company intends to file a Registration Statement covering a primary or secondary offering
of any of its Common Stock, Series A Preferred Stock, Non-Voting Common Stock or Other Securities, whether or not the sale for
its own account, which is not a registration solely to implement an employee benefit plan pursuant to a registration statement
on Form S-8 (or successor form), a registration statement on Form S-4 (or successor form) or a transaction to which Rule 145 or
any other similar rule of the Commission is applicable, the Company will promptly (and in any event at least ten (10) Business
Days before the anticipated filing date) give written notice to the Holders of its intention to effect such a registration. The
Company will effect the registration under the Securities Act of all Registrable Securities that the Holder(s) request(s) be included
in such registration (a “Piggyback Registration”) by a written notice delivered to the Company within five (5)
Business Days after the notice given by the Company in the preceding sentence. Subject to Section 3(b), securities requested to
be included in a Company registration pursuant to this Section 3 shall be included by the Company on the same form of Registration
Statement as has been selected by the Company for the securities the Company is registering for sale referred to above. The Holders
shall be permitted to withdraw all or part of the Registrable Securities from the Piggyback Registration at any time at least two
(2) Business Days prior to the effective date of the Registration Statement relating to such Piggyback Registration. If the Company
elects to terminate any registration filed under this Section 3 prior to the effectiveness of such registration, the Company will
have no obligation to register the securities sought to be included by the Holders in such registration under this Section 3. There
shall be no limit to the number of Piggybank Registrations pursuant to this Section 3(a).

(b)                       
If a Registration Statement under this Section 3 relates to an underwritten offering and the
managing underwriter(s) advise(s) the Company that in its or their reasonable opinion the number of securities requested to be
included in such offering exceeds the number which can be sold without adversely affecting the marketability of such offering (including
an adverse effect on the per share offering price), the Company will include in such registration or Prospectus only such number
of securities that in the reasonable opinion of such underwriter(s) can be sold without adversely affecting the marketability of
the offering (including an adverse effect on the per share offering price), which securities will be so included in the following
order of priority: (i) first, the Common Stock and other securities the Company proposes to sell, (ii) second, the Registrable
Securities of the Holders who have requested inclusion of Registrable Securities pursuant to this Section 3, pro rata on the basis
of the aggregate number of such securities or shares owned by each such person, or as such Holders may otherwise agree, and (iii)
third, any other securities of the Company that have been requested to be so included, subject to the terms of this Agreement.
The Company shall select the investment banking firm or firms to act as the lead underwriter or underwriters in connection with
an underwritten offering made pursuant to this Section 3. No Holder may participate in any underwritten registration under this
Section 3 unless such Holder (i) agrees to sell the Registrable Securities it desires to have covered by the underwritten offering
on the basis provided in any underwriting arrangements in customary form and (ii) completes and executes all questionnaires, powers
of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements.

4.                 
Underwritten Shelf Offerings.

(a)                        
At any time that a shelf registration statement covering Registrable Securities pursuant to
Section 2 or Section 3 is effective, if any Holder delivers a notice to the Company (a “Take-Down Notice”) stating
that it intends to sell all or part of its Registrable Securities included by it on the shelf registration statement (a “Shelf
Offering”), then, the Company shall amend or supplement the shelf registration statement as may be necessary in order
to enable such Registrable Securities to be distributed pursuant to the Shelf Offering (taking into account the inclusion of Registrable
Securities by any other Holders pursuant to this Section 4(a)). In connection with any Shelf Offering, including any Shelf Offering
that is an underwritten offering, such proposing holder(s) shall also deliver the Take-Down Notice to all other holders of Registrable
Securities included on such shelf Registration Statement and permit each such Holder to include its Registrable Securities included
on the shelf Registration Statement in the Shelf Offering if such holder notifies the proposing holder(s) and the Company within
five days after delivery of the Take-Down Notice to such Holder .

    	 	A-7	 

     

    

Exhibit 10.1

 

(b)                       
The Company shall have no obligation to effect an underwritten offering under this Section
4 on behalf of the holders of Registrable Securities electing to participate in such offering unless the expected gross proceeds
from such offering exceed $5,000,000.

(c)                        
If a Shelf Offering of Registrable Securities included in a Required Registration Statement
is to be conducted as an underwritten offering, then the Holders of the majority of the Registrable Securities included in a Required
Registration Statement shall select the investment banking firm or firms to act as the lead underwriter or underwriters in connection
with such offering; provided, that such selection shall be reasonably acceptable to the Company. If, in connection with any such
underwritten offering, the managing underwriter(s) advise(s) the Company that in its or their reasonable opinion the number of
securities requested to be included in such offering exceeds the number which can be sold without adversely affecting the marketability
of such offering (including an adverse effect on the per share offering price), the Company will include in such registration or
Prospectus only such number of securities that in the reasonable opinion of such underwriter(s) can be sold without adversely affecting
the marketability of the offering (including an adverse effect on the per share offering price), which securities will be so included
in the following order of priority: (i) first, the Registrable Securities of the Holders who have requested registration of Registrable
Securities pursuant to this Section 4, pro rata on the basis of the aggregate number of such securities or shares owned by each
such person, or as the Holders may otherwise agree amongst themselves, (ii) second, the Common Stock and other securities the Company
proposes to sell, and (iii) third, any other securities of the Company that have been requested to be so included, subject to the
terms of this Agreement. No Holder may participate in any underwritten registration under this Section 4 unless such Holder (i)
agrees to sell the Registrable Securities it desires to include in the underwritten offering on the basis provided in any underwriting
arrangements in customary form and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting
agreements and other documents required under the terms of such underwriting arrangements.

(d)                       
In addition to Sections (a) and (b) of this Section 4, a Shelf Offering of Registrable Securities
included on a Piggyback Registration Statement initiated by Holders shall be subject to the procedures set forth in Section 3(b).

5.                 
Registration Procedures

In connection with
the Company’s registration obligations hereunder:

(a)                        
the Company shall, not less than three (3) Trading Days prior to the filing of a Registration
Statement or any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K, Quarterly Reports
on Form 10-Q, proxy statements and Current Reports on Form 8-K and any similar or successor reports), furnish to one counsel designated
by a majority of the outstanding Registrable Securities (“Holders Counsel”), copies of such Registration Statement,
Prospectus or amendment or supplement thereto, as proposed to be filed, which documents will be subject to the reasonable review
of Holders Counsel. The Company shall not file any Registration Statement or amendment or supplement thereto containing information
which Holders Counsel reasonably objects in good faith, unless the Company shall have been advised by its counsel that the information
objected to is required under the Securities Act or the rules or regulations adopted thereunder 

    	 	A-8	 

     

    

Exhibit 10.1

 

(b)                       
(i) the Company shall prepare and file with the Commission such amendments, including post-effective
amendments and supplements, to each Registration Statement and the Prospectus used in connection therewith as may be necessary
to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period
(except during an Allowable Grace Period); (ii) the Company shall cause the related Prospectus to be amended or supplemented by
any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424 (except during an Allowable Grace Period); (iii) the Company shall respond as promptly as reasonably practicable to
any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly
as reasonably possible, provide the Holders Counsel true and complete copies of all correspondence from and to the Commission relating
to such Registration Statement that pertains to the Holders as “Selling Shareholders”; and (iv) the Company shall comply
in all material respects with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
covered by a Registration Statement until such time as all of such Registrable Securities shall have been disposed of (subject
to the terms of this Agreement) in accordance with the intended methods of disposition by the Holders thereof as set forth in such
Registration Statement as so amended or in such Prospectus as so supplemented; provided, that each Holder shall be responsible
for the delivery of the Prospectus to the Persons to whom such Registration Rights Purchaser sells any of the Registrable Securities
(including in accordance with Rule 172 under the Securities Act), and each Holder agrees to dispose of Registrable Securities in
compliance with applicable federal and state securities laws. In the case of amendments and supplements to a Registration Statement
which are required to be filed pursuant to this Agreement (including pursuant to this Section 5(b)) by reason of the Company filing
a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report under the Exchange Act, the Company shall have incorporated
such report by reference into such Registration Statement, if applicable, or shall file such amendments or supplements with the
Commission as promptly as practicable.

(c)                        
the Company shall notify the Holders (which notice shall, pursuant to clauses (ii) through
(iv) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made,
if applicable) as promptly as reasonably practicable following the day (i)(A) when a Prospectus or any Prospectus supplement or
post-effective amendment to a Registration Statement has been filed with the Commission; (B) with respect to each Registration
Statement or any post-effective amendment, when the same has become effective; (ii) of the issuance by the Commission or any other
federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any
or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iii) of the receipt by the Company
of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable
Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (iv) of the occurrence
of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion
therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or
other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under
which they were made), not misleading. 

    	 	A-9	 

     

    

Exhibit 10.1

 

(d)                       
Notwithstanding anything to the contrary herein, at any time after the Registration Statement
has been declared effective by the Commission, the Company may delay the disclosure of material non-public information concerning
the Company if the disclosure of such information at the time is not, in the good faith judgment of the Company, in the best interests
of the Company (such delay, a “Grace Period”). During the Grace Period, the Company shall not be required to
maintain the effectiveness of any Registration Statement filed hereunder and, in any event, Holders shall suspend sales of Registrable
Securities pursuant to such Registration Statements during the pendancy of the Grace Period provided, the Company shall promptly
(i) notify the Holders in writing of the existence of material non-public information giving rise to a Grace Period or the need
to file a post-effective amendment, as applicable, and the date on which such Grace Period will begin, (ii) use commercially reasonable
efforts to terminate a Grace Period as promptly as practicable provided that such termination is, in the good faith judgment of
the Company, in the best interest of the Company and (iii) notify the Holders in writing of the date on which the Grace Period
ends; provided, further, that, with respect to a Required Registration Statement only, no single Grace Period shall exceed forty-five
(45) consecutive days, and during any three hundred sixty-five (365) day period, the aggregate of all Grace Periods shall not exceed
an aggregate of ninety (90) days (each Grace Period complying with this provision being an “Allowable Grace Period”).
For purposes of determining the length of a Grace Period, the Grace Period shall be deemed to begin on and include the date the
Holders receive the notice referred to in clause (i) above and shall end on and include the later of the date the Holders receive
the notice referred to in clause (iii) above and the date referred to in such notice; provided, that no Grace Period shall be longer
than an Allowable Grace Period. Notwithstanding anything to the contrary, the Company shall use commercially reasonable efforts
to cause the Transfer Agent to deliver unlegended Shares to a transferee of a Holder in accordance with the terms of the Purchase
Agreement in connection with any sale of Registrable Securities with respect to which a Holder has entered into an irrevocable
contract for sale prior to the Holder’s receipt of the notice of a Grace Period and for which the Holder has not yet settled.

(e)                        
the Company shall use commercially reasonable efforts to avoid the issuance of, or, if issued,
obtain the withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any suspension of the
qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.

(f)                        
the Company shall, if requested by a Holder, furnish to such Holder, without charge, at least
one (1) conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such
Holder (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the
Commission; provided, that the Company shall have no obligation to provide any document pursuant to this clause that is available
on the Commission’s EDGAR or successor system.

(g)                        
the Company agrees to promptly deliver to each Holder whose Registrable Securities are included
in the applicable Registration Statement, without charge, as many copies of each Prospectus or Prospectuses (including each form
of prospectus) and each amendment or supplement thereto as such Persons may reasonably request. The Company hereby consents to
the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering
and sale of Registrable Securities covered by such Prospectus and any amendment or supplement thereto.

(h)                       
the Company shall, prior to any resale of Registrable Securities by a Holder, use its commercially
reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification
(or exemption from the registration or qualification) of such Registrable Securities for the resale by the Holder under the securities
or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration
or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things
reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration
Statement; provided, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is
not then so qualified, subject the Company to any general tax in any such jurisdiction where it is not then so subject or file
a consent to service of process in any such jurisdiction.

    	 	A-10	 

     

    

Exhibit 10.1

 

(i)                         
the Company shall enter into such customary agreements (including an underwriting agreement
in customary form) and take all such other actions reasonably requested by the Holders of a majority of the Registrable Securities
being sold in connection therewith or by the managing underwriter(s), if any, in order to expedite or facilitate the disposition
of such Registrable Securities. In connection with any such permitted underwritten offering of Registrable Securities, (i) the
Company shall (A) make such representations and warranties to the selling Holders and the managing underwriter(s), if any, with
respect to the business of the Company and its subsidiaries, and the Registration Statement, Prospectus and documents, if any,
incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made
by issuers in underwritten offerings, and, if true, confirm the same if and when requested, (B) use its commercially reasonable
efforts to furnish opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance)
shall be reasonably satisfactory to the managing underwriter(s), if any, addressed to each of the managing underwriter(s), if any,
covering the matters customarily covered in opinions requested in underwritten offerings, (C) use its commercially reasonable efforts
to obtain “cold comfort” letters and updates thereof from the independent certified public accountants of the Company
(and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired
by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement)
who have certified the financial statements included in such Registration Statement, addressed to each of the managing underwriter(s),
if any, such letters to be in customary form and covering matters of the type customarily covered in “cold comfort”
letters in connection with underwritten offerings, (D) the underwriting agreement shall contain indemnification provisions and
procedures customary in such underwritten offerings and (v) deliver such documents and certificates as may be reasonably requested
by the Holders of a majority of the Registrable Securities being sold in connection therewith, their counsel and the managing underwriter(s),
if any, to evidence the continued validity of the representations and warranties made pursuant to clause (A) above and to evidence
compliance with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company,
(ii) each Holder shall not, during such period (which period shall in no event exceed one hundred and eighty (180) days, subject
to any then customary “booster shot” extension (which extension shall not exceed thirty (30) days) following the effective
date of any Registration Statement to the extent requested by any managing underwriter, sell, pledge, hypothecate, transfer, make
any short sale of, loan, grant any option or right to purchase of, or otherwise transfer or dispose of (other than to donees who
agree to be similarly bound) any Registrable Securities owned by it at any time during such period, except Registrable Securities
included in such registration; provided that any release of Registrable Securities from such agreement shall be effected among
the Holders on a pro rata basis according to the Registrable Securities then owned by them, and (iii) the Company shall use its
commercially reasonable efforts to cause each of its directors and senior executive officers to execute and deliver customary lockup
agreements in such form and for such time period up to one hundred and eighty (180) days (subject to any then customary “booster
shot” extensions) as may be requested by any managing underwriter. The above shall be done at each closing under such underwriting
or similar agreement, or as and to the extent required thereunder.

(j)                         
the Company shall make available for inspection by any Holder of Registrable Securities included
in such Registration Statement, any underwriter participating in any disposition pursuant to such Registration Statement, and any
attorney, accountant or other agent retained by any such seller or underwriter (collectively, the “Inspectors”),
at the offices where normally kept, during reasonable business hours, all financial and other records, pertinent corporate documents
and properties of the Company and its Subsidiaries (collectively, the “Records”), as shall be reasonably necessary
to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees
to supply all information reasonably requested by any such Inspector in connection with such Registration Statement; provided,
however, that any Records that are not generally publicly available at the time of delivery of such Records shall be kept confidential
by such Inspectors unless (i) the disclosure of such Records is necessary in the reasonable judgment of the Inspectors to avoid
or correct a misstatement or omission in the Registration Statement, or (ii) the release of such Records is ordered pursuant to
a subpoena or other order from a court of competent jurisdiction; provided, further, that each Holder of Registrable Securities
agrees that it will, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, give notice
to the Company to the extent legally permitted and allow the Company, at its expense, to undertake appropriate action and to prevent
disclosure of the Records deemed confidential.

    	 	A-11	 

     

    

Exhibit 10.1

 

(k)                       
the Company shall, in the case of an underwritten offering, cause its officers to use their
commercially reasonable efforts to support the marketing of the Registrable Securities covered by the Registration Statement (including,
without limitation, by participation in “road shows”) if requested by the managing underwriter(s) and taking into account
the Company’s business needs.

(l)                         
the Company shall reasonably cooperate with the Holders to facilitate the timely preparation
and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement,
which certificates shall be free, to the extent permitted by the Purchase Agreement and under law, of all restrictive legends,
and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably
request. Certificates for Registrable Securities free from all restrictive legends may be transmitted by the transfer agent to
a Holder by crediting the account of such Holder’s prime broker with DTC as directed by such Holder.

(m)                     
the Company shall following the occurrence of any event contemplated by Sections 5(c)(ii)-(iv),
as promptly as reasonably practicable, as applicable: (i) use its commercially reasonable efforts to prevent the issuance of any
stop order or obtain its withdrawal at the earliest possible moment if the stop order have been issued, or (ii) taking into account
the Company’s good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure
of such event, prepare and file a supplement or amendment, including a post-effective amendment, to the affected Registration Statements
or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file
any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they
were made), not misleading.

(n)                       
the Company may require each selling Holder to furnish to the Company a certified statement
as to (i) the number of securities of the Company beneficially owned by such Holder and any Affiliate thereof, (ii) any Financial
Industry Regulatory Authority (“FINRA”) affiliations, (iii) any natural persons who have the power to vote or dispose
of the Common Stock and (iv) any other information as may be requested by the Commission, FINRA, any state securities commission
or any other government or regulatory body with jurisdiction over the Company or its activities. During any periods that the Company
is unable to meet its obligations hereunder with respect to the registration of Registrable Securities because any Holder fails
to furnish such information within five (5) Trading Days of the Company’s request, any Liquidated Damages that are accruing
at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be
suspended as to such Holder only, until such information is delivered to the Company.

    	 	A-12	 

     

    

Exhibit 10.1

 

(o)                       
the Company shall cooperate with any registered broker through which a Holder proposes to
resell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder
and the Company shall pay the filing fee required for the first such filing (but not additional filings) within two (2) Business
Days of the request therefore.

(p)                       
if the Company becomes eligible to use Form S-3 during the term of this Agreement, the Company
shall use its commercially reasonable efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the
registration of the resale of Registrable Securities.

(q)                       
if requested by a Holders Counsel, the Company shall (i) promptly incorporate in a Prospectus
supplement or post-effective amendment to the Registration Statement such information as the Company reasonably agrees (upon advice
of counsel) is required to be included therein and (ii) make all required filings of such Prospectus supplement or such post-effective
amendment as soon as reasonably practicable after the Company has received notification of the matters to be incorporated in such
Prospectus supplement or post-effective amendment.

The Company may
require each Holder of Registrable Securities as to which any registration is being effected to furnish to the Company in writing
such information required in connection with such registration regarding such Holder and the distribution of such Registrable Securities
as the Company may, from time to time, reasonably request in writing and the Company may exclude from such registration the Registrable
Securities of any Holder who fails to furnish such information within a reasonable time after receiving such request.

6.                 
Registration Expenses. All fees and expenses incident to the Company’s performance
of or compliance with its obligations under this Agreement (excluding any underwriting discounts and selling commissions, stock
transfer taxes and fees of counsel for the Holders) shall be borne by the Company whether or not any Registrable Securities are
sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence that are the Company’s
responsibility shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and
expenses (A) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading,
(B) with respect to compliance with applicable state securities or Blue Sky laws (including, without limitation, fees and disbursements
of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities and determination
of the eligibility of the Registrable Securities for investment under the laws of such jurisdictions as requested by the Holders)
and (C) if not previously paid by the Company in connection with an issuer filing, with respect to any filing that may be required
to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule
5110, so long as the broker is receiving no more than a customary brokerage commission in connection with such sale, (ii) printing
expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing prospectuses
if the printing of prospectuses is reasonably requested by the Holders of a majority of the Registrable Securities included in
the Registration Statement), (iii) messenger, telephone and delivery expenses of the Company, (iv) fees and disbursements of counsel
for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, (vi) fees and expenses of all
other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement, and
(vii) those expenses of the selling Holders actually and reasonably incurred, including without limitation, the reasonable fees
of Holders Counsel. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with
the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of
its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred
in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. 

    	 	A-13	 

     

    

Exhibit 10.1

 

7.                 
Indemnification.

(a)                        
Indemnification by the Company. The Company shall, notwithstanding any termination
of this Agreement, indemnify, defend and hold harmless each Holder, the officers, directors, agents, general partners, managing
members, managers, Affiliates and employees, each Person who controls any such Holder (within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act) and the officers, directors, general partners, managing members, managers, agents
and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and
reasonable and documented attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise
out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising
out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make
the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange
Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under
this Agreement, except to the extent, but only to the extent, that (A) such untrue statements, alleged untrue statements, omissions
or alleged omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder
or on behalf of such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s
proposed method of distribution of Registrable Securities and was reviewed and approved by such Holder or Holders Counsel expressly
for use in the Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto, (B)
Holder’s failure to deliver or cause to be delivered the Prospectus or any amendment or supplement thereto made available
by the Company in compliance with Section 8(g), or (C) in the case of an occurrence of an event of the type specified in Sections
5(c)(ii)-(iv), related to the use by a Holder of an outdated or defective Prospectus after the Company has notified such Holder
in writing or electronic mail that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice
contemplated and defined in Section 8(h) below, but only if and to the extent that following the receipt of the Advice the misstatement
or omission giving rise to such Loss would have been corrected. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of an Indemnified Party (as defined in Section 7(c)) and shall survive the transfer of
the Registrable Securities by the Holders.

(b)                       
Indemnification by Holders. Each Holder shall, notwithstanding any termination of this
Agreement, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each
Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and
the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from
and against all Losses, as incurred, arising out of or are based upon (i) any untrue or alleged untrue statement of a material
fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any Prospectus, or any form of prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading (A) to the extent, but only to the extent, that
such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company
by or on behalf of such Holder expressly for use therein, or (B) to the extent, but only to the extent, that such information relates
to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved by
such Holder or Holders Counsel expressly for use in a Registration Statement, such Prospectus or such form of Prospectus or in
any amendment or supplement thereto or (C) in the case of an occurrence of an event of the type specified in Sections 5(c)(ii)-(iv),
to the extent, but only to the extent, related to the use by such Holder of an outdated or defective Prospectus after the Company
has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the
Advice contemplated in Section 8(h), but only if and to the extent that following the receipt of the Advice the misstatement or
omission giving rise to such Loss would have been corrected, or (ii) Holder’s failure to deliver or cause to be delivered
the Prospectus or any amendment or supplement thereto made available by the Company in compliance with Section 8(g). In no event
shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by
such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation. 

    	 	A-14	 

     

    

Exhibit 10.1

 

(c)                        
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted
against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly
notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying
Party shall have the right to assume the defense thereof, including the employment of one (1) counsel reasonably satisfactory to
the Indemnified Party and the payment of all reasonable and documented fees and expenses incurred in connection with defense thereof;
provided, that the failure of any Indemnified Party to give such written notice within a reasonable time of commencement of any
such Proceeding shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and
only) to the extent that such failure shall have materially and adversely prejudiced the Indemnifying Party in its ability to defend
such Proceeding.

An Indemnified Party
shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has
agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of
such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named
parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and such Indemnified Party shall have been advised by counsel in writing that a conflict of interest exists if the same counsel
were to represent such Indemnified Party and the Indemnifying Party; provided, that the Indemnifying Party shall not be liable
for the fees and expenses of more than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying
Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not
be unreasonably withheld, delayed or unreasonably conditioned. No Indemnifying Party shall, without the prior written consent of
the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless
such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter
of such Proceeding.

Subject to the terms
of this Agreement, all documented fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section
7(c)) shall be paid to the Indemnified Party, as incurred, within twenty (20) Trading Days of written notice thereof to the Indemnifying
Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses
applicable to such actions for which such Indemnified Party is finally judicially determined to not be entitled to indemnification
hereunder.

    	 	A-15	 

     

    

Exhibit 10.1

 

(d)                       
Contribution. If a claim for indemnification under Section 7(a) or 7(b) is unavailable
to an Indemnified Party (other than in accordance with its terms) or insufficient to hold an Indemnified Party harmless for any
Losses, then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable
by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party, on the one hand, and Indemnified Party, on the other hand, in connection with the actions, statements or omissions
that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party,
on the one hand, and Indemnified Party, on the other hand, shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The
amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in
this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with
any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for
in this Section 7(d) was available to such party in accordance with its terms. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this Section 7(d) were determined by pro rata allocation or by any other method of allocation
that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding
the provisions of this Section 7(d), no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount
by which the net proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding
exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

The indemnity and
contribution agreements contained in this Section 7 are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties and are not in diminution or limitation of the indemnification provisions under the Purchase Agreement.

8.                 
Miscellaneous.

(a)                        
Remedies. In the event of a breach by the Company or by a Holder of any of their obligations
under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted
by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this
Agreement. The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred
by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action
for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate.

(b)                       
Prohibition on Other Registrations. The Company agrees (i) not to effect or initiate
a registration statement for any public sale or distribution of any securities similar to those being registered pursuant to this
Agreement, or any securities convertible into or exchangeable or exercisable for such securities (other than a registration solely
to implement an employee benefit plan pursuant to a registration statement on Form S-8 (or successor form), a registration statement
on Form S-4 (or successor form) or a transaction to which Rule 145 or any other similar rule of the Commission is applicable),
during the fourteen (14) calendar days prior to, and during the sixty (60) calendar-day period beginning on, the effective date
of any Registration Statement in which the Holders of Registrable Securities are participating (except as part of any such registration,
if permitted). 

    	 	A-16	 

     

    

Exhibit 10.1

 

(c)                        
Rule 144 Requirements. For so long as the Company is subject to the reporting requirements
of the Exchange Act, the Company will use its commercially reasonable efforts to timely file with the Commission such reports and
information required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the
Commission thereunder and as the Commission may require. The Company shall furnish to any Holder of Registrable Securities forthwith
upon request a written statement as to its compliance with the reporting requirements of Rule 144 (or any successor exemptive rule),
the Securities Act and the Exchange Act (at any time that it is subject to such reporting requirements); a copy of its most recent
annual or quarterly report; and such other reports and documents as such Person may reasonably request in availing itself of any
rule or regulation of the Commission allowing it to sell any such securities without registration.

(d)                       
Obligations of Holders and Others in a Registration. Each Holder agrees to timely furnish
in writing such information regarding such Person, the securities sought to be registered and the intended method of disposition
of the Registrable Securities held by it, as shall be reasonably be required to effect the registration of such Registrable Securities
(the “Requested Information”) and shall take such other action as the Company may reasonably request in connection
with the registration, qualification or compliance or as otherwise provided herein. At least ten (10) Business Days prior to the
first anticipated filing date of a Registration Statement, the Company shall notify each holder of the information the Company
requires from such Holder if such Holder elects to have any of such Holder’s Registrable Securities included in the Registration
Statement. If at least five (5) business days prior to the filing date, the Company has not received the Requested Information
from a Holder (a “Non-Responsive Holder”), then the Company may exclude from any Registration Statement the
Registrable Securities of such Non-Responsive Holder. 

(e)                        
Rule 144A. The Company agrees that, upon the request of any Holder of Registrable Securities
or any prospective purchaser of Registrable Securities designated by a Holder, the Company shall promptly provide (but in any case
within fifteen (15) calendar days of a request) to such Holder or potential purchaser, the following information:

(i)                
a brief statement of the nature of the business of the Company and any subsidiaries and the
products and services they offer;

(ii)              
the most recent consolidated balance sheets and profit and losses and retained earnings statements,
and similar financial statements of the Company for the two (2) most recent fiscal years (such financial information shall be audited,
to the extent reasonably available); and

(iii)            
such other information about the Company, any subsidiaries, and their business, financial
condition and results of operations as the requesting Holder or purchaser of such Registrable Securities shall reasonably request
in order to comply with Rule 144A, as amended, and in connection therewith the anti-fraud provisions of the federal and state securities
laws.

The Company hereby
represents and warrants to any such requesting Holder and any prospective purchaser of Registrable Securities from such Holder
that the information provided by the Company pursuant to this Section 6(e) will, as of their dates, not contain any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances
under which they were made, not misleading.

    	 	A-17	 

     

    

Exhibit 10.1

 

(f)                        
Limitations on Subsequent Registration Rights. The Company will not enter into any
agreements with any holder or prospective holder of any securities of the Company which would grant such holder or prospective
holder registration rights with respect to the securities of the Company which would have priority over the Registrable Securities
with respect to the inclusion of such securities in any registration. If the Company enters into an agreement that contains terms
more favorable, in form or substance, to any shareholders than the terms provided to the Holders under this Agreement, then the
Company will modify or revise the terms of this Agreement in order to reflect any such more favorable terms for the benefit of
the Holders. 

(g)                        
Compliance. Each Holder covenants and agrees that it will comply with the prospectus
delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with
sales of Registrable Securities pursuant to the Registration Statement and shall sell the Registrable Securities only in accordance
with a method of distribution described in the Registration Statement.

(h)                       
Discontinued Disposition. By its acquisition of Registrable Securities, each Holder
agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Sections 5(c)(ii)-(iv),
such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised
in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented
or amended) may be resumed. The Company may provide appropriate stop orders to enforce the provisions of this paragraph.

(i)                         
No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered,
as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date hereof, enter into any agreement
with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof.

(j)                         
Amendments and Waivers. The provisions of this Agreement, including the provisions
of this sentence, may not be amended, modified or supplemented, or waived unless the same shall be in writing and signed by the
Company and Holders of a majority of the then outstanding Registrable Securities; provided that any such amendment, modification,
supplement or waiver that materially, adversely and disproportionately effects the rights or obligations of any Holder vis a vis
the other Holders shall require the prior written consent of such Holder.

(k)                       
Notices. Any and all notices or other communications or deliveries required or permitted
to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission,
if such notice or communication is delivered via facsimile or e-mail (provided the sender receives a machine-generated confirmation
of successful facsimile transmission or e-mail notification or confirmation of receipt of an e-mail transmission) at the facsimile
number or e-mail address specified in this Section prior to 5:00 p.m., New York City time, on a Trading Day, (b) the next Trading
Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified
in this Section on a day that is not a Trading Day or later than 5:00 p.m., New York City time, on any Trading Day, (c) the Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified,
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as follows:

	 	If to the Company:   	HCSB Financial Corporation	 
	 	 	5009 Broad Street	 
	 	 	Loris, SC  29569	 
	 	 	Attention: Chief Executive Officer	 

 

    	 	A-18	 

     

    

Exhibit 10.1

 

	 	 	 	 
	 	With a copy to:  	Nelson Mullins Riley & Scarborough LLP	 
	 	 	Poinsett Plaza, Suite 900	 
	 	 	104 South Main Street	 
	 	 	Greenville, SC  29601	 
	 	 	Attention:  Neil E. Grayson	 
	 	 	Fax:  (864) 250-2359	 
	 	 	Email:  neil.grayson@nelsonmullins.com	 

 

If to a Registration
Rights Purchaser:

To the address set
forth under such Registration Rights Purchaser’s name on the signature page hereof or such other address as may be designated
in writing hereafter, in the same manner, by such Person.

(l)                         
Successors and Assigns. This Agreement shall inure to the benefit of and be binding
upon the successors and permitted assigns of each of the parties. Nothing in this Agreement, express or implied, is intended to
confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign
its rights (except by merger or in connection with another entity acquiring all or substantially all of the Company’s assets)
or obligations hereunder without the prior written consent of all the Holders of the then outstanding Registrable Securities. The
rights to have the Company register Registrable Securities pursuant to this Agreement shall be automatically assigned by Registration
Rights Purchaser to any transferee of the Shares only if: (a) the transferee or assignee (i) acquires Shares of the Registration
Rights Purchaser’s Registrable Securities with an original value as of the Closing Date of $2,000,000; (b) the Registration
Rights Purchaser agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished
to the Company within a reasonable period of time after such assignment; (c) the Company is, within a reasonable time after such
transfer or assignment, furnished with written notice of (i) the name and address of such transferee or assignee and (ii) the securities
with respect to which such registration rights are being transferred or assigned; (d) immediately following such transfer or assignment
the further disposition of such securities by the transferee or assignee is restricted under the Securities Act and applicable
state securities laws; and (e) at or before the time the Company received the written notice contemplated by clause (c) of this
sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein with
respect to a Holder or Registration Rights Purchaser. In the event of any delay in filing or effectiveness of the Registration
Statement as a result of such assignment by a Registration Rights Purchaser or its transferee, the Company shall not be liable
for any damages arising from such delay.

(m)                     
Execution and Counterparts. This Agreement may be executed in two (2) or more counterparts,
each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the
same Agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it
being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile
transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature were the original thereof.

    	 	A-19	 

     

    

Exhibit 10.1

 

(n)                       
Governing Law. This Agreement shall be governed by and construed in accordance with
the internal laws of the State of New York applicable to contracts made and to be performed entirely within such State. All questions
concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with
the provisions of the Purchase Agreement.

(o)                       
Cumulative Remedies. Except as provided in Section 2(c) with respect to Liquidated
Damages, the remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

(p)                       
Severability. If any term, provision, covenant or restriction of this Agreement is
held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions,
covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or
invalidated, and the parties hereto shall use their good faith reasonable efforts to find and employ an alternative means to achieve
the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated
and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions
without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

(q)                       
Headings. The headings in this Agreement are for convenience only and shall not limit
or otherwise affect the meaning hereof.

(r)                         
Independent Nature of Registration Rights Purchasers’ Obligations and Rights.
The obligations of each Registration Rights Purchaser under this Agreement are several and not joint with the obligations of any
other Registration Rights Purchaser hereunder, and no Registration Rights Purchaser shall be responsible in any way for the performance
of the obligations of any other Registration Rights Purchaser hereunder. The decision of each Registration Rights Purchaser to
purchase the Shares pursuant to the Purchase Agreement has been made independently of any other Registration Rights Purchaser.
Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Registration
Rights Purchaser pursuant hereto or thereto, shall be deemed to constitute the Registration Rights Purchasers as a partnership,
an association, a joint venture or any other kind of entity, or create a presumption that the Registration Rights Purchasers are
in any way acting in concert with respect to such obligations or the transactions contemplated by this Agreement. Each Registration
Rights Purchaser acknowledges that no other Registration Rights Purchaser has acted as agent for such Registration Rights Purchaser
in connection with making its investment hereunder and that no Registration Rights Purchaser will be acting as agent of such Registration
Rights Purchaser in connection with monitoring its investment in the Shares or enforcing its rights under the Purchase Agreement.
Each Registration Rights Purchaser shall be entitled to protect and enforce its rights, including, without limitation, the rights
arising out of this Agreement, and it shall not be necessary for any other Registration Rights Purchaser to be joined as an additional
party in any Proceeding for such purpose. The Company acknowledges that each of the Registration Rights Purchasers has been provided
with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Registration Rights Purchasers
and not because it was required or requested to do so by any Registration Rights Purchaser. It is expressly understood and agreed
that each provision contained in this Agreement is between the Company and a Registration Rights Purchaser, solely, and not between
the Company and the Registration Rights Purchasers collectively and not between and among the Registration Rights Purchasers.

    	 	A-20	 

     

    

Exhibit 10.1

 

(s)                        
Entire Agreement. This Agreement and the Purchase Agreement constitute the entire agreement
among the parties hereto with respect to the subject matter hereof. There are no restrictions, promises, warranties or undertakings,
other than as set forth or referred to herein and in the Purchase Agreement. This Agreement supersedes all prior agreements and
understandings among the parties hereto with respect to the subject matter hereof. 

[REMAINDER OF
PAGE INTENTIONALLY LEFT BLANK]

    	 	A-21	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF,
the parties have executed this Registration Rights Agreement as of the date first written above.

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page
to Registration Rights Agreement]

 

    	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF,
the parties have executed this Registration Rights Agreement as of the date first written above.

	 	NAME OF INVESTING ENTITY
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	AUTHORIZED SIGNATORY
	 	 	 
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	ADDRESS FOR NOTICE
	 	 	 
	 	c/o:  	 
	 	 	 
	 	Street:   	 
	 	 	 
	 	City/State/Zip:  	 
	 	 	 
	 	Attention:   	 
	 	 	 
	 	Tel:	 
	 	 	 
	 	Fax:	 
	 	 	 
	 	E-mail:   	 

 

[Signature Page to Registration Rights Agreement]

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT B 

ACCREDITED INVESTOR QUESTIONNAIRE 

(ALL INFORMATION WILL BE TREATED CONFIDENTIALLY)

 

	To:	HCSB Financial Corporation 

 

This Accredited Investor Questionnaire (“Questionnaire”)
must be completed by each potential investor in connection with the offer and sale by HCSB Financial Corporation, a South Carolina
corporation (the “Company”), of its shares of (i) common stock, $0.01 par value per share (the “Common
Shares”) and (ii) a newly-issued series of convertible perpetual preferred stock, series A, par value $0.01 per share,
of the Company (the “Series A Preferred Shares”) which shall be convertible into shares of the Common Stock
subject to the terms and conditions set forth in the Articles of Amendment described in the attached Stock Purchase Agreement and,
following the adoption of the Articles of Amendment, the non-voting common stock of the Company, par value $0.01 per share (the
“Non-Voting Common Stock”). The Common Shares and the Series A Preferred Shares shall be collectively referred
herein to as the “Shares”. The Shares are being offered and sold by the Company without registration under the
Securities Act of 1933, as amended (the “Act”), and the securities laws of certain states, in reliance on the
exemptions contained in Section 4(a)(2) of the Act and on Regulation D promulgated thereunder and in reliance on similar exemptions
under applicable state laws. The Company must determine that a potential investor meets certain suitability requirements before
offering or selling Shares to such investor. The purpose of this Questionnaire is to assure the Company that each investor will
meet the applicable suitability requirements. The information supplied by you will be used in determining whether you meet such
criteria, and reliance upon the private offering exemptions from registration is based in part on the information herein supplied.

 

This Questionnaire does not constitute an offer
to sell or a solicitation of an offer to buy any security. Your answers will be kept strictly confidential. However, by signing
this Questionnaire, you will be authorizing the Company to provide a completed copy of this Questionnaire to such parties as the
Company deems appropriate in order to ensure that the offer and sale of the Shares will not result in a violation of the Act or
the securities laws of any state and that you otherwise satisfy the suitability standards applicable to purchasers of the Shares.
All potential investors must answer all applicable questions and complete, date and sign this Questionnaire. Please print or type
your responses and attach additional sheets of paper if necessary to complete your answers to any item.

 

	PART A.	BACKGROUND INFORMATION 

 

	 	 	 
	Name of Beneficial Owner of the Shares:	 	
 

 

	 	 	 	 	 
	Business Address:	 	
 

	 	 	(Number and Street)	 	 
	 	 	 	 	 
	
 

	(City)	 	(State)	 	(Zip Code)

 

	 	 	 
	Telephone Number: (    )	 	
 

	 	 	
 

 

    	 	B-1	 

     

    

Exhibit 10.1

 

 

	 	 	 	 	 
	If a corporation, partnership, limited liability company, trust or other entity:

 

	 	 	 
	Type of entity:	 	
 

 

	 	 	 
	Were you formed for the purpose of investing in the securities being offered?

Yes o            No o

 

	 	 	 	 	 
	If an individual:	 	 	 	 
	 	 
	Residence Address:	 	
 

	 	 	(Number and Street)	 	 
	 	 	 	 	 
	
 

	(City)	 	(State)	 	(Zip Code)

 

	 	 	 	 	 
	Telephone Number: (    )	 	
 

	 	 	
 

 

	 	 	 	 	 	 	 	 	 	 	 
	Age:	 	
 

	 	Citizenship:	 	
 

	 	Where registered to vote:	 	
 

 

Set forth in the space provided below the state(s), if any, in the
United States in which you maintained your residence during the past two years and the dates during which you resided in each state:

 

 

 

 

 

Are you a director or executive officer of the Company?

Yes o            No
o

 

	 	 	 
	Social Security or Taxpayer Identification No.	 	
 

	 	 	
 

 

	PART B.	ACCREDITED INVESTOR QUESTIONNAIRE 

 

In order for the Company to offer and sell the Shares in conformance
with state and federal securities laws, the following information must be obtained regarding your investor status. Please initial
each category applicable to you as a Purchaser of Shares.

 

	 	 	 	 	 
	o	 	1.	 	A bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;
	 	 	 
	o	 	2.	 	A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934;
	 	 	 
	o	 	3.	 	An insurance company as defined in Section 2(a)(13) of the Securities Act;
	 	 	 

 

    	 	B-2	 

     

    

Exhibit 10.1

 

 

	o	 	4.	 	An investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act;
	 	 	 
	o	 	5.	 	A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;
	 	 	 
	o	 	6.	 	A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
	 	 	 
	o	 	7.	 	An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;
	 	 	 
	o	 	8.	 	A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;
	 	 	 
	o	 	9.	 	An organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the Shares, with total assets in excess of $5,000,000;
	 	 	 
	o	 	10.	 	A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of investing in the Company;
	 	 	 
	o	 	11.	 	A natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his or her purchase exceeds $1,000,000 (see Note 11 below);
	 	 	 
	o	 	12.	 	A natural person who had an individual income in excess of $200,000 in each of the two most recent years, or joint income with that person’s spouse in excess of $300,000 in each of those years, and has a reasonable expectation of reaching the same income level in the current year;
	 	 	 
	o	 	13.	 	An executive officer or director of the Company; and
	 	 	 
	o	 	14.	 	An entity in which all of the equity owners qualify under any of the above subparagraphs. If the undersigned belongs to this investor category only, list the equity owners of the undersigned, and the investor category which each such equity owner satisfies.

 

	Note 11.  	For purposes of calculating net worth under paragraph (11):

 

	 	(A)	The person’s primary residence shall not be included as an asset; 

 

	 	(B)	Indebtedness that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and 

 

    	 	B-3	 

     

    

Exhibit 10.1

 

 

	 	(C)	Indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability. 

 

	A.	FOR EXECUTION BY AN INDIVIDUAL: 

 

	 	 	 
	Date:	 	
 

 

 

	 	 	 
	By:	 	
 

	 	 	Print Name:

 

	B.	FOR EXECUTION BY AN ENTITY: 

 

	 	 	 
	Entity Name:	 	
 

 

 

	 	 	 
	Date:	 	
 

 

	 	 	 
	By:	 	
 

	 	 	Print Name:
	 	 	Title:

 

	C.	ADDITIONAL SIGNATURES (if required by partnership, corporation or trust document): 

 

	 	 	 
	Entity Name:	 	
 

 

 

	 	 	 
	Date:	 	
 

 

	 	 	 
	By:	 	
 

	 	 	Print Name:
	 	 	Title:

 

 

	 	 	 
	Entity Name:	 	
 

 

 

	 	 	 
	Date:	 	
 

 

	 	 	 
	By:	 	
 

	 	 	Print Name:
	 	 	Title:

 

    	 	B-4	 

     

    

Exhibit 10.1

 

EXHIBIT C 

Form of Opinion of Company Counsel

 

[Company Counsel to add Preamble and Carveouts] 

 

	1.	The Company validly exists as a corporation in good standing under the laws of the State of South Carolina. 

 

	2.	The Company has the corporate power and authority to execute and deliver and to perform its obligations under the Transaction Documents, including, without limitation, to issue the Shares. 

 

	3.	The Company is a registered bank holding company under the Bank Holding Company Act of 1956, as amended. 

 

	4.	The deposit accounts of the Bank are insured by the Federal Deposit Insurance Corporation under the provisions of the Federal Deposit Insurance Act. 

 

	5.	Each of the Transaction Documents has been duly authorized, executed, and delivered by the Company and, assuming due authorization, execution, and delivery by the Purchasers (to the extent they are a party), each of the Transaction Documents constitutes a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms. 

 

	6.	The execution and delivery by the Company of each of the Transaction Documents and the performance by the Company of its obligations under such agreements, including its issuance and sale of the Shares, do not and will not: (a) require any consent, approval, license or exemption by, order or authorization of, or filing, recording, or registration by the Company with any federal or state governmental authority, except (1) as may be required by federal securities laws with respect to the Company’s obligations under the Registration Rights Agreement, (2) the filing of Form D pursuant to Securities and Exchange Commission Regulation D, and (3) the filings required in accordance with Section 4.5 of the Stock Purchase Agreement, (b) violate any federal or state statute, rule, or regulation, or any rule or regulation of the OTC Pink, or any court order, judgment, or decree, if any, listed in Exhibit A hereto, which exhibit lists all court orders, judgments, and decrees that the Company has certified to us are applicable to it, (c) result in any violation of the Articles of Incorporation or Bylaws of the Company, or (d) result in a breach of, or constitute a default under, any contract listed on Schedule 3.1(zz) hereto. 

 

	7.	Assuming the accuracy of the representations, warranties, and compliance with the covenants and agreements of the Purchasers and the Company contained in the Stock Purchase Agreement, it is not necessary, in connection with the offer, sale, and delivery of the Shares and Underlying Shares to the Purchasers to register the Shares or Underlying Shares under the Securities Act. 

 

	8.	The Shares being delivered to the Purchasers pursuant to the Stock Purchase Agreement have been duly and validly authorized and, when issued, delivered, and paid for as contemplated in the Stock Purchase Agreement, will be duly and validly issued, fully paid and non-assessable, and free of any preemptive right or similar rights contained in the Company’s Articles of Incorporation or Bylaws. The Underlying Shares to be issued upon conversion have been authorized on the part of the Company, have been duly and validly reserved for issuance by all necessary corporate action on the part of the Company and, when issued as provided for in the Articles of Amendment, will be validly issued, fully paid and non-assessable, and free of any preemptive rights except for those herein pursuant to law or the Company’s Articles of Incorporation, as amended, or Bylaws.

 

Exhibit C

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT D 

Form of Tax Opinion

 

KPMG LLP (the “Accounting Firm”)
shall deliver to HCSB an opinion, in the Accounting Firm’s customary form and otherwise reasonably satisfactory to HCSB,
and on which HCSB is expressly permitted to rely, to the effect that, based on the most current information available prior to
the Closing Date as provided by the Company to the Accounting Firm, the consummation of (i) the private placement offering contemplated
by that certain Stock Purchase Agreement between HCSB and the purchasers identified on the signature pages thereto (the “Offering”),
and (ii) the additional issuances of Common Stock pursuant to a proposed registered offering to existing shareholders and certain
other persons for up to an aggregate of $3,000,000 in shares of HCSB Common Stock at the same price per share as in this Offering
(the “Follow-On Offering”), should not cause an “ownership change” within the meaning of Section
382 of the Internal Revenue Code of 1986, as amended (the “Code”). In addition, the Accounting Firm shall deliver
to any Purchaser an opinion as described in the preceding sentence, in the Accounting Firm’s customary form and otherwise
reasonably satisfactory to Purchaser, and on which Purchaser is expressly permitted to rely, subject to such Purchaser’s
execution of a reliance letter with the Accounting Firm pursuant to which Purchaser shall agree to the Accounting Firm’s
standard terms and conditions, forms of which have been previously provided to Purchaser.

 

Exhibit D

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT E 

Form of Secretary’s Certificate

 

The undersigned hereby certifies that he is
the duly elected, qualified, and acting Secretary of HCSB Financial Corporation, a South Carolina corporation (the “Company”),
and that as such he is authorized to execute and deliver this certificate in the name and on behalf of the Company in connection
with the Stock Purchase Agreement, dated as of March 2, 2016, by and among the Company and the investors party thereto (the “Stock
Purchase Agreement”), and further certifies in his official capacity, in the name and on behalf of the Company,
the items set forth below. Capitalized terms used but not otherwise defined herein shall have the meaning set forth in the Stock
Purchase Agreement.

 

	1.	Attached hereto as Exhibit A is a true, correct and complete copy of the resolutions duly adopted by the Board of Directors of the Company at a meeting held on [•], 2016. Such resolutions have not in any way been amended, modified, revoked, or rescinded, have been in full force and effect since their adoption to and including the date hereof and are now in full force and effect. 

 

	2.	Attached hereto as Exhibit B is a copy of the Company’s Articles of Incorporation, as amended. Such Articles of Incorporation, as amended, constitute true, correct, and complete copies of the Articles of Incorporation, as amended, of the Company as in effect on the date hereof. 

 

	3.	Attached hereto as Exhibit C is a copy of the Company’s bylaws. Such bylaws constitute true, correct, and complete copies of the bylaws of the Company as in effect on the date hereof. 

 

	4.	Each person listed below has been duly elected or appointed to the position(s) indicated opposite his name and is duly authorized to sign the Stock Purchase Agreement and each of the Transaction Documents on behalf of the Company, and the signature appearing opposite such person’s name below is such person’s genuine signature. 

 

	 	 	 	 	 
	Name	 	Position	 	Signature
	 	 	 
	 	 	 	 	
 

	 	 	 	 	
 

 

IN WITNESS WHEREOF, the undersigned has hereunto set his
hand as of this [•] day of [•], 2016.

 

	 	 
	 	
 

	 	[                                          ]
	 	Secretary

 

I, [____________],[President and Chief Executive
Officer], hereby certify that [____________] is the duly elected, qualified, and acting Secretary of the Company and that the signature
set forth above is his true signature.

 

	 	 
	 	
 

	 	[                                          ]
	 	President and Chief Financial Officer

 

Exhibit E

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT F

Form of Officer’s Certificate

 

The undersigned, the [President and Chief Executive
Officer] [Chief Financial Officer] of HCSB Financial Corporation, a South Carolina corporation (the “Company”),
pursuant to Section 2.2(a)(vii) of the Stock Purchase Agreement, dated as of March 2, 2016, by and among the Company and the
investors signatory thereto (the “Agreement”), hereby represents, warrants, and certifies as follows (capitalized
terms used but not otherwise defined herein shall have the meaning set forth in the Agreement):

 

	1.	The representations and warranties of the Company contained in the Stock Purchase Agreement are true and correct as of the date when made and as of the Closing Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific date. 
	 	 
	 2.	The Company has performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing. 

 

	3.	Since the date of the Agreement, there has not occurred any circumstance, event, change, development or effect that, individually or in the aggregate, has had or could reasonably be expected to have a Material Adverse Effect on the Company or the Bank.

 

IN WITNESS WHEREOF, the undersigned has
executed this certificate this [•] day of [•], 2016.

 

	 	 
	 	
 

	 	
        [                          
                       ]

        [President and Chief Executive Officer] [Chief Financial Officer]

 

Exhibit F

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT G

Form of VCOC Letter Agreement

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[●], 2016

 

Castle Creek Capital Partners VI, L.P.

6051 El Tordo

Rancho Santa Fe, CA 92091

 

Dear Sir/Madam:

 

Reference is made to the Stock Purchase Agreement
by and between HCSB Financial Corporation, a South Carolina corporation (the “Corporation”), and Castle Creek
Capital Partners VI, L.P., a Delaware limited partnership (the “VCOC Investor”), dated as of March 2, 2016 (the
“Stock Purchase Agreement”), pursuant to which the VCOC Investor agreed to purchase from the Corporation shares
of its voting common stock, $0.01 par value per share (the “Common Stock”), and shares of its Series A Convertible
Perpetual Preferred Stock, $0.01 par value per share (the “Series A Preferred Stock”). Capitalized terms used
herein without definition shall have the respective meanings in the Stock Purchase Agreement.

 

For good and valuable consideration acknowledged
to have been received, the Corporation hereby agrees that it shall:

 

		●	For so long as the VCOC Investor, directly or through one or more Affiliates, continues to hold any Common Stock, Series A
Preferred Stock, or Non-Voting Common Stock, provide the VCOC Investor or its designated representative with the governance rights
set forth in the Castle Creek Side Letter;

 

		●	For so long as the VCOC Investor, directly or through one or more Affiliates, continues to hold any Common Stock, Series A
Preferred Stock, or Non-Voting Common Stock, without limitation or prejudice of any of the rights provided to the VCOC Investor
under the Stock Purchase Agreement, the Castle Creek Side Letter, or any other agreement or otherwise, provide the VCOC Investor
or its designated representative with:

 

      (i)    the right to visit and
inspect any of the offices and properties of the Corporation and its subsidiaries and inspect the books and records of the Corporation
and its subsidiaries at such times as the VCOC Investor shall reasonably request upon three (3) business days’ notice but
not more frequently than once per calendar quarter, provided, however, that such rights shall not extend to confidential bank supervisory
communications, customer financial records or other “exempt records” as defined by 12 C.F.R. Part 309, or reports of
examination of any national or state chartered insured bank, which information may only be disclosed by the Corporation or any
subsidiary of the Corporation in accordance with the provisions and subject to the limitations of applicable law or regulation;

 

      (ii)    consolidated balance
sheets and statements of income and cash flows of the Corporation and its subsidiaries prepared in conformity with generally accepted
accounting principles in the United States applied on a consistent basis (A) as of the end of each quarter of each fiscal year
of the Corporation as soon as practicable after preparation thereof but in no event later than ninety (90) days after the end of
such quarter, and (B) with respect to each fiscal year end statement, as soon as practicable after preparation thereof but in no
event later than one hundred and twenty (120) days after the end of such fiscal year together with an auditor’s report thereon
of a firm of established national reputation; and

 

    		G-1	 

     

    

Exhibit 10.1

 

      (iii)  to the extent the Corporation
or any of its subsidiaries is required by law or pursuant to the terms of any outstanding indebtedness of the Corporation or any
subsidiary to prepare such reports, any annual reports, quarterly reports and other periodic reports pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934 or otherwise, actually prepared by the Corporation or any of its subsidiaries as soon
as available;

 

provided that, in each case, if the Corporation makes
the information described in clauses (ii) and (iii) of this bullet point available through public filings on the EDGAR system or
any successor or replacement system of the U.S. Securities and Exchange Commission, the delivery of the information shall be deemed
satisfied by such public filings.

 

		●	Make appropriate officers and directors of the Corporation, and its subsidiaries, available periodically and at such times
as reasonably requested by the VCOC Investor for consultation with the VCOC Investor or its designated representative, but not
more frequently than once per calendar quarter, with respect to matters relating to the business and affairs of the Corporation
and its subsidiaries; and

 

		●	If the VCOC Investor’s regular outside counsel determines in writing that other rights of consultation are reasonably
necessary under applicable legal authorities promulgated after the date of this agreement to preserve the qualification of VCOC
Investor’s investment in the Corporation as a “venture capital investment” for purposes of the United States
Department of Labor Regulation published at 29 C.F.R. Section 2510.3-101(d)(3)(i) (the “Plan Asset Regulation”),
the Corporation agrees to cooperate in good faith with the VCOC Investor to amend this letter agreement to reflect such other rights
that are mutually satisfactory to the Corporation and the VCOC Investor and consistent with the Federal Reserve Policy Statement
on Equity Investments in Banks and Bank Holding Companies; provided that such consultation rights shall be limited to once per
calendar quarter.

 

The Corporation agrees to consider, in good
faith, the recommendations of the VCOC Investor or its designated representative in connection with the matters on which it is
consulted as described above, recognizing that the ultimate discretion with respect to all such matters shall be retained by the
Corporation.

 

The VCOC Investor agrees, and will require each
designated representative of the VCOC Investor to agree, to hold in confidence and not use or disclose to any third party (other
than its legal counsel and accountants) any confidential information provided to or learned by such party in connection with the
VCOC Investor’s rights under this letter agreement except as may otherwise be required by law or legal, judicial or regulatory
process, provided that the VCOC Investor takes reasonable steps to minimize the extent of any such required disclosure.

 

In the event the VCOC Investor transfers all
or any portion of its investment in the Corporation to an affiliated entity (or to a direct or indirect wholly-owned conduit subsidiary
of any such affiliated entity) that is intended to qualify as a venture capital operating company under the Plan Asset Regulation,
such affiliated entity shall be afforded the same rights that the Corporation has afforded to the VCOC Investor hereunder and shall
be treated, for such purposes, as a third party beneficiary hereunder.

 

    		G-2	 

     

    

Exhibit 10.1

 

The rights of the VCOC Investor under this letter
agreement are unique to the VCOC Investor and shall not be assignable or transferrable other than to an affiliated entity that
is intended to qualify as a venture capital operating company under the Plan Asset Regulation.

 

This letter agreement and the rights and the
duties of the parties hereto shall be governed by, and construed in accordance with, the laws of the State of New York and may
be executed in counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall
constitute one and the same instrument.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    		G-3	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties have executed
this letter agreement as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

 

CASTLE CREEK CAPITAL PARTNERS VI, L.P.

 

By: Castle Creek Capital VI LLC, its general partner

 

	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page to VCOC Letter Agreement]

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT H

Form of Castle Creek Side Letter

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[•], 2016

 

 

Castle Creek Capital Partners VI, L.P.

6051 El Tordo

Rancho Santa Fe, CA 92091

Ladies and Gentlemen:

      Reference is made to that certain
Stock Purchase Agreement, dated as March 2, 2016 (the “Purchase Agreement”), between HCSB Financial Corporation, a
South Carolina corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “Purchasers”).
In connection with the execution and delivery of the Purchase Agreement, the Company and Castle Creek Capital Partners, VI, L.P.
(“Castle Creek”) are contemporaneously entering into this agreement (the “Side Letter Agreement”) and,
as such, the parties hereto acknowledge and agree that this Side Letter Agreement shall remain in full force and effect notwithstanding
the execution and delivery of the Purchase Agreement. Capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms in the Purchase Agreement.

 

      The Company and Castle Creek hereby agree
as follows:

 

1. Board Appointment.

 

      (a)       Following the Closing and upon the written request of
Castle Creek, the Company will promptly cause a person designated by Castle Creek who shall be reasonably acceptable to the Company
(provided that all managing principals and principals of Castle Creek shall be deemed reasonably acceptable to the Company for
purposes hereof) (the “Board Representative”) to be elected or appointed to the Board of Directors of the Company (the
“Board of Directors”), subject to satisfaction of all legal and regulatory requirements regarding service and election
or appointment as a director of the Company, and the Horry County State Bank (the “Bank”) board of directors (the “Bank
Board”), subject to all legal and regulatory requirements regarding service and election or appointment as a director of
the Bank, in each case for as long as Castle Creek, together with its Affiliates, owns either in the aggregate, 50% or more of
all of the purchased Shares (“Qualifying Ownership Interest”) or, in the aggregate, 5.0% of the Common Stock then outstanding
(“Minimum Ownership Interest”). Notwithstanding anything to the contrary herein, in no event shall any failure to meet
any applicable residency requirement be a valid reason for withholding approval of the Board Representative (or any replacement
Board Representative) by the Board, the Bank Board or the Company, as the case may be. So long as Castle Creek, together with its
Affiliates, has a Minimum Ownership Interest, the Company will recommend to its shareholders the election of the Board Representative
to the Board of Directors at the Company’s annual meeting of shareholders, subject to satisfaction of all legal requirements
regarding service and election or appointment as a director of the Company. If Castle Creek no longer has a Minimum Ownership Interest,
Castle Creek will have no further rights under Sections 1(a) through 1(b) and, at the written request of the Board of Directors,
shall use all reasonable best efforts to cause its Board Representative to resign from the Board of Directors and the Bank Board
as promptly as possible thereafter. Castle Creek shall promptly inform the Company if and when it ceases to hold a Minimum Ownership
Interest in the Company.

 

    	 	H-1	 

     

    

Exhibit 10.1

 

      (b)       The
Board Representative shall, subject to applicable law, be one of the Company’s nominees to serve on the Board of Directors.
The Company shall use its reasonable best efforts to have the Board Representative elected as a director of the Company by the
shareholders of the Company, and the Company shall solicit proxies for the Board Representative to the same extent as it does
for any of its other Company nominees to the Board of Directors. At the option of the Board Representative, the Board of Directors
shall cause such Board Representative to be appointed to the Compensation Committee of the Board of Directors, and any equivalent
committee of the Bank, so long as the Board Representative qualifies to serve on such committees under the Company’s or
the Bank’s committee charters currently in effect, as applicable, and applicable rules of any exchange on which the Common
Stock is then listed, and such service is consistent with commitments that Castle Creek has provided to the Federal Reserve in
connection with the transaction and would not result in Castle Creek being deemed in control of the Company for purposes of the
BHC Act. The Company shall ensure, and shall cause the Bank to ensure, that the Board of Directors, the Bank Board, the Compensation
Committee of the Board of Directors and any equivalent committee of the Bank shall have at least four members for so long as Castle
Creek shall have the right to appoint a Board Representative. Castle Creek covenants and agrees to hold any information obtained
from its Board Representative in confidence (except to the extent that such information can be shown to have been (1) previously
known by such party on a nonconfidential basis, (2) in the public domain through no fault of such party, or (3) later lawfully
acquired from other sources by the party to which it was furnished). Notwithstanding anything to the contrary contained herein,
at all times when Castle Creek maintains a Minimum Ownership Interest, it shall comply in all respects with the Federal Reserve’s
Policy Statement on equity investments in banks and bank holding companies and any other guidance promulgated in connection with
the matters addressed therein.

 

      (c)       Subject
to Section 1(a), upon the death, resignation, retirement, disqualification, or removal from office as a member of the Board or
the Bank Board of the Board Representative, Castle Creek shall have the right to designate the replacement for such Board Representative,
which replacement shall satisfy all legal, bank regulatory and governance requirements regarding service as a director of the
Company, and shall be reasonably acceptable to the Company (provided that all managing principals and principals of Castle Creek
shall be deemed reasonably acceptable to the Company for purposes hereof). The Board and the Bank Board shall use their respective
commercially reasonable efforts to take all action required to fill the vacancy resulting therefrom with such person (including
such person, subject to applicable Law, being one of the Company’s nominees to serve on the Board and the Bank Board), using
all reasonable best efforts to have such person elected as director of the Company by the shareholders of the Company and the
Company soliciting proxies for such person to the same extent as it does for any of its other nominees to the Board, as the case
may be.

 

      (d)       The
Board Representative shall be entitled to compensation, including fees, and indemnification and insurance coverage in connection
with his or her role as a director to the same extent as other directors on the Board or the Bank Board, as applicable, and the
Board Representative shall be entitled to reimbursement for reasonable documented, out-of- pocket expenses incurred in attending
meetings of the Board and the Bank Board, or any committee thereof in accordance with Company policy.

 

      (e)       The
Company acknowledges that the Board Representative may have certain rights to indemnification, advancement of expenses and/or
insurance provided by Castle Creek and/or certain of its Affiliates (collectively, the “Castle Creek Indemnitors”).
The Company hereby agrees on behalf of itself and the Bank that with respect to a claim by the Board Representative for indemnification
arising out his or her service as a director of the Company and/or the Bank (1) that it is the indemnitor of first resort (i.e.,
its obligations to the Board Representative with respect to indemnification, advancement of expenses and/or insurance (which obligations
shall be the same as, but in no event greater than, any such obligations to members of the Board or the Bank Board, as applicable)
are primary and any obligation of the Castle Creek Indemnitors to advance expenses or to provide indemnification for the same
expenses or liabilities incurred by the Board Representative are secondary), and (2) the Castle Creek Indemnitors shall have a
right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of the
Board Representative against the Company.

    	 	H-2	 

     

    

Exhibit 10.1

 

2. Board Observer. The Company
hereby agrees that, from and after the Closing Date, for so long as Castle Creek and its Affiliates in the aggregate have a Minimum
Ownership Interest, and do not have a Board Representative currently serving on the Board of Directors and the Bank Board, the
Company shall invite a person designated by Castle Creek and reasonably acceptable to the Company (provided that all managing principals
and principals of Castle Creek shall be deemed reasonably acceptable to the Company for purposes hereof) (the “Observer”)
to attend meetings of the Board of Directors and the Bank Board (including any meetings of committees thereof on which the Board
Representative would be permitted to attend) in a nonvoting, nonparticipating observer capacity. The Observer shall be entitled
to attend such meetings only in the event Castle Creek does not have a Board Representative on the Board of Directors and the Bank
Board. The Observer shall not have any right to vote on any matter presented to the Board of Directors or the Bank Board or any
committee thereof. The Company shall give the Observer written notice of each meeting of the Board of Directors and the Bank Board
at the same time and in the same manner as the members of the Board of Directors or the Bank Board (as the case may be), shall
provide the Observer with all written materials and other information given to members of the Board of Directors or the Bank Board
(as the case may be) at the same time such materials and information are given to such members (provided, however, that the Observer
shall not be provided any confidential supervisory information) and shall permit the Observer to attend as an observer at all meetings
thereof, and in the event the Company proposes to take any action by written consent in lieu of a meeting, the Company shall give
written notice thereof to the Observer prior to the effective date of such consent describing the nature and substance of such
action and including the proposed text of such written consents provided, however, that (1) the Observer may be excluded from executive
sessions comprised solely of independent directors by the Chairman of the Board (or, if applicable, the lead or presiding independent
director) if, in the written advice of counsel, such exclusion is necessary in order for the Company to comply with applicable
law, regulation or stock exchange listing standards (it being understood that it is not expected that the Observer would be excluded
from routine executive sessions), (2) the Company, the Board of Directors, the Bank and the Bank Board shall have the right to
withhold any information and to exclude the Observer from any meeting or portion thereof if doing so is, in the written advice
of counsel, (A) necessary to protect the attorney-client privilege between such party and counsel, (B) necessary to avoid a violation
of fiduciary requirements under applicable law, or (C) necessary to avoid a violation of the Health Insurance Portability &
Accountability Act of 1996, as amended, or any similar law, and (3) Castle Creek shall cause its Observer to agree to hold in confidence
and trust and to act in a fiduciary manner with respect to all information provided to such Observer (except to the extent that
such information can be shown to have been (1) previously known by such party on a nonconfidential basis, (2) in the public domain
through no fault of such party, or (3) later lawfully acquired from other sources by the party to which it was furnished). The
Company also may exclude the Observer from portions of meetings of the Board of Directors as well as the Bank Board to the extent
that the Board of Directors or the Bank Board, as the case may be, will, in any such portion thereof be discussing any matters
related to Castle Creek, the Transaction Documents, or any of Castle Creek’s rights or obligations under any of the Transaction
Documents or any other matter that the Chairman of the Board of Directors or the Chairman of the Bank Board determines in good
faith is or may be adverse to the interests of Castle Creek provided, however, no matter shall be deemed to be adverse to the interests
of Castle Creek merely because such matter may adversely impact the price of any of the Company’s Securities. Castle Creek
covenants and agrees to hold all information obtained from its Observer as provided in the prior sentence in confidence to comply
with all requirements and obligations applicable to members of the Board of Directors under the Securities Act, the Exchange Act,
the Sarbanes Oxley Act of 2002 and all other Laws, in each case, only to the extent (if at all) applicable to the Observer. If
Castle Creek and its Affiliates in the aggregate no longer have a Minimum Ownership Interest, Castle Creek will have no further
rights under this Section 2.

 3. Reimbursement for Legal
Expenses. The Company shall pay the reasonable legal fees and expenses of counsel to Castle Creek, not to exceed $75,000,
incurred by Castle Creek in connection with the transactions contemplated by the Transaction Documents, which amount shall be
paid directly by the Company to counsel for Castle Creek at the Closing.

4. Governing Law. This
Side Letter Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in accordance
with the laws of the State of New York without giving effect to principles of conflicts of laws.

5. Conflicting Terms. This Side
Letter Agreement constitutes a valid and binding agreement of the Company and Castle Creek and shall survive the execution and
delivery of the Purchase Agreement. In the event of any conflict between the provisions of this Side Letter Agreement and the
provisions of the Purchase Agreement, the provisions of this Side Letter Agreement shall prevail and be given effect.

6. Counterparts. This Side Letter
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same
effect as if all parties had signed the same document. All such counterparts will be deemed an original, will be construed together
and will constitute one and the same instrument.

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	 	H-3	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties have executed
this Side Letter Agreement as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

 

CASTLE CREEK CAPITAL PARTNERS VI, L.P.

 

By: Castle Creek Capital VI LLC, its general partner

 

	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page to Castle Creek Side Letter]

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT I

Form of Mendon Side Letter

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[•], 2016

 

 

RMB Capital Management, LLC, as Investment Advisor

115 S. LaSalle, 34th Floor

Chicago, IL 60603

 

Ladies and Gentlemen:

      Reference is made to that certain
Stock Purchase Agreement, dated as March 2, 2016 (the “Purchase Agreement”), between HCSB Financial Corporation, a
South Carolina corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “Purchasers”).
In connection with the execution and delivery of the Purchase Agreement, the Company and RMB Capital Management, LLC, as investment
advisor to Iron Road Multi-Strategy Fund LP, Mendon Capital Master Fund Ltd., and Mendon Capital QP LP (“RMB Capital”),
or one or more of its controlled Affiliates, are contemporaneously entering into this agreement (the “Side Letter Agreement”)
and, as such, the parties hereto acknowledge and agree that this Side Letter Agreement shall remain in full force and effect notwithstanding
the execution and delivery of the Purchase Agreement. Capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms in the Purchase Agreement.

 

      The Company and RMB Capital hereby agree
as follows:

 

1. Board Appointment.

 

      (a)       Following
the Closing and upon the written request of RMB Capital, the Company will promptly cause a person designated by RMB Capital who
shall be reasonably acceptable to the Company (the “Board Representative”) to be elected or appointed to the Board
of Directors of the Company (the “Board of Directors”), subject to satisfaction of all legal and regulatory requirements
regarding service and election or appointment as a director of the Company, and the Horry County State Bank (the “Bank”)
board of directors (the “Bank Board”), subject to all legal and regulatory requirements regarding service and election
or appointment as a director of the Bank, in each case for as long as RMB Capital, together with its Affiliates, owns either in
the aggregate, 50% or more of all of the purchased Shares (“Qualifying Ownership Interest”) or, in the aggregate,
5.0% of the Common Stock then outstanding (“Minimum Ownership Interest”). Notwithstanding anything to the contrary
herein, in no event shall any failure to meet any applicable residency requirement be a valid reason for withholding approval
of the Board Representative (or any replacement Board Representative) by the Board, the Bank Board or the Company, as the case
may be. So long as RMB Capital, together with its Affiliates, has a Minimum Ownership Interest, the Company will recommend to
its shareholders the election of the Board Representative to the Board of Directors at the Company’s annual meeting of shareholders,
subject to satisfaction of all legal requirements regarding service and election or appointment as a director of the Company.
If RMB Capital no longer has a Minimum Ownership Interest, RMB Capital will have no further rights under Sections 1(a) through
1(b) and, at the written request of the Board of Directors, shall use all reasonable best efforts to cause its Board Representative
to resign from the Board of Directors and the Bank Board as promptly as possible thereafter. RMB Capital shall promptly inform
the Company if and when it ceases to hold a Minimum Ownership Interest in the Company.

 

    	 	I-1	 

     

    

Exhibit 10.1

 

      (b)       The
Board Representative shall, subject to applicable law, be one of the Company’s nominees to serve on the Board of Directors.
The Company shall use its reasonable best efforts to have the Board Representative elected as a director of the Company by the
shareholders of the Company, and the Company shall solicit proxies for the Board Representative to the same extent as it does
for any of its other Company nominees to the Board of Directors. At the option of the Board Representative, the Board of Directors
shall cause such Board Representative to be appointed to the Compensation Committee of the Board of Directors, and any equivalent
committee of the Bank, so long as the Board Representative qualifies to serve on such committees under the Company’s or
the Bank’s committee charters currently in effect, as applicable, and applicable rules of any exchange on which the Common
Stock is then listed, and such service is consistent with commitments that RMB Capital has provided to the Federal Reserve in
connection with the transaction and would not result in RMB Capital being deemed in control of the Company for purposes of the
BHC Act. The Company shall ensure, and shall cause the Bank to ensure, that the Board of Directors, the Bank Board, the Compensation
Committee of the Board of Directors and any equivalent committee of the Bank shall have at least four members for so long as RMB
Capital shall have the right to appoint a Board Representative. RMB Capital covenants and agrees to hold any information obtained
from its Board Representative in confidence (except to the extent that such information can be shown to have been (1) previously
known by such party on a nonconfidential basis, (2) in the public domain through no fault of such party, or (3) later lawfully
acquired from other sources by the party to which it was furnished). Notwithstanding anything to the contrary contained herein,
at all times when RMB Capital maintains a Minimum Ownership Interest, it shall comply in all respects with the Federal Reserve’s
Policy Statement on equity investments in banks and bank holding companies and any other guidance promulgated in connection with
the matters addressed therein.

 

      (c)       Subject
to Section 1(a), upon the death, resignation, retirement, disqualification, or removal from office as a member of the Board or
the Bank Board of the Board Representative, RMB Capital shall have the right to designate the replacement for such Board Representative,
which replacement shall satisfy all legal, bank regulatory and governance requirements regarding service as a director of the
Company, and shall be reasonably acceptable to the Company. The Board and the Bank Board shall use their respective commercially
reasonable efforts to take all action required to fill the vacancy resulting therefrom with such person (including such person,
subject to applicable Law, being one of the Company’s nominees to serve on the Board and the Bank Board), using all reasonable
best efforts to have such person elected as director of the Company by the shareholders of the Company and the Company soliciting
proxies for such person to the same extent as it does for any of its other nominees to the Board, as the case may be.

 

      (d)       The
Board Representative shall be entitled to compensation, including fees, and indemnification and insurance coverage in connection
with his or her role as a director to the same extent as other directors on the Board or the Bank Board, as applicable, and the
Board Representative shall be entitled to reimbursement for reasonable documented, out-of- pocket expenses incurred in attending
meetings of the Board and the Bank Board, or any committee thereof in accordance with Company policy.

 

      (e)       The
Company acknowledges that the Board Representative may have certain rights to indemnification, advancement of expenses and/or
insurance provided by RMB Capital and/or certain of its Affiliates (collectively, the “RMB Capital Indemnitors”).
The Company hereby agrees on behalf of itself and the Bank that with respect to a claim by the Board Representative for indemnification
arising out his or her service as a director of the Company and/or the Bank (1) that it is the indemnitor of first resort (i.e.,
its obligations to the Board Representative with respect to indemnification, advancement of expenses and/or insurance (which obligations
shall be the same as, but in no event greater than, any such obligations to members of the Board or the Bank Board, as applicable)
are primary and any obligation of the RMB Capital Indemnitors to advance expenses or to provide indemnification for the same expenses
or liabilities incurred by the Board Representative are secondary), and (2) the Mendon Capital shall have a right of contribution
and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of the Board Representative
against the Company.

    	 	I-2	 

     

    

Exhibit 10.1

 

2. Board Observer. The Company
hereby agrees that, from and after the Closing Date, for so long as RMB Capital and its Affiliates in the aggregate have a Minimum
Ownership Interest, and do not have a Board Representative currently serving on the Board of Directors and the Bank Board, the
Company shall invite a person designated by RMB Capital and reasonably acceptable to the Company (the “Observer”) to
attend meetings of the Board of Directors and the Bank Board (including any meetings of committees thereof on which the Board Representative
would be permitted to attend) in a nonvoting, nonparticipating observer capacity. The Observer shall be entitled to attend such
meetings only in the event RMB Capital does not have a Board Representative on the Board of Directors and the Bank Board. The Observer
shall not have any right to vote on any matter presented to the Board of Directors or the Bank Board or any committee thereof.
The Company shall give the Observer written notice of each meeting of the Board of Directors and the Bank Board at the same time
and in the same manner as the members of the Board of Directors or the Bank Board (as the case may be), shall provide the Observer
with all written materials and other information given to members of the Board of Directors or the Bank Board (as the case may
be) at the same time such materials and information are given to such members (provided, however, that the Observer shall not be
provided any confidential supervisory information) and shall permit the Observer to attend as an observer at all meetings thereof,
and in the event the Company proposes to take any action by written consent in lieu of a meeting, the Company shall give written
notice thereof to the Observer prior to the effective date of such consent describing the nature and substance of such action and
including the proposed text of such written consents provided, however, that (1) the Observer may be excluded from executive sessions
comprised solely of independent directors by the Chairman of the Board (or, if applicable, the lead or presiding independent director)
if, in the written advice of counsel, such exclusion is necessary in order for the Company to comply with applicable law, regulation
or stock exchange listing standards (it being understood that it is not expected that the Observer would be excluded from routine
executive sessions), (2) the Company, the Board of Directors, the Bank and the Bank Board shall have the right to withhold any
information and to exclude the Observer from any meeting or portion thereof if doing so is, in the written advice of counsel, (A)
necessary to protect the attorney-client privilege between such party and counsel, (B) necessary to avoid a violation of fiduciary
requirements under applicable law, or (C) necessary to avoid a violation of the Health Insurance Portability & Accountability
Act of 1996, as amended, or any similar law, and (3) RMB Capital shall cause its Observer to agree to hold in confidence and trust
and to act in a fiduciary manner with respect to all information provided to such Observer (except to the extent that such information
can be shown to have been (1) previously known by such party on a nonconfidential basis, (2) in the public domain through no fault
of such party, or (3) later lawfully acquired from other sources by the party to which it was furnished). The Company also may
exclude the Observer from portions of meetings of the Board of Directors as well as the Bank Board to the extent that the Board
of Directors or the Bank Board, as the case may be, will, in any such portion thereof be discussing any matters related to RMB
Capital, the Transaction Documents, or any of RMB Capital’s rights or obligations under any of the Transaction Documents
or any other matter that the Chairman of the Board of Directors or the Chairman of the Bank Board determines in good faith is or
may be adverse to the interests of RMB Capital provided, however, no matter shall be deemed to be adverse to the interests of RMB
Capital merely because such matter may adversely impact the price of any of the Company’s Securities. RMB Capital covenants
and agrees to hold all information obtained from its Observer as provided in the prior sentence in confidence to comply with all
requirements and obligations applicable to members of the Board of Directors under the Securities Act, the Exchange Act, the Sarbanes
Oxley Act of 2002 and all other Laws, in each case, only to the extent (if at all) applicable to the Observer. If RMB Capital and
its Affiliates in the aggregate no longer have a Minimum Ownership Interest, RMB Capital will have no further rights under this
Section 2.

    	 	I-3	 

     

    

Exhibit 10.1

 

3. Governing Law. This
Side Letter Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in accordance
with the laws of the State of New York without giving effect to principles of conflicts of laws.

5. Conflicting Terms. This Side
Letter Agreement constitutes a valid and binding agreement of the Company and RMB Capital and shall survive the execution and delivery
of the Purchase Agreement. In the event of any conflict between the provisions of this Side Letter Agreement and the provisions
of the Purchase Agreement, the provisions of this Side Letter Agreement shall prevail and be given effect.

6. Counterparts. This Side Letter
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same
effect as if all parties had signed the same document. All such counterparts will be deemed an original, will be construed together
and will constitute one and the same instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	 	I-4	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties have executed
this Side Letter Agreement as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

 

RMB Capital Management,
LLC, as investment advisor to

Iron Road Multi-Strategy Fund LP, Mendon Capital Master

Fund Ltd., and Mendon Capital QP LP

 

	By:	 	 
	 	Name: 	Walter Clark	 
	 	Title: 	Chief Operating Officer	 

 

[Signature Page to Mendon Side Letter]

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT J

Form of EJF Side Letter

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[•], 2016

 

 

EJF Sidecar Fund, Series LLC – Series E

2107 Wilson Boulevard, Suite 410

Arlington, VA 22201

Ladies and Gentlemen:

      Reference is made to that certain
Stock Purchase Agreement, dated as March 2, 2016 (the “Purchase Agreement”), between HCSB Financial Corporation, a
South Carolina corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “Purchasers”).
In connection with the execution and delivery of the Purchase Agreement, the Company and EJF Sidecar Fund, Series LLC – Series
E (“EJF”), or one or more of its controlled Affiliates, are contemporaneously entering into this agreement (the “Side
Letter Agreement”) and, as such, the parties hereto acknowledge and agree that this Side Letter Agreement shall remain in
full force and effect notwithstanding the execution and delivery of the Purchase Agreement. Capitalized terms used herein and not
otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement.

 

      The Company and EJF hereby agree as follows:

 

1. Board Observer. The Company hereby
agrees that, from and after the Closing Date, for so long as EJF and its Affiliates own in the aggregate 5.0% of the Common Stock
then outstanding (“Minimum Ownership Interest”), the Company shall invite a person designated by EJF and reasonably
acceptable to the Company (the “Observer”) to attend meetings of the Board of Directors and the Bank Board (including
any meetings of committees thereof unless such attendance would be inconsistent with commitments that EJF has provided to the Federal
Reserve in connection with the transaction) in a nonvoting, nonparticipating observer capacity. The Observer shall not have any
right to vote on any matter presented to the Board of Directors or the Bank Board or any committee thereof. The Company shall give
the Observer written notice of each meeting of the Board of Directors and the Bank Board at the same time and in the same manner
as the members of the Board of Directors or the Bank Board (as the case may be), shall provide the Observer with all written materials
and other information given to members of the Board of Directors or the Bank Board (as the case may be) at the same time such materials
and information are given to such members (provided, however, that the Observer shall not be provided any confidential supervisory
information) and shall permit the Observer to attend as an observer at all meetings thereof, and in the event the Company proposes
to take any action by written consent in lieu of a meeting, the Company shall give written notice thereof to the Observer prior
to the effective date of such consent describing the nature and substance of such action and including the proposed text of such
written consents provided, however, that (1) the Observer may be excluded from executive sessions comprised solely of independent
directors by the Chairman of the Board (or, if applicable, the lead or presiding independent director) if, in the written advice
of counsel, such exclusion is necessary in order for the Company to comply with applicable law, regulation or stock exchange listing
standards (it being understood that it is not expected that the Observer would be excluded from routine executive sessions), (2)
the Company, the Board of Directors, the Bank and the Bank Board shall have the right to withhold any information and to exclude
the Observer from any meeting or portion thereof if doing so is, in the written advice of counsel, (A) necessary to protect the
attorney-client privilege between such party and counsel, (B) necessary to avoid a violation of fiduciary requirements under applicable
law, or (C) necessary to avoid a violation of the Health Insurance Portability & Accountability Act of 1996, as amended, or
any similar law, and (3) EJF shall cause its Observer to agree to hold in confidence and trust and to act in a fiduciary manner
with respect to all information provided to such Observer (except to the extent that such information can be shown to have been
(1) previously known by such party on a nonconfidential basis, (2) in the public domain through no fault of such party, or (3)
later lawfully acquired from other sources by the party to which it was furnished). The Company also may exclude the Observer from
portions of meetings of the Board of Directors as well as the Bank Board to the extent that the Board of Directors or the Bank
Board, as the case may be, will, in any such portion thereof be discussing any matters related to EJF, the Transaction Documents,
or any of EJF’s rights or obligations under any of the Transaction Documents or any other matter that the Chairman of the
Board of Directors or the Chairman of the Bank Board determines in good faith is or may be adverse to the interests of EJF provided,
however, no matter shall be deemed to be adverse to the interests of EJF merely because such matter may adversely impact the price
of any of the Company’s Securities. EJF covenants and agrees to hold all information obtained from its Observer as provided
in the prior sentence in confidence to comply with all requirements and obligations applicable to members of the Board of Directors
under the Securities Act, the Exchange Act, the Sarbanes Oxley Act of 2002 and all other Laws, in each case, only to the extent
(if at all) applicable to the Observer. If EJF and its Affiliates in the aggregate no longer have a Minimum Ownership Interest,
EJF will have no further rights under this Section 1.

 

    	 	J-1	 

     

    

Exhibit 10.1

 

2. Issuance of Shares. Either immediately
prior to, or simultaneously with, the issuance to EJF of the shares of Common Stock that it has a right to acquire pursuant to
the Purchase Agreement, all other purchasers of the Company’s shares of Common Stock pursuant to the Purchase Agreement shall
be issued the shares of Common Stock which each purchaser has agreed to acquire (and the Company has agreed to issue) pursuant
to the Purchase Agreement, it being understood and agreed that, (i) prior to such time, EJF shall not have any obligation, nor
any right, to acquire any shares of Common Stock pursuant to the Purchase Agreement and (ii) following such issuance, EJF will
not own more than 9.9% of the Company’s outstanding shares of Common Stock.

3. Governing Law. This
Side Letter Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in accordance
with the laws of the State of New York without giving effect to principles of conflicts of laws.

4. Conflicting Terms. This Side
Letter Agreement constitutes a valid and binding agreement of the Company and EJF and shall survive the execution and delivery
of the Purchase Agreement. In the event of any conflict between the provisions of this Side Letter Agreement and the provisions
of the Purchase Agreement, the provisions of this Side Letter Agreement shall prevail and be given effect.

5. Counterparts. This Side Letter
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same
effect as if all parties had signed the same document. All such counterparts will be deemed an original, will be construed together
and will constitute one and the same instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	 	J-2	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties have executed
this Side Letter Agreement as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

 

EJF Sidecar Fund, Series
LLC – Series E 

 

	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page to EJF Side Letter]

 

    	 

     

    

Exhibit 10.1

 

EXHIBIT K

Form of SVI Side Letter

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[•], 2016

 

 

Strategic Value Investors, LP

2000 Auburn Drive, Suite 300

Beachwood, OH 44122

Ladies and Gentlemen:

Reference is made to that certain
Stock Purchase Agreement, dated as March 2, 2016 (the “Purchase Agreement”), between HCSB Financial Corporation, a
South Carolina corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “Purchasers”).
In connection with the execution and delivery of the Purchase Agreement, the Company and Strategic Value Investors, LP (“SVI”),
or one or more of its controlled Affiliates, are contemporaneously entering into this agreement (the “Side Letter Agreement”)
and, as such, the parties hereto acknowledge and agree that this Side Letter Agreement shall remain in full force and effect notwithstanding
the execution and delivery of the Purchase Agreement. Capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms in the Purchase Agreement.

 

The Company and SVI hereby agree as follows:

 

1. Board Observer. The Company hereby
agrees that, from and after the Closing Date, for so long as SVI and its Affiliates own in the aggregate 5.0% of the Common Stock
then outstanding (“Minimum Ownership Interest”), the Company shall invite a person designated by SVI and reasonably
acceptable to the Company (the “Observer”) to attend meetings of the Board of Directors and the Bank Board (including
any meetings of committees thereof unless such attendance would be inconsistent with commitments that SVI has provided to the Federal
Reserve in connection with the transaction) in a nonvoting, nonparticipating observer capacity. The Observer shall not have any
right to vote on any matter presented to the Board of Directors or the Bank Board or any committee thereof. The Company shall give
the Observer written notice of each meeting of the Board of Directors and the Bank Board at the same time and in the same manner
as the members of the Board of Directors or the Bank Board (as the case may be), shall provide the Observer with all written materials
and other information given to members of the Board of Directors or the Bank Board (as the case may be) at the same time such materials
and information are given to such members (provided, however, that the Observer shall not be provided any confidential supervisory
information) and shall permit the Observer to attend as an observer at all meetings thereof, and in the event the Company proposes
to take any action by written consent in lieu of a meeting, the Company shall give written notice thereof to the Observer prior
to the effective date of such consent describing the nature and substance of such action and including the proposed text of such
written consents provided, however, that (1) the Observer may be excluded from executive sessions comprised solely of independent
directors by the Chairman of the Board (or, if applicable, the lead or presiding independent director) if, in the written advice
of counsel, such exclusion is necessary in order for the Company to comply with applicable law, regulation or stock exchange listing
standards (it being understood that it is not expected that the Observer would be excluded from routine executive sessions), (2)
the Company, the Board of Directors, the Bank and the Bank Board shall have the right to withhold any information and to exclude
the Observer from any meeting or portion thereof if doing so is, in the written advice of counsel, (A) necessary to protect the
attorney-client privilege between such party and counsel, (B) necessary to avoid a violation of fiduciary requirements under applicable
law, or (C) necessary to avoid a violation of the Health Insurance Portability & Accountability Act of 1996, as amended, or
any similar law, and (3) SVI shall cause its Observer to agree to hold in confidence and trust and to act in a fiduciary manner
with respect to all information provided to such Observer (except to the extent that such information can be shown to have been
(1) previously known by such party on a nonconfidential basis, (2) in the public domain through no fault of such party, or (3)
later lawfully acquired from other sources by the party to which it was furnished). The Company also may exclude the Observer from
portions of meetings of the Board of Directors as well as the Bank Board to the extent that the Board of Directors or the Bank
Board, as the case may be, will, in any such portion thereof be discussing any matters related to SVI, the Transaction Documents,
or any of SVI’s rights or obligations under any of the Transaction Documents or any other matter that the Chairman of the
Board of Directors or the Chairman of the Bank Board determines in good faith is or may be adverse to the interests of SVI provided,
however, no matter shall be deemed to be adverse to the interests of SVI merely because such matter may adversely impact the price
of any of the Company’s Securities. SVI covenants and agrees to hold all information obtained from its Observer as provided
in the prior sentence in confidence to comply with all requirements and obligations applicable to members of the Board of Directors
under the Securities Act, the Exchange Act, the Sarbanes Oxley Act of 2002 and all other Laws, in each case, only to the extent
(if at all) applicable to the Observer. If SVI and its Affiliates in the aggregate no longer have a Minimum Ownership Interest,
SVI will have no further rights under this Section 1.

 

    	 	K-1	 

     

    

Exhibit 10.1

 

2. Governing Law. This Side Letter
Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in accordance with the laws
of the State of New York without giving effect to principles of conflicts of laws.

3. Conflicting Terms. This Side
Letter Agreement constitutes a valid and binding agreement of the Company and SVI and shall survive the execution and delivery
of the Purchase Agreement. In the event of any conflict between the provisions of this Side Letter Agreement and the provisions
of the Purchase Agreement, the provisions of this Side Letter Agreement shall prevail and be given effect.

4. Counterparts. This Side Letter
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same
effect as if all parties had signed the same document. All such counterparts will be deemed an original, will be construed together
and will constitute one and the same instrument.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	 	K-2	 

     

    

Exhibit 10.1

 

IN WITNESS WHEREOF, the parties have executed
this Side Letter Agreement as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

STRATEGIC VALUE INVESTORS,
LP

 

	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page to SVI Side Letter]

 

    	 

     

    

Exhibit 10.1

 

ARTICLES OF AMENDMENT

TO THE

ARTICLES OF INCORPORATION

OF

HCSB FINANCIAL CORPORATION

 

In accordance with Sections 33-6-102
and 33-10-106 of the South Carolina Business Corporation Act of 1988 (the “Code”), HCSB Financial Corporation
(the “Corporation”), a corporation organized and existing under and by virtue of the Code, does hereby certify:

 

1.      The name of the Corporation is HCSB Financial Corporation.

 

2.      Date of Incorporation: March 15, 1999.

 

3.      Agent’s Name and Address:  James R. Clarkson,
5201 Broad Street, Loris, South Carolina 29569.

 

4.      On [•], 2016, the Corporation adopted the following
Amendment to its Article Three of its Articles of Incorporation, as set forth in the following Certificates of Designations:

 

Certificate of Designations of Series A Convertible Perpetual
Preferred Stock attached hereto

 

Such amendment does thereby designate, create, authorize
and provide for the issue of a series of preferred stock, having $0.01 par value per share, which shall be designated as Series
A Convertible Perpetual Preferred Stock, having the voting powers, preferences and relative, participating, optional and other
special rights, and qualifications, limitations and restrictions thereof set forth on the Certificate of Designations attached
hereto and made a part hereof.

 

5.      Such amendment was duly authorized by the Board of
Directors and shareholder action was not required, pursuant to the authority granted in the Corporation’s Amended and Restated
Articles of Incorporation and Section 33-6-102 of the Code.

 

6.      The effective date of these Articles of Amendment shall
be [•]:00 am on [•], 2016 in accordance with the provisions of Section 33-1-230 of the Code.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	 	L-1	 

     

    
Exhibit 10.1

 

IN WITNESS WHEREOF, the undersigned,
being duly authorized thereto, does hereby affirm, under penalties of perjury, that this certificate is the act and deed of the
Corporation and that the facts herein stated are true, and accordingly has hereunto set his hand this as of the [•] day
of [•], 2016.

 

 

	 	HCSB FINANCIAL CORPORATION
	 	 
	 	 
	 	By:	 
	 	Name:  
	 	Title:  

 

 

    	 	L-2	 

     

    
Exhibit 10.1

 

CERTIFICATE OF DESIGNATIONS

OF

SERIES A CONVERTIBLE PERPETUAL PREFERRED
STOCK

OF

HCSB FINANCIAL CORPORATION

 

Pursuant to the provisions of the articles
of incorporation and the bylaws of the Corporation and applicable law, a series of preferred stock, $0.01 par value per share,
of the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:

 

1. Definitions.

 

(a) “Affiliate”
has the meaning set forth in 12 C.F.R. § 225.2(a) or any successor provision.

 

(b) “Articles of
Incorporation” means the Articles of Incorporation of the Corporation, as amended and in effect from time and time.

 

(c) “Board
of Directors” means the board of directors of the Corporation.

 

(d) A “business day”
means any day other than a Saturday or a Sunday or a day on which banks in South Carolina are authorized or required by law, executive
order or regulation to close.

 

(e) “Certificate”
means a certificate representing one (1) or more shares of Series A Preferred Stock.

 

(f) “Common Stock”
means the voting common stock of the Corporation, $0.01 par value per share.

 

(g) “Conversion” has the meaning
set forth in Section 5.

 

(h) “Conversion Date”
means the date that a share of Series A Preferred Stock is converted into Common Stock in accordance with Section 5.

 

(i) “Corporation” means HCSB
Financial Corporation, a South Carolina corporation.

 

(j) “Dividends”
has the meaning set forth in Section 3.

 

(k) “Exchange Agent”
means Broadridge Financial Services, Inc. solely in its capacity as transfer and exchange agent for the Corporation, or any successor
transfer and exchange agent for the Corporation.

 

(l) “Liquidation
Distribution” has the meaning set forth in Section 4.

 

(m) “Mandatory Conversion
Date” means, with respect to shares of Series A Preferred Stock of any and all holders thereof, the Shareholder Approval
Date.

 

(n) “New Capital
Requirements” has the meaning set forth in Section 19.

 

    	 	L-3	 

     

    
Exhibit 10.1

 

(o) “Non-Voting Common
Stock” means, if authorized by all necessary action on the part of the Corporation, a class of common equity of the Corporation
containing terms substantially as set forth in Annex A to these Articles of Amendment.

 

(p) “Permissible
Transfer” means a transfer by the holder of Series A Preferred Stock (i) to the Corporation; (ii) in a widely distributed
public offering of Common Stock or Series A Preferred Stock; (iii) that is part of an offering that is not a widely distributed
public offering of Common Stock or Series A Preferred Stock but is one in which no one transferee (or group of associated transferees)
acquires the rights to receive two percent (2%) or more of any class of the Voting Securities of the Corporation then outstanding
(including pursuant to a related series of transfers); (iv) that is part of a transfer of Common Stock or Series A Preferred Stock
to an underwriter for the purpose of conducting a widely distributed public offering; (v) to a transferee that controls more than
50 percent (50%) of the Voting Securities of the Corporation without giving effect to such transfer; or (vi) that is part of a
transaction approved by the Board of Governors of the Federal Reserve System (the “Federal Reserve”).

 

(q) “Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization, or any other form of entity not specifically listed herein.

 

(r) “Series A Preferred
Stock” has the meaning set forth in Section 2.

 

(s) “Shareholder
Approval Date” means the date that the Corporation shall have obtained shareholder approval in the manner required by
the South Carolina Business Corporation Act for an amendment to the Articles of Incorporation to authorize a class of Non-Voting
Common Stock in an amount of shares sufficient to permit the full conversion of the Series A Preferred Stock into shares of Non-Voting
Common Stock.

 

(t) “Voting Security”
has the meaning set forth in 12 C.F.R. § 225.2(q) or any successor provision.

 

2. Designation; Number of Shares.
The series of shares of Preferred Stock hereby authorized shall be designated the “Series A Convertible Perpetual Preferred
Stock” (the “Series A Preferred Stock”). The initial number of authorized shares of the Series A Preferred
Stock shall be 660,000 shares. The Series A Preferred Stock shall have $0.01 par value per share. Each share of Series A Preferred
Stock has the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends,
qualifications, or terms or conditions of redemption as described herein. Each share of Series A Preferred Stock is identical in
all respects to every other share of Series A Preferred Stock.

 

3. Dividends. The Series A Preferred
Stock will rank pari passu with the Common Stock with respect to the payment of dividends or distributions, whether payable
in cash, securities, options or other property, and with respect to issuance, grant or sale of any rights to purchase stock, warrants,
securities or other property (collectively, the “Dividends”) on a pro rata basis with the Common Stock determined
on an as-converted basis assuming all shares had been converted pursuant to Section 5 as of immediately prior to the record date
of the applicable Dividend (or if no record date is fixed, the date as of which the record holders of Common Stock entitled to
such Dividends are to be determined). Accordingly, the holders of record of Series A Preferred Stock will be entitled to receive
as, when, and if declared by the Board of Directors, Dividends in the same per share amount as paid on the number of shares of
Common Stock with respect to the number of shares of Common Stock into which the shares of Series A Preferred Stock would be converted,
and no Dividends will be payable on the Common Stock or any other class or series of capital stock ranking with respect to Dividends
pari passu with the Common Stock unless a Dividend identical to that paid on the Common Stock is payable at the same time
on the Series A Preferred Stock in an amount per share of Series A Preferred Stock equal to the product of (i) the per share Dividend
declared and paid in respect of each share of Common Stock and (ii) the number of shares of Common Stock into which such share
of Series A Preferred Stock is then convertible (without regard to any limitations on conversion of the Series A Preferred Stock);
provided however, that if a stock Dividend is declared on Common Stock payable solely in Common Stock, the holders of Series
A Preferred Stock will be entitled to a stock Dividend payable solely in shares of Series A Preferred Stock. Dividends that are
payable on Series A Preferred Stock will be payable to the holders of record of Series A Preferred Stock as they appear on the
stock register of the Corporation on the applicable record date, as determined by the Board of Directors, which record date will
be the same as the record date for the equivalent Dividend of the Common Stock. In the event that the Board of Directors does not
declare or pay any Dividends with respect to shares of Common Stock, then the holders of Series A Preferred Stock will have no
right to receive any Dividends.

 

    	 	L-4	 

     

    
Exhibit 10.1

 

4. Liquidation.

 

(a) Rank. The Series
A Preferred Stock will, with respect to rights upon liquidation, winding up and dissolution, rank (i) subordinate and junior in
right of payment to all other securities of the Corporation which, by their respective terms, are senior to the Series A Preferred
Stock or the Common Stock, and (ii) pari passu with the Common Stock pro rata on an as-converted basis. Not in limitation
of anything contained herein, and for purposes of clarity, the Series A Preferred Stock is subordinated to the general creditors
and subordinated debt holders of the Company, and the depositors of the Company’s bank subsidiaries, in any receivership,
insolvency, liquidation or similar proceeding.

 

(b) Liquidation Distributions.
In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary,
holders of Series A Preferred Stock will be entitled to receive, for each share of Series A Preferred Stock, out of the assets
of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation,
subject to the rights of any Persons to whom the Series A Preferred Stock is subordinate, a distribution (“Liquidation
Distribution”) equal to (i) any authorized and declared, but unpaid, Dividends with respect to such share of Series
A Preferred Stock at the time of such liquidation, dissolution or winding up, and (ii) the amount the holder of such share of Series
A Preferred Stock would receive in respect of such share if such share had been converted into shares of Common Stock at the then
applicable conversion rate at the time of such liquidation, dissolution or winding up (assuming the conversion of all shares of
Series A Preferred Stock at such time, without regard to any limitations on conversion of the Series A Preferred Stock). All Liquidating
Distributions to the holders of the Series A Preferred Stock and Common Stock set forth in clause (ii) above will be made pro rata
to the holders thereof.

 

(c) Merger, Consolidation
and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with any
other corporation or other entity, including a merger or consolidation in which the holders of Series A Preferred Stock receive
cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or property) of all or
substantially all of the assets of the Corporation, will not constitute a liquidation, dissolution or winding up of the Corporation.

 

5. Conversion.

 

(a) General.

 

		(i)	Unless the shares of Series A Preferred Stock shall have previously been converted into shares
of Non-Voting Common Stock pursuant to Section 5(a)(iii), a holder of Series A Preferred Stock shall be permitted to convert, or
upon the written request of the Corporation shall convert, shares of Series A Preferred Stock into shares of Common Stock at any
time or from time to time, provided that upon such conversion the holder, together with all Affiliates of the holder, will not
own or control in the aggregate more than 9.9% of the Common Stock (or of any class of Voting Securities issued by the Corporation),
excluding for the purpose of this calculation any reduction in ownership resulting from transfers by such holder of Voting Securities
of the Corporation (which, for the avoidance of doubt, does not include Series A Preferred Stock). In any such conversion, each
share of Series A Preferred Stock will convert initially into one hundred (100) shares of Common Stock, subject to adjustment as
provided in Section 6 below.

 

    	 	L-5	 

     

    
Exhibit 10.1

 

 

		(ii)	Unless the shares of Series A Preferred Stock shall have previously been converted into shares
of Non-Voting Common Stock pursuant to Section 5(a)(iii), each share of Series A Preferred Stock will automatically convert into
one hundred (100) shares of Common Stock, without any further action on the part of any holder, subject to adjustment as provided
in Section 6, below, on the date a holder of Series A Preferred Stock transfers any shares of Series A Preferred Stock to a non-affiliate
of the holder in a Permissible Transfer.

 

		(iii)	Effective as of the close of business on the Mandatory Conversion Date, each share of Series A
Preferred Stock will automatically convert into one hundred (100) shares of Non-Voting Common Stock, without any further action
on the part of any holder.

 

		(iv)	To effect any permitted conversion under Section 5(a)(i) or Section 5(a)(ii), the holder shall
surrender the certificate or certificates evidencing such shares of Series A Preferred Stock, duly endorsed, at the registered
office of the Corporation, and provide written instructions to the Corporation as to the number of whole shares for which such
conversion shall be effected, together with any appropriate documentation that may be reasonably required by the Corporation. Upon
the surrender of such certificate(s), the Corporation will issue and deliver to such holder (in the case of a conversion under
Section 5(a)(i)) or such holder’s transferee (in the case of a conversion under Section 5(a)(ii)) a certificate or certificates
for the number of shares of Common Stock into which the Series A Preferred Stock has been converted and, in the event that such
conversion is with respect to some, but not all, of the holder’s shares of Series A Preferred Stock, the Corporation shall
deliver to such holder a certificate or certificate(s) representing the number of shares of Series A Preferred Stock that were
not converted to Common Stock or Non-Voting Common Stock.

 

		(v)	Upon occurrence of the Mandatory Conversion Date, the Corporation shall promptly provide notice
of such event and the resulting conversion of the Series A Preferred Stock to each registered holder of the Series A Preferred
Stock. Such notice shall provide instructions for the surrender to the Corporation of certificates for shares of Series A Preferred
Stock held of record by such holders for issuance of certificates representing shares of Non-Voting Common Stock into which the
Series A Preferred Stock have been converted pursuant to Section 5(a)(iii).

 

		(vi)	All shares of Common Stock or Non-Voting Common Stock delivered upon conversion of the Series A
Preferred Stock shall be duly authorized, validly issued, fully paid and non- assessable, free and clear of all liens, claims,
security interests, charges and other encumbrances.

 

    	 	L-6	 

     

    
Exhibit 10.1

 

(b) Reservation of Shares
Issuable Upon Conversion. The Corporation will at all times reserve and keep available out of its authorized but unissued Common
Stock and Non-Voting Common Stock solely for the purpose of effecting the conversion of the Series A Preferred Stock such number
of shares of Common Stock or Non-Voting Common Stock as will from time to time be sufficient to effect the conversion of all outstanding
Series A Preferred Stock; and if at any time the number of shares of authorized but unissued Common Stock or Non-Voting Common
Stock will not be sufficient to effect the conversion of all then outstanding Series A Preferred Stock, the Corporation will take
such action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued Common Stock or Non-Voting
Common Stock to such number of shares as will be sufficient for such purpose.

 

(c) No Impairment.
The Corporation will not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the
carrying out of all the provisions of this Section 5 and in the taking of all such actions as may be necessary or appropriate in
order to protect the conversion rights of the holders of the Series A Preferred Stock against impairment.

 

6. Adjustments.

 

(a) Combinations or Divisions
of Common Stock. In the event that the Corporation at any time or from time to time will effect a division of the Common Stock
into a greater number of shares (by stock split, reclassification or otherwise other than by payment of a Dividend in Common Stock
or in any right to acquire the Common Stock), or in the event the outstanding Common Stock will be combined or consolidated, by
reclassification, reverse stock split or otherwise, into a lesser number of shares of the Common Stock, then the dividend, liquidation,
and conversion rights of each share of Series A Preferred Stock in effect immediately prior to such event will, concurrently with
the effectiveness of such event, be proportionately decreased or increased, as appropriate.

 

(b) Reclassification, Exchange
or Substitution. If the Common Stock is changed into the same or a different number of shares of any other class or classes
of stock, whether by capital reorganization, reclassification or otherwise (other than a division or combination of shares provided
for in 6(a) above), (1) the conversion ratio then in effect will, concurrently with the effectiveness of such transaction, be adjusted
so that each share of the Series A Preferred Stock will be convertible into, in lieu of the number of shares of Common Stock which
the holders of the Series A Preferred Stock would otherwise have been entitled to receive, a number of shares of such other class
or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a
share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which
such share of Series A Preferred Stock is then convertible (without regard to any limitations on conversion of the Series A Preferred
Stock) immediately before that transaction and (2) the Dividend and Liquidation Distribution rights then in effect will, concurrently
with the effectiveness of such transaction, be adjusted so that each share of Series A Preferred Stock will be entitled to a Dividend
and Liquidation Distribution right, in lieu of with respect to the number of shares of Common Stock which the holders of the Series
A Preferred Stock would otherwise have been entitled to receive, with respect to a number of shares of such other class or classes
of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common
Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Series
A Preferred Stock is then convertible (without regard to any limitations on conversion of the Series A Preferred Stock) immediately
before that transaction.

 

    	 	L-7	 

     

    
Exhibit 10.1

 

(c) Certificates as to
Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 6, the Corporation at its expense
will promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder
of Series A Preferred Stock a certificate executed by the Corporation’s President (or other appropriate officer) setting
forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The
Corporation will, upon the written request at any time of any holder of Series A Preferred Stock, furnish or cause to be furnished
to such holder a like certificate setting forth (i) such adjustments and readjustments, and (ii) the number of shares of Common
Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Series A Preferred
Stock.

 

7. Reorganization, Mergers, Consolidations
or Sales of Assets. If at any time or from time to time there will be a capital reorganization of the Common Stock (other than
a subdivision, combination, reclassification or exchange of shares otherwise provided for in Section 6) or a merger or consolidation
of the Corporation with or into another corporation, or the sale of all or substantially all the Corporation’s properties
and assets to any other Person, then, as a part of such reorganization, merger, consolidation or sale, provision will be made so
that the holders of the Series A Preferred Stock will thereafter be entitled to receive upon conversion of the Series A Preferred
Stock, the number of shares of stock or other securities or property of the Corporation, or of the successor company resulting
from such merger or consolidation or sale, to which a holder of that number of shares of Common Stock deliverable upon conversion
of the Series A Preferred Stock would have been entitled to receive on such capital reorganization, merger, consolidation or sale
(without regard to any limitations on conversion of the Series A Preferred Stock).

 

8. Redemption. Except to the
extent a liquidation under Section 4 may be deemed to be a redemption, the Series A Preferred Stock will not be redeemable at the
option of the Corporation or any holder of Series A Preferred Stock at any time. Notwithstanding the foregoing, the Corporation
will not be prohibited from repurchasing or otherwise acquiring shares of Series A Preferred Stock in voluntary transactions with
the holders thereof, subject to compliance with any applicable legal or regulatory requirements, including applicable regulatory
capital requirements. Any shares of Series A Preferred Stock repurchased or otherwise acquired may be cancelled by the Corporation
and thereafter be reissued as shares of any series of preferred stock of the Corporation.

 

9. Voting Rights. The holders
of Series A Preferred Stock will not have any voting rights, except as may otherwise from time to time be required by law. If the
holders of Series A Preferred Stock shall be entitled by law to vote as a single class with the holders of outstanding shares of
Common Stock, with respect to any and all matters presented to the shareholders of the Corporation for their action or consideration
(by vote or written consent), each share of Series A Preferred Stock shall be entitled to a number of votes equal to the number
of shares of Common Stock into which such share is convertible pursuant to Section 5.

 

10. Protective Provisions. So
long as any shares of Series A Preferred Stock are issued and outstanding, the Corporation will not (including by means of merger,
consolidation or otherwise), without obtaining the approval (by vote or written consent) of the holders of a majority of the issued
and outstanding shares of Series A Preferred Stock, (i) alter or change the rights, preferences, privileges or restrictions provided
for the benefit of the holders of the Series A Preferred Stock, (ii) increase or decrease the authorized number of shares of Series
A Preferred Stock or (iii) enter into any agreement, merger or business consolidation, or engage in any other transaction, or take
any action that would have the effect of changing any preference or any relative or other right provided for the benefit of the
holders of the Series A Preferred Stock. In the event that the Corporation offers to repurchase shares of Common Stock, the Corporation
shall offer to repurchase shares of Series A Preferred Stock pro rata based upon the number of shares of Common Stock such holders
would be entitled to receive if such shares were converted into shares of Common Stock immediately prior to such repurchase.

 

    	 	L-8	 

     

    
Exhibit 10.1

 

11. Notices. All notices required
or permitted to be given by the Corporation with respect to the Series A Preferred Stock shall be in writing, and if delivered
by first class United States mail, postage prepaid, to the holders of the Series A Preferred Stock at their last addresses as they
shall appear upon the books of the Corporation, shall be conclusively presumed to have been duly given, whether or not the holder
actually receives such notice; provided, however, that failure to duly give such notice by mail, or any defect in such notice,
to the holders of any stock designated for repurchase, shall not affect the validity of the proceedings for the repurchase of any
other shares of Series A Preferred Stock, or of any other matter required to be presented for the approval of the holders of the
Series A Preferred Stock.

 

12. Record Holders. To the fullest
extent permitted by law, the Corporation will be entitled to recognize the record holder of any share of Series A Preferred Stock
as the true and lawful owner thereof for all purposes and will not be bound to recognize any equitable or other claim to or interest
in such share or shares on the part of any other Person, whether or not it will have express or other notice thereof.

 

13. Term. The Series A Preferred
Stock shall have perpetual term unless converted in accordance with Section 5.

 

14. No Preemptive Rights. The
holders of Series A Preferred Stock are not entitled to any preemptive or preferential right to purchase or subscribe for any capital
stock, obligations, warrants or other securities or rights of the Corporation, except for any such rights that may be granted by
way of separate contract or agreement to one or more holders of Series A Preferred Stock.

 

15. Replacement Certificates.
In the event that any Certificate will have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the
Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Corporation, the posting by such Person
of a bond in such amount as the Corporation may determine is necessary as indemnity against any claim that may be made against
it with respect to such Certificate, the Corporation or the Exchange Agent, as applicable, will deliver in exchange for such lost,
stolen or destroyed Certificate a replacement Certificate.

 

16. Other Rights. The shares
of Series A Preferred Stock have no preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends,
qualifications, or rights, other than as set forth herein or as provided by applicable law.

 

17. No Implied Limitations. Nothing
herein shall limit, by inference or otherwise, the discretionary right of the Board of Directors to divide any or all of the shares
of any preferred or special classes into series and, within the limitations set forth in applicable South Carolina law, to fix
and determine the relative rights and preferences of the shares of any series so established, to the full extent provided in the
Articles of Incorporation of the Corporation.

 

18. General Provisions. In addition
to the above provisions with respect to the Series A Preferred Stock, such Series A Preferred Stock shall be subject to, and entitled
to the benefits of, the provisions set forth in the Corporation’s Articles of Incorporation with respect to preferred stock
generally.

 

    	 	L-9	 

     

    
Exhibit 10.1

 

Annex A

 

Form of Articles of Amendment

Establishing a Class of Non-Voting Common Stock

 

The shares of Non-Voting Common Stock
of the Corporation into which the Series A Preferred Stock shall be mandatorily convertible upon the taking by the Corporation
of all action necessary under the South Carolina Business Corporation Act to authorize a class of Non-Voting Common Stock shall
have the following terms and provisions:

 

ARTICLES OF AMENDMENT

TO THE

ARTICLES OF INCORPORATION

OF

HCSB FINANCIAL CORPORATION

 

 

NON-VOTING COMMON STOCK

 

1. Definitions.

 

			(a) “Affiliate” has the meaning set forth in 12 C.F.R. § 225.2(a) or any
successor provision.

 

			(b) “Articles of Incorporation” means the Articles of Incorporation of the Corporation,
as amended and in effect from time and time.

 

			(c) “Board of Directors” means the board of directors of the Corporation.

 

			(d) A “business day” means any day other than a Saturday or a Sunday or a day
on which banks in the South Carolina are authorized or required by law, executive order or regulation to close.

 

			(e) “Certificate” means a certificate representing one (1) or more shares of
Non-Voting Common Stock.

 

			(f) “Common Stock” means the voting common stock of the Corporation, $0.01 par
value per share.

 

			(g) “Conversion” has the meaning set forth in Section 5.

 

			(h) “Conversion Date” means the date that a share of Non-Voting Common Stock
is converted into Common Stock in accordance with Section 5.

 

			(i) “Corporation” means HCSB Financial Corporation, a South Carolina corporation.

 

			(j) “Dividends” has the meaning set forth in Section 3.

 

			(k) “Exchange Agent” means Broadridge Financial Services, Inc. solely in its
capacity as transfer and exchange agent for the Corporation, or any successor transfer and exchange agent for the Corporation.

 

			(l) “Liquidation Distribution” has the meaning set forth in Section 4.

 

    	 	L-10	 

     

    
Exhibit 10.1

 

 

			(m) “Mandatory Conversion Date” means, with respect to shares of Series A Preferred
Stock of any and all holders thereof, the Shareholder Approval Date.

 

			(n) “Non-Voting Common Stock” has the meaning set forth in Section 2.

 

			(o) “Permissible Transfer” means a transfer by the holder of Non-Voting Common
Stock (i) to the Corporation; (ii) in a widely distributed public offering of Common Stock or Non-Voting Common Stock; (iii) that
is part of an offering that is not a widely distributed public offering of Common Stock or Non-Voting Common Stock but is one in
which no one transferee (or group of associated transferees) acquires the rights to receive two percent (2%) or more of any class
of the Voting Securities of the Corporation then outstanding (including pursuant to a related series of transfers); (iv) that is
part of a transfer of Common Stock or Non-Voting Common Stock to an underwriter for the purpose of conducting a widely distributed
public offering; (v) to a transferee that controls more than 50 percent (50%) of the Voting Securities of the Corporation without
giving effect to such transfer; or (vi) that is part of a transaction approved by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”).

 

			(p) “Person” means an individual, corporation, partnership, limited liability
company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization,
or any other form of entity not specifically listed herein.

 

			(q) “Series A Preferred Stock” means the series of shares of preferred stock
of the Corporation designated as “Series A Convertible Perpetual Preferred Stock” which were automatically converted
into shares of Non-Voting Common Stock on the Mandatory Conversion Date.

 

			(r) “Shareholder Approval Date” means the date of shareholder approval of an
amendment to the Articles of Incorporation authorizing a class of Non-Voting Common Stock in an amount of shares sufficient to
permit the full conversion of the Series A Preferred Stock into shares of Non-Voting Common Stock.

 

			(s) “Voting Security” has the meaning set forth in 12 C.F.R. § 225.2(q)
or any successor provision.

 

2. Designation; Number of Shares.
The class of shares of capital stock hereby authorized shall be designated as “Non-Voting Common Stock” (the “Non-Voting
Common Stock”). The number of authorized shares of the Non-Voting Common Stock shall be 66,000,000 shares. The Non-Voting
Common Stock shall have $0.01 par value per share. Each share of Non-Voting Common Stock has the designations, preferences, conversion
or other rights, voting powers, restrictions, limitations as to dividends, qualifications, or terms or conditions of redemption
as described herein. Each share of Non-Voting Common Stock is identical in all respects to every other share of Non-Voting Common
Stock.

 

3. Dividends. The Non-Voting
Common Stock will rank pari passu with the Common Stock with respect to the payment of dividends or distributions, whether
payable in cash, securities, options or other property, and with respect to issuance, grant or sale of any rights to purchase stock,
warrants, securities or other property (collectively, the “Dividends”). Accordingly, the holders of record of
Non-Voting Common Stock will be entitled to receive as, when, and if declared by the Board of Directors, Dividends in the same
per share amount as paid on the Common Stock, and no Dividends will be payable on the Common Stock or any other class or series
of capital stock ranking with respect to Dividends pari passu with the Common Stock unless a Dividend identical to that
paid on the Common Stock is payable at the same time on the Non-Voting Common Stock in an amount per share of Non-Voting Common
Stock equal to the product of (i) the per share Dividend declared and paid in respect of each share of Common Stock and (ii) the
number of shares of Common Stock into which such share of Non-Voting Common Stock is then convertible (without regard to any limitations
on conversion of the Non-Voting Common Stock); provided however, that if a stock Dividend is declared on Common Stock payable
solely in Common Stock, the holders of Non-Voting Common Stock will be entitled to a stock Dividend payable solely in shares of
Non-Voting Common Stock. Dividends that are payable on Non-Voting Common Stock will be payable to the holders of record of Non-Voting
Common Stock as they appear on the stock register of the Corporation on the applicable record date, as determined by the Board
of Directors, which record date will be the same as the record date for the equivalent Dividend of the Common Stock. In the event
that the Board of Directors does not declare or pay any Dividends with respect to shares of Common Stock, then the holders of Non-Voting
Common Stock will have no right to receive any Dividends.

 

    	 	L-11	 

     

    
Exhibit 10.1

 

4. Liquidation.

 

(a) Rank. The Non-Voting Common
Stock will, with respect to rights upon liquidation, winding up and dissolution, rank (i) subordinate and junior in right of payment
to all other securities of the Corporation which, by their respective terms, are senior to the Non-Voting Common Stock or the Common
Stock, and (ii) pari passu with the Common Stock. Not in limitation of anything contained herein, and for purposes of clarity,
the Non-Voting Common Stock is subordinated to the general creditors and subordinated debt holders of the Company, and the depositors
of the Company’s bank subsidiaries, in any receivership, insolvency, liquidation or similar proceeding.

 

(b) Liquidation Distributions.
In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary,
holders of Non-Voting Common Stock will be entitled to receive, for each share of Non-Voting Common Stock, out of the assets of
the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation,
subject to the rights of any Persons to whom the Non-Voting Common Stock is subordinate, a distribution (“Liquidation
Distribution”) equal to (i) any authorized and declared, but unpaid, Dividends with respect to such share of Non-Voting
Common Stock at the time of such liquidation, dissolution or winding up, and (ii) the amount the holder of such share of Non-Voting
Common Stock would receive in respect of such share if such share had been converted into shares of Common Stock at the then applicable
conversion rate at the time of such liquidation, dissolution or winding up (assuming the conversion of all shares of Non-Voting
Common Stock at such time, without regard to any limitations on conversion of the Non-Voting Common Stock). All Liquidating Distributions
to the holders of the Non-Voting Common Stock and Common Stock set forth in clause (ii) above will be made pro rata to the holders
thereof.

 

(c) Merger, Consolidation and Sale
of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with any other corporation
or other entity, including a merger or consolidation in which the holders of Non-Voting Common Stock receive cash, securities or
other property for their shares, or the sale, lease or exchange (for cash, securities or property) of all or substantially all
of the assets of the Corporation, will not constitute a liquidation, dissolution or winding up of the Corporation.

 

5. Conversion.

 

(a) General.

 

(i)      A holder of Non-Voting Common
Stock shall be permitted to convert, or upon the written request of the Corporation shall convert, shares of Non-Voting Common
Stock into shares of Common Stock at any time or from time to time, provided that upon such conversion the holder, together with
all Affiliates of the holder, will not own or control in the aggregate more than 9.9% of the Common Stock (or of any class of Voting
Securities issued by the Corporation), excluding for the purpose of this calculation any reduction in ownership resulting from
transfers by such holder of Voting Securities of the Corporation (which, for the avoidance of doubt, does not include Non-Voting
Common Stock). In any such conversion, each share of Non-Voting Common Stock will convert initially into one (1) share of Common
Stock, subject to adjustment as provided in Section 6 below.

 

    	 	L-12	 

     

    
Exhibit 10.1

 

(ii)      Each share of Non-Voting Common
Stock will automatically convert into one (1) share of Common Stock, without any further action on the part of any holder, subject
to adjustment as provided in Section 6 below, on the date a holder of Non-Voting Common Stock transfers any shares of Non-Voting
Common Stock to a non-affiliate of the holder in a Permissible Transfer.

 

(iii)      To effect any permitted conversion
under Section 5(a)(i) or Section 5(a)(ii), the holder shall surrender the certificate or certificates evidencing such shares of
Non-Voting Common Stock, duly endorsed, at the registered office of the Corporation, and provide written instructions to the Corporation
as to the number of whole shares for which such conversion shall be effected, together with any appropriate documentation that
may be reasonably required by the Corporation. Upon the surrender of such certificate(s), the Corporation will issue and deliver
to such holder (in the case of a conversion under Section 5(a)(i)) or such holder’s transferee (in the case of a conversion
under Section 5(a)(ii)) a certificate or certificates for the number of shares of Common Stock into which the Non-Voting Common
Stock has been converted and, in the event that such conversion is with respect to some, but not all, of the holder’s shares
of Non-Voting Common Stock, the Corporation shall deliver to such holder a certificate or certificate(s) representing the number
of shares of Non-Voting Common Stock that were not converted to Common Stock.

 

(iv)      All shares of Common Stock delivered
upon conversion of the Non-Voting Common Stock shall be duly authorized, validly issued, fully paid and non- assessable, free and
clear of all liens, claims, security interests, charges and other encumbrances.

 

(b) Reservation of Shares Issuable
Upon Conversion. The Corporation will at all times reserve and keep available out of its authorized but unissued Common Stock
solely for the purpose of effecting the conversion of the Non-Voting Common Stock such number of shares of Common Stock as will
from time to time be sufficient to effect the conversion of all outstanding Non-Voting Common Stock; and if at any time the number
of shares of authorized but unissued Common Stock will not be sufficient to effect the conversion of all then outstanding Non-Voting
Common Stock, the Corporation will take such action as may, in the opinion of its counsel, be necessary to increase its authorized
but unissued Common Stock to such number of shares as will be sufficient for such purpose.

 

(c) No Impairment. The Corporation
will not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the carrying
out of all the provisions of this Section 5 and in the taking of all such actions as may be necessary or appropriate in order to
protect the conversion rights of the holders of the Non-Voting Common Stock against impairment.

 

    	 	L-13	 

     

    
Exhibit 10.1

 

6. Adjustments.

 

(a) Combinations or Divisions of
Common Stock. In the event that the Corporation at any time or from time to time will effect a division of the Common Stock
into a greater number of shares (by stock split, reclassification or otherwise other than by payment of a Dividend in Common Stock
or in any right to acquire the Common Stock), or in the event the outstanding Common Stock will be combined or consolidated, by
reclassification, reverse stock split or otherwise, into a lesser number of shares of the Common Stock, then the dividend, liquidation,
and conversion rights of each share of Non-Voting Common Stock in effect immediately prior to such event will, concurrently with
the effectiveness of such event, be proportionately decreased or increased, as appropriate.

 

(b) Reclassification, Exchange or
Substitution. If the Common Stock is changed into the same or a different number of shares of any other class or classes of
stock, whether by capital reorganization, reclassification or otherwise (other than a division or combination of shares provided
for in 6(a) above), (1) the conversion ratio then in effect will, concurrently with the effectiveness of such transaction, be adjusted
so that each share of the Non-Voting Common Stock will be convertible into, in lieu of the number of shares of Common Stock which
the holders of the Non-Voting Common Stock would otherwise have been entitled to receive, a number of shares of such other class
or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a
share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which
such share of Non-Voting Common Stock is then convertible (without regard to any limitations on conversion of the Non-Voting Common
Stock) immediately before that transaction and (2) the Dividend and Liquidation Distribution rights then in effect will, concurrently
with the effectiveness of such transaction, be adjusted so that each share of Non-Voting Common Stock will be entitled to a Dividend
and Liquidation Distribution right, in lieu of with respect to the number of shares of Common Stock which the holders of the Non-Voting
Common Stock would otherwise have been entitled to receive, with respect to a number of shares of such other class or classes of
stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common
Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Non-Voting
Common Stock is then convertible (without regard to any limitations on conversion of the Non-Voting Common Stock) immediately before
that transaction.

 

(c) Certificates as to Adjustments.
Upon the occurrence of each adjustment or readjustment pursuant to this Section 6, the Corporation at its expense will promptly
compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Non-Voting
Common Stock a certificate executed by the Corporation’s President (or other appropriate officer) setting forth such adjustment
or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation will, upon
the written request at any time of any holder of Non-Voting Common Stock, furnish or cause to be furnished to such holder a like
certificate setting forth (i) such adjustments and readjustments, and (ii) the number of shares of Common Stock and the amount,
if any, of other property which at the time would be received upon the conversion of the Non-Voting Common Stock.

 

7. Reorganization, Mergers, Consolidations
or Sales of Assets. If at any time or from time to time there will be a capital reorganization of the Common Stock (other than
a subdivision, combination, reclassification or exchange of shares otherwise provided for in Section 6) or a merger or consolidation
of the Corporation with or into another corporation, or the sale of all or substantially all the Corporation’s properties
and assets to any other Person, then, as a part of such reorganization, merger, consolidation or sale, provision will be made so
that the holders of the Non-Voting Common Stock will thereafter be entitled to receive upon conversion of the Non-Voting Common
Stock, the number of shares of stock or other securities or property of the Corporation, or of the successor company resulting
from such merger or consolidation or sale, to which a holder of that number of shares of Common Stock deliverable upon conversion
of the Non-Voting Common Stock would have been entitled to receive on such capital reorganization, merger, consolidation or sale
(without regard to any limitations on conversion of the Non-Voting Common Stock).

 

8. Redemption. Except to the
extent a liquidation under Section 4 may be deemed to be a redemption, the Non-Voting Common Stock will not be redeemable at the
option of the Corporation or any holder of Non-Voting Common Stock at any time. Notwithstanding the foregoing, the Corporation
will not be prohibited from repurchasing or otherwise acquiring shares of Non-Voting Common Stock in voluntary transactions with
the holders thereof, subject to compliance with any applicable legal or regulatory requirements, including applicable regulatory
capital requirements. Any shares of Non-Voting Common Stock repurchased or otherwise acquired may be reissued as additional shares
of Non-Voting Common Stock.

 

    	 	L-14	 

     

    
Exhibit 10.1

 

9. Voting Rights. The holders
of Non-Voting Common Stock will not have any voting rights, except as may otherwise from time to time be required by law.

 

10. Protective Provisions. So
long as any shares of Non-Voting Common Stock are issued and outstanding, the Corporation will not (including by means of merger,
consolidation or otherwise), without obtaining the approval (by vote or written consent) of the holders of a majority of the issued
and outstanding shares of Non-Voting Common Stock, (i) alter or change the rights, preferences, privileges or restrictions provided
for the benefit of the holders of the Non-Voting Common Stock, (ii) increase or decrease the authorized number of shares of Non-Voting
Common Stock or (iii) enter into any agreement, merger or business consolidation, or engage in any other transaction, or take any
action that would have the effect of changing any preference or any relative or other right provided for the benefit of the holders
of the Non-Voting Common Stock. In the event that the Corporation offers to repurchase shares of Common Stock, the Corporation
shall offer to repurchase shares of Non-Voting Common Stock pro rata based upon the number of shares of Common Stock such holders
would be entitled to receive if such shares were converted into shares of Common Stock immediately prior to such repurchase.

 

11. Notices. All notices required
or permitted to be given by the Corporation with respect to the Non-Voting Common Stock shall be in writing, and if delivered by
first class United States mail, postage prepaid, to the holders of the Non-Voting Common Stock at their last addresses as they
shall appear upon the books of the Corporation, shall be conclusively presumed to have been duly given, whether or not the holder
actually receives such notice; provided, however, that failure to duly give such notice by mail, or any defect in such notice,
to the holders of any stock designated for repurchase, shall not affect the validity of the proceedings for the repurchase of any
other shares of Non-Voting Common Stock, or of any other matter required to be presented for the approval of the holders of the
Non-Voting Common Stock.

 

12. Record Holders. To the fullest
extent permitted by law, the Corporation will be entitled to recognize the record holder of any share of Non-Voting Common Stock
as the true and lawful owner thereof for all purposes and will not be bound to recognize any equitable or other claim to or interest
in such share or shares on the part of any other Person, whether or not it will have express or other notice thereof.

 

13. Term. The Non-Voting Common
Stock shall have perpetual term unless converted in accordance with Section 5.

 

14. No Preemptive Rights. The
holders of Non-Voting Common Stock are not entitled to any preemptive or preferential right to purchase or subscribe for any capital
stock, obligations, warrants or other securities or rights of the Corporation, except for any such rights that may be granted by
way of separate contract or agreement to one or more holders of Non-Voting Common Stock.

 

15. Replacement Certificates.
In the event that any Certificate will have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the
Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Corporation, the posting by such Person
of a bond in such amount as the Corporation may determine is necessary as indemnity against any claim that may be made against
it with respect to such Certificate, the Corporation or the Exchange Agent, as applicable, will deliver in exchange for such lost,
stolen or destroyed Certificate a replacement Certificate.

 

16. Other Rights. The shares
of Non-Voting Common Stock have no preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends,
qualifications, or rights, other than as set forth herein or as provided by applicable law.

 

    	 	L-15	 

     

    

Exhibit 10.1

 

EXHIBIT M

Form of Transferee Letter

 

[●], 2016

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

      RE:       Purchase of ___ shares of _________ Stock of HCSB Financial
Corporation (the             “Purchased Shares”)

 

Ladies and Gentlemen:

 

I acknowledge that the Company has valuable
NOL carry-forwards the use of which would be limited if the Company were to experience an “ownership change” under
Section 382 of the Internal Revenue Code, and accordingly, I hereby certify that, following this purchase of the Purchased Shares,
either:

 

_____ I will not be a 5% Shareholder of the
Company;

 

_____ I am or pursuant to this transfer will
become a 5% Shareholder of the Company, but the Company has delivered a letter to the Transfer Agent stating that my attainment
of 5% Shareholder status will not jeopardize or endanger the Company's utilization of the Tax Benefits or is otherwise in the best
interests of the Company; or

 

_____ I do not meet either of the foregoing
qualifications, and I acknowledge that my acquisition of the Purchased Shares may cause a material and irreparable economic harm
to the Company and the value of the Purchase Shares that I am acquiring.

 

For purposes of this letter, the following definitions
shall apply:

 

“5% Shareholder” means (i) a Person
or group of Persons that is a “5-percent shareholder” of the Company pursuant to Treasury Regulation Section 1.382-2T(g)
or (ii) a Person that is a “first tier entity” or “higher tier entity” (as such terms are defined in Treasury
Regulation Section 1.382-2T(f)) of the Company if that Person has a “public group” or individual, or a “higher
tier entity” of that Person has a “public group” or individual, that is treated as a “5-percent shareholder”
of the Company pursuant to Treasury Regulation Section 1.382-2T(g).

 

“Person” means any individual, firm,
corporation, partnership, trust association, limited liability company, limited liability partnership, governmental entity, or
other entity, or any group of Persons making a “coordinated acquisition” of shares or otherwise treated as an entity
within the meaning of Treasury Regulation Section 1.382-3(a)(1)(i) and shall include any successor (by merger or otherwise) of
any such entity.

 

“Section 382” means Section 382
of the Code, or any comparable successor provision.

 

“Subsidiary” of any Person means
any other Person of which securities or other ownership interests having ordinary voting power, in the absence of contingencies,
to elect a majority of the board of directors or other Persons performing similar functions are at the time directly or indirectly
owned by such first Person.

 

    	 	M-1	 

     

    

Exhibit 10.1

 

“Tax Benefits” means the net operating
loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum tax credit carryovers and foreign
tax credit carryovers, as well as any loss or deduction attributable to a “net unrealized built-in loss” within the
meaning of Section 382, of

the Company or any of its Subsidiaries.      

 

“Treasury Regulation” means any
final, proposed or temporary regulation of the Department of Treasury under the Code and any successor regulation.

 

In connection with the matters described above,
I acknowledge that the Company is relying on the statements made herein.

 

	 	Very truly yours, 
	 	 	 	 
	 	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

    	 	M-2	 

     

    

Exhibit 10.1

 

EXHIBIT N

Form of Prior Notice Letter

 

HCSB Financial Corporation

5009 Broad Street

Loris, SC 29569

 

[●], 2016

 

To Purchaser Named Below

 

Ladies and Gentlemen:

 

Reference is made to that certain Stock Purchase
Agreement, dated as March 2, 2016 (the “Purchase Agreement”), between HCSB Financial Corporation, a South Carolina
corporation (the “Company”), and the purchasers identified on the signature pages thereto (the “Purchasers”).
In connection with the execution and delivery of the Purchase Agreement, the Company and the Purchasers are contemporaneously entering
into this agreement (the “Prior Notice Letter Agreement”) and, as such, the parties hereto acknowledge and agree that
this Prior Notice Letter Agreement shall remain in full force and effect until the third anniversary of the Closing, notwithstanding
the execution and delivery of the Purchase Agreement. Capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms in the Purchase Agreement.

 

The Company and the undersigned Purchaser hereby
agree as follows:

 

      1.      The Company has valuable NOL carry-forwards the use of
which would be limited if the Company were to experience an “ownership change” under Section 382 of the Internal Revenue
Code. Accordingly, until the third anniversary of the Closing, the undersigned Purchaser agrees to consult with the Company at
least 10 days prior to any proposed purchase or sale of Shares regarding the potential adverse tax impact that the purchase or
sale could have on the NOLs and, if requested by the Company, to provide to the other party to the proposed purchase or sale any
disclosure prepared by the Company describing the potential adverse tax impact.

 

      2.      The
undersigned Purchaser further acknowledges that the Company will place a legend similar to the following on each of the stock
certificates issued in connection with the offering to ensure that a prospective transferee is aware of this notice requirement:

 

UNTIL THE THIRD ANNIVERSARY OF THE ISSUANCE
OF THE SHARES REPRESENTED BY THIS CERTIFICATE, THE HOLDER OF THIS CERTIFICATE MUST COMPLY WITH THE NOTICE REQUIREMENT SET FORTH
IN THE APPLICABLE SUBSCRIPTION AGREEMENT PRIOR TO ANY PURCHASE OR SALE OF SHARES.

 

      3.      The undersigned Purchaser further acknowledges that any
attempted transfer in violation of the notice requirement set forth in Section 4.1(d) of the Purchase Agreement and otherwise acknowledged
herein shall not be valid and binding upon the Company, and the Company shall be entitled to refuse to register the name of any
transferee of such Shares as a shareholder of the Company on its records if the transfer of such Shares was effected without compliance
with these provisions. Notwithstanding the foregoing, the Company shall have the right to waive this prior notice requirement for
any reason in its sole discretion.

 

    	 	N-1	 

     

    

Exhibit 10.1

 

      4.       This
Prior Notice Letter Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in accordance
with the laws of the State of Delaware without giving effect to principles of conflicts of laws.

 

      5.       This
Prior Notice Letter Agreement constitutes a valid and binding agreement of the Company and the undersigned Purchaser and shall
survive the execution and delivery of the Purchase Agreement. In the event of any conflict between the provisions of this Prior
Notice Letter Agreement and the provisions of the Purchase Agreement, the provisions of this Prior Notice Agreement shall prevail
and be given effect.

 

      6.       This
Prior Notice Letter Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts,
with the same effect as if all parties had signed the same document. All such counterparts will be deemed an original, will be
construed together and will constitute one and the same instrument.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	N-2	 

     

    

Exhibit 10.1

 

      IN WITNESS WHEREOF, the parties have executed
this Prior Notice Letter as of the date first above written.

 

	 	HCSB FINANCIAL CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 	 
	 	 	Title: 	 	 

 

Agreed and acknowledged as of the date first above written:

 

 

 

	By:	 	 
	 	Name: 	 	 
	 	Title: 	 	 

 

[Signature Page to Prior Notice Letter]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]